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Editorial
Tuberculosis in Pakistan: A decade of progress, a future of challenge
Sten H. Vermund,1 Arshad Altaf,2 Rab Nawaz Samo,3 Rafiq Khanani,4 Noor Baloch,5 Ejaz Qadeer,5 Sharaf Ali Shah,3,4
Institute of Global Health and Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee-USA,1 Canada-Pakistan
HIV/AIDS Surveillance Project, Sindh AIDS Control Programme, Karachi-Pakistan,2 BRIDGE Consultants Foundation, Karachi-Pakistan,3 Dow
University of Health Sciences, Karachi-Pakistan,4 National TB Control Program, Ministry of Health, Islamabad-Pakistan.5

Tuberculosis (TB) is a major public health problem in
Pakistan. TB has been prevalent in Pakistan and unfortunately
it has been one of the neglected health areas in the past.
Pakistan ranks 8th amongst the countries with highest burden
of TB in the world. Pakistan contributes about 44% of
tuberculosis burden in the Eastern Mediterranean Region.
According to the World Health Organization (WHO), the
incidence of sputum positive TB cases in Pakistan is
80/100,000 per year and for all types it is 177/100,000. TB is
responsible for 5.1 percent of the total national disease burden
in Pakistan. The impact of TB on socio economic status is
substantial.1 The National TB Control Program, is
responsiable for developing national guidelines, framing
policies and generating resources for implementation of TB
control measures at Provincial and district level. The DOTS
was adopted as National Stretegy in 2000 and expanded to all
public health facilities as part of primary health care. The
Program was success ful in achieving 70 % case detection and
85 % treatment outcome of the global target set by STOP TB
Partnership. Despite rapid expansion and consolidation of TB
care there are still many issues related to TB Control. The
disease is directly linked with socioeconomic status and 75 %
patients are in productive age group.
Many patients consult untrained practitioners in the
informal health sector with delays in diagnoses. Suboptimal
case detection and treatment, lead to failure in acvhieving
program target goals. This special supplement of the Journal
of the Pakistan Medical Association presents several peerreviewed papers originally published elsewhere2-27 that we
have assembled to provide an update on key issues of the
Pakistani TB situation. In addition, there are three28-30 original
articles in this issue to stimulate debate as to how TB control
and prevention can be revitalized in Pakistan.

Origin of this special issue
It is easier to make research results readily available to
persons who need them now in the internet age. Nonetheless,
there are many health professionals in Pakistan who do not
have reliable access to the worldwide web. If a health
professional or worker has a computer with excellent internet
access, HINARI (http://www.who.int/hinari/en/) is a WHOsponsored system that enables journal article access free-ofcharge from computer networks in lower income countries.
S-1

The PubMed system is used worldwide to read abstracts and
increasingly has full reference access thanks to the PubMed
Central system (http://www.ncbi.nlm.nih.gov/PubMed/) and
liberalization of access by some journals, particular on-line
journals. If someone does not have good internet access, but
has
a
computer,
eGranery
(http://www.widernet.org/digitallibrary/ ) is an effort to bring
global resources to an intra-net, rather than inter-net, i.e., one
can access it from a local computer network without being
logged onto the internet. This is important for institutions and
individuals with computers whose internet access may be
limited by availability, cost, or the low band width so familiar
in many lower-income settings. However, for someone with
no or limited computer access, there is still a need for a
special supplement like this one to reach a diverse audience
of front line service providers.
Many Pakistani researchers have overcome obstacles,
both scientific and other, to make important contributions to
TB research. Many are cited here, but space and costs
prohibited accommodation of all eligible references. Hence,
we provide a comprehensive list of 218 articles at the end of
this editorial which is title "Special Bibliography", found in a
PubMed search from 1997 through 3 December 2008. They
include human-related articles published in English that came
from searching "Pakistan AND tuberculosis". We have
reproduced 26 papers selected from 1998-2007 in this special
issue.2-26 They are all original manuscripts. We hope that this
will inspire government leaders and donors to recognize the
research talent and opportunity in the nation, as well as the
research need.
For this special issue, only Index Medicus-referenced
articles were selected, with a priority given to those with
public health importance focusing on pertinent issues in
Pakistan. Thanks to the generosity of many publishers listed
below, we were able to reproduce the publications of these key
TB studies from Pakistan without cost, thereby increasing the
convenience of their access to readers of the JPMA. There
were a few articles which could not be included because
publishers required a processing fee to reprint their articles;
we preferred to devote our limited budget to purchase and
distributions of additional copies of the supplement. We
believe that the publishers demanding fees should reconsider
these policies to permit free reproduction of articles for
J Pak Med Assoc (Suppl. 1)

legitimate purposes in the developing country where the
research was conducted.
This supplemental issue seeks to reach practicing
physicians, policy makers, health care managers, senior
nurses, microbiologists, medical researchers, university
faculty and students, and public health staff in Pakistan. We
believe that an earlier analogous supplement met a similar
need in the HIV/AIDS field.

Infrastructure and Tuberculosis Management
Challenges in Pakistan
The WHO directly observed therapy-short course
(DOTS) strategy was implemented in Pakistan in year 2001. It
took four years to bring DOTS coverage to all public health
facilities (by mid-2005), and the country remains far behind
the global targets of case detection rate of 70% and treatment
success rate of 85%. Among the important challenges for TB
control in Pakistan are a lack of community involvement,
limited engagement of the private sector, increasing number of
multiple drug-resistant (MDR) cases and a recent rise in HIV
cases among injection drug users who are also at much higher
risk of TB.30 We anticipate an increased burden of TB-HIV coinfection and continuing rise in the proportion of MDR-TB
cases, unless there is aggressive intervention.
Pakistan spends a relatively small proportion of its
gross domestic product (GDP) on health. In 2000, Pakistan
spent 0.8% of GDP, lower than investments by its south Asian
neighbors: India, 0.7%; Bangladesh, 1.7%; Nepal, 1.2%; Sri
Lanka, 1.5%.31,32 All are far below such nations as the United
States with its 9.7% GDP investment in health in 2003.33 Low
health expenditures correlate with high military investments.
Pakistan spent 22% of its total governmental budget on
defense in 2000.34 Medical and public health research
investments are exceedingly low in Pakistan. The overall low
governmental commitment to the health sector results in the
particular neglect of prevention, as curative services command
the lion's share of these scarce resources.
The articles in this special issue identify these specific
needs of the Pakistani national TB control program:

1. ENGAGE THE PRIVATE SECTOR
A significant proportion of patients seek medical
advice from private sector, including formal and informal
sectors. Given the magnitude of the TB problem, the role of
the private sector cannot be underestimated. The importance
of private health care providers has also been recognized by
the Stop TB Partnership with its emphasis on integrating
private health care providers into DOTS strategy efforts. Wellorganized educational efforts and logistical support to private
sector health care providers can make it easier for them to
follow standard TB control guidelines (both DOTS and
Vol. 59, No. 4 (Suppl. 1), April 2009

DOTS-Plus for MDR-TB).35 We had success in upgrading the
syndromic management of sexually transmitted diseases by
private providers in the informal sector in one Karachi study,
but the government did not expand (or even continue) this
model program.36

2. DRUG MANAGEMENT AND LOGISTICS
Proper anti-TB drug management is an essential
component for success of TB DOTS strategy.37 Frequent
stock-outs of TB drugs and diagnostic supplies at first level
care facilities are major impediments to the TB case detection
and treatment, fueling incidence and MDR-TB.38 The stock
management systems at the central and district levels are weak
such that distribution of TB drugs is far less reliable than
distribution of most private sector products (e.g., petrol for
autos and trucks, soft drinks, commercial goods).37 Effective
drug supply systems, inventory managment, methods of drug
quality assurance, and proper use of anti-TB drugs by
practitioners is essential.

3. SPECIAL FACILITIES
Targeted programs must engage prisons, jails,
HIV/STD programs, specific high-risk occupational groups,
illicit drug users, and persons living on the street. Links to
community services are essential for persons leaving
incarceration.

4. OPERATIONS RESEARCH
Operations research (OR) is necessary to address
issues like now-uncontrolled private sector activities, poor
management of defaulters, and lack of community
involvement.39 Field-based research at the community level is
essential to better identify problems from patient, provider,
and policy-maker perspectives; solutions to improve program
utilization can then be much better informed.35

5. MDR-TB and TB/HIV
MDR-TB and TB/HIV are the emerging health issues
in Pakistan and a great challenge to public health sector. In
Pakistan, there is a lack of technical expertise in both areas.
MDR-TB (through DOTS-Plus) and TB/HIV (via programme
coordination and communication) are now identified as one of
the challenges in broadening the activities of the National TB
Programme beyond basic DOTS.40
These issues are very familiar to experts in TB, but
may not be familiar to the diverse readership of the JPMA.

Role of future research in the fight against TB
in Pakistan
We are confident that research will play a vital role in
the fight against TB. We need answers to many questions:
S-2

u

How should primary, asymptomatic TB be
diagnosed and managed with high background BCG usage
rates (complicating diagnosis) and INH resistance levels
(complicating treatment)? Will isoniazid preventive therapy
be appropriate or are alternatives needed?

J Pak Med Assoc. 2005 Jan;55(1):17-9.
9.

Rao NA, Sadiq MA. Recent Trends in the Radiological Presentation of
Pulmonary Tuberculosis in Pakistani Adults. J Pak Med Assoc. 2002
Nov;52(11):501-3.

10.

Israr SM. Is Ministry of Health fully prepared to implement an effective DOTS
program in Pakistan? An operations research on TB control program in the public
health sector in Sindh. J Pak Med Assoc. 2003 Aug;53(8):324-7.

11.

Rao NA. New drugs in resistant tuberculosis. J Pak Med Assoc. 2007
May;57(5):252-6.

12.

Ahmed M, Aziz S. Pattern of tuberculosis in general practice. J Pak Med Assoc.
1998 Jun;48(6):183-4.

13.

De Muynck A, Siddiqi S, Ghaffar A, Sadiq H. Tuberculosis control in Pakistan:
critical analysis of its implementation. J Pak Med Assoc. 2001 Jan;51(1):41-7.

14.

Liefooghe R, Muynck AD. The dynamics of tuberculosis treatment adherence. J
Pak Med Assoc. 2001 Jan;51(1):3-9.

15.

Aziz S, Lodi T, Alam SE. BCG scar survey in Karachi schools. J Pak Med Assoc.
1994 Jan;44(1):17.

16.

Irfan S, Hassan Q, Hasan R. Assessment of resistance in multi drug resistant
tuberculosis patients. J Pak Med Assoc. 2006 Sep;56(9):397-400.

17.

Shah SK, Sadiq H, Khalil M, Noor A, Rasheed G, Shah SM, Ahmad N. Do
private doctors follow national guidelines for managing pulmonary tuberculosis
in Pakistan? East Mediterr Health J. 2003 Jul;9(4):776-88.

18.

Agboatwalla M, Kazi GN, Shah SK, Tariq M. Gender perspectives on
knowledge and practices regarding tuberculosis in urban and rural areas in
Pakistan. East Mediterr Health J. 2003 Jul;9(4):732-40.

How can Pakistan's politicians and powerful
business leaders be influenced to invest more into health?

19.

Shah SA, Mujeeb SA, Mirza A, Nabi KG, Siddiqui Q. Prevalence of pulmonary
tuberculosis in Karachi juvenile jail, Pakistan. East Mediterr Health J. 2003
Jul;9(4):667-74.

These and many other questions remain unanswered
for Pakistan, suggesting an urgent need for research, even as
we seek to improve programs. Implementation science is a
term for the work needed to increase coverage of programs
that we already have in place.41 Operations research is a
component of implementation science that uses program
process and outcome data in a feedback loop to improve
program functioning. The guest editors are pleased that
original articles have been provided for this special
supplement and that publishers permitted reproduction of
papers that we felt to be especially salient. We think they
represent, in aggregate, a call-to-arms in the fight against TB
in Pakistan.

20.

Rathi SK, Akhtar S, Rahbar MH, Azam SI. Prevalence and risk factors associated
with tuberculin skin test positivity among household contacts of smear-positive
pulnionary tuberculosis cases in Umerkot, Pakistan. Int J Tuberc Lung Dis. 2002
Oct;6(10):851-7.

21.

Ali NS, Hussain SF, Azam SI. Is there a value of mantoux test and erythrocyte
sedimentation rate in pre-employment screening of health care workers for
tuberculosis in a high prevalence country? Int J Tuberc Lung Dis. 2002
Nov;6(11):1012-6.

22.

Alvi AR, Hussain SF, Shah MA, Khalida M, Shamsudin M. Prevalence of
pulmonary tuberculosis on the roof of the world. Int J Tuberc Lung Dis. 1998
Nov;2(11):909-13.

23.

Khan N, Mian I, Zia-Ullah , Muhammad J. Performance of ICT-TB test in the
detection of pulmonary and extra-pulmonary tuberculosis. J Ayub Med Coll
Abbottabad. 2004 Apr-Jun;16(2):55-6.

24.

Khan JA, Akbani F, Malik A, Kazi GN, Aslam F, Hussain SF. Effect of providing
free sputum microscopy service to private practitioners on case notification to
National Tuberculosis Control Program. J Ayub Med Coll Abbottabad. 2005 OctDec;17(4):31-5.

25.

Ibrahim KM, Khan S, Laaser U. Tuberculosis control: current status, challenges
and barriers ahead in 22 high endemic countries. J Ayub Med Coll Abbottabad.
2002 Oct-Dec;14(4):11-5.

26.

Yasmeen N, Kanjee A. Cutaneous tuberculosis: a three year prospective study. J
Pak Med Assoc. 2005 Jan;55(1):10-2.

27.

Hasan Z, Tanveer M, Kanji A, Hasan Q, Ghebremichael S, Hasan R.
Spoligotyping of Mycobacterium tuberculosis isolates from Pakistan reveals
predominance of Central Asian Strain 1 and Beijing isolates. J Clin Microbiol.
2006 May;44(5):1763-8.

28.

Ghiyas Ahmad, Qadeer Ejaz, Noor Ahmad, R Fatima, Z Khursheed. Defaulting
Rate of TB Patients among Seasonal Migrants: A Case Study of Balochistan.

u
What strategies will work to maximize DOTS
coverage, given Pakistani logistical challenges? Can we
succeed in rural areas, including areas of civil strife, through
community engagement?
u

How do we optimize HIV and TB diagnosis and
care, including program integration to enable simpler care
logistics from a patient's point of view?
u
Can we do better than the classic sputum
examination to diagnose TB to diagnose TB? What is the most
suitable resistance assay, given limitations in laboratories,
especially in rural areas?
u What programs work best and why? What programs
work most poorly and why?
u
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Abstract

pulmonary TB cases.

Study Population and Setting: Household contacts of
acid-fast bacilli (AFB) sputum smear-positive
tuberculosis patients in the Umerkot Taluka, Sindh,
Pakistan.

Key Words: Mycobacterium tuberculosis; tuberculin skin
test; household contact; cross-sectional study; risk factors;
Pakistan.

Objective: To estimate the prevalence of and identify risk
factors associated with tuberculin skin test (TST)
positivity among household contacts of acid-fast bacilli
(AFB) sputum smear-positive pulmonary tuberculosis
cases.
Design: A cross-sectional study of household contacts of
AFB sputum smear-positive tuberculosis cases, registered at
the Umerkot Anti-Tuberculosis Association clinic from
August 1999 to September 1999. The contact's
Mycobacterium tuberculosis infection status was assessed
using TST. On the day of the TST, a predesigned
questionnaire was administered to collect data on putative
risk factors for TST positivity among contacts. The data
were analysed using a marginal logistic regression model by
the method of generalised estimating equations (GEE) to
determine risk factors independently associated with TST
positivity.
Results: The prevalence of TST positivity among
household contacts of AFB sputum smear-positive index
patients was 49.4%. The final multivariate GEE model
showed that contact's age and sleeping site relative to the
index case, the intensity of the index case's AFB
sputumsmear positivity and the contact's BCG scar status
were independent predictors of TST positivity among
household contacts of AFB sputum smear-positive index
cases.
Conclusions: The results suggest that the household
contacts of AFB sputum smear-positive tuberculosis
patients in a poor neighbourhood of rural Sindh had a
high prevalence of M. tuberculosis infection as
determined by TST. Poor housing conditions seem to
contribute to the spread of M. tuberculosis infection.
Early diagnosis of pulmonary TB through evaluation of
TST-positive household contacts, followed by
appropriate therapy, may prevent further spread of M.
tuberculosis infection. We recommend an awareness
programme to prevent household contacts from
acquiring M. tuberculosis infection from smear-positive
S-9

Introduction
Tuberculosis (TB) is one of the leading causes of
mortality, accounting for 26% of preventable adult deaths
in the developing world.1,2 An estimated onethird of the
world's population (1.86 million) is infected with
Mycobacterium tuberculosis, and during the last decade
the incidence of tuberculous infection has increased even
in industrialised countries.3 Varying levels of endemicity
of tuberculous infection have been reported worldwide,
and South-east Asia seems to be the most afflicted: 44%
of its population is reported to be M. tuberculosis
infected.3 Pakistan has been ranked fifth among the 22
highest-incidence countries of TB.3
Screening of high-risk populations for M.
tuberculosis infection to identify individuals eligible for
chemoprophylaxis is one of the strategies recommended
to combat TB.4,5 Contacts of TB cases constitute a highrisk group for acquiring M. tuberculosis infection,6,7 as
approximately 30% of close contacts demonstrate
evidence of infection, and at least half of infected
contacts exhibit progression to disease in the first 2
years.8 So far, only a limited number of studies have
evaluated the risk factors associated with acquiring M.
tuberculosis infection among household contacts of
index TB cases in other parts of the world.9-12 However,
comparable data on the frequency of tuberculous
infection among household contacts of index TB patients
are not available for Pakistan and other neighbouring
countries. The magnitude and the predominant risk
factors for M. tuberculosis infection among contacts of
TB patients, particularly in rural areas of Pakistan, are
uncertain. Furthermore, for primary prevention sound
scientific knowledge about such risk factors is a
prerequisite for suggesting preventive measures. We
therefore conducted the present study to estimate the
prevalence and identify the risk factors for tuberculin
skin test (TST) positivity among household contacts of
acid-fast bacilli (AFB) smear-positive index cases of
pulmonary TB in Umerkot, a rural area of Sindh
J Pak Med Assoc (Suppl. 1)

province, Pakistan.

power of at least 80%.17

Study Population and Methods

To select household contacts of index TB patients, a
list of 680 TB cases maintained at UATA clinic was
obtained and used to select a simple random sample of 77
index cases. Using the Ziehl-Neelsen staining method,18
each selected TB case was screened for AFB in three
sputum samples, one on the spot and two on two
consecutive days in the early morning. If a TB case turned
out to be AFB smear-positive on at least one sputum smear,
that case was enrolled as an index case and interviewed. If
a registered TB case turned out to be AFB sputum smearnegative or declined to participate in the study, then the next
TB case in the list was contacted and the screening
procedure conducted.

Study design, setting and study population
A cross-sectional study was conducted in August and
September 1999 in Umerkot, a remote district of Sindh
covering an area of 5608 km2 with a population of around
0.7 million, 83% of whom live in rural areas.
Topographically the Umerkot district has two distinct partsthe irrigated area in the north-west and rain-fed desert in the
south-east. Agriculture is the main occupation in the area.
About 57% of the housing units are single room houses with
an average household size of 5.4 persons. The Muslim
population constitutes 51% of the district's total population,
and about 90% of the people speak Sindhi.13
Our study site, the Umerkot Taluka, an
administrative sub-unit of Umerkot district, has a
population of about 0.3 million. The local health care
system is comprised of a government health centre, a
clinic-Umerkot
nongovernmental
organisation
Antituberculosis Association (UATA) clinic-and about 20
private clinics. TB control is provided for most patients of
this study area by UATA clinic. The majority of patients are
diagnosed and treated as out-patients.
Our study population was comprised of household
contacts of index TB patients in Umerkot Taluka. An index
TB case was defined as the first member of a household
aged 15 years or more who presented and registered for TB
treatment at the UATA clinic and was found positive on at
least one AFB sputum smear. The initial TB diagnosis in an
index case at UATA clinic is based on a combination of two
or more methods including TST, radiography, AFB sputum
smear status and bacterial culture.9,14 A household contact
was defined as any person over 3 months of age who had
lived in the same house as the index case for at least 3
months and had slept in the same house for on average at
least 4 nights per week, throughout this 3- month period.15

Selection of index cases and household
contacts
The objectives of this study were to estimate the
prevalence and determine factors associated with TST
positivity among household contacts of index patients. For
the estimation of M. tuberculosis infection prevalence
among household contacts of index TB cases, we included
385 contacts of 77 index cases based on the following
assumptions: an estimated prevalence of TST positivity of
0.5 among contacts of TB cases, with a bound on error of
0.05 at a significance level of 0.05.16 This sample size was
also sufficient for identification of factors associated with
TST positivity, with an odds ratio (OR) _2 and a study
Vol. 59, No. 4 (Suppl. 1), April 2009

During the first household visit, verbal informed
consent was obtained from all persons aged 12 years or
more and from the parents of household contacts less than
12 years of age who fulfilled our contact definition. The
study protocol was reviewed and approved by the
departmental ethical review committee.

Tuberculin skin test and data collection
In addition to the principal author, three medical
graduates (two male and one female) who had at least 2
years of experience in the field since graduation were
recruited for interview purposes. All were quite fluent in
Sindhi. The principal author briefed the team on the
interviewing process during a training session which
included obtaining the subject's consent, being polite and
considerate, using a standardised delivery of questions,
recording the responses and performing the TST.
A pre-designed and pre-tested questionnaire was
used to collect data on potential risk factors from the index
case and from household contacts. Information on
household level variables was collected from the head of
household or a representative on the day TST was
performed. For household contacts aged < 12 years, the
mother or guardian answered the questions on behalf of the
contact. Bacille Calmette-Guérin (BCG) vaccination status
was assessed by physical examination for the presence or
absence of BCG scar. However, vaccination records were
not available for most of the contacts for verification of
BCG vaccination history.
Household contacts of index cases were subjected to
TST using the Mantoux method, a recommended technique
for mass screening of M. tuberculosis infection in
epidemiological studies.19,20 It was performed on the volar
aspect of the forearm with 0.1 ml of Tubersol (purified
protein derivative [PPD] RT 23, 5 tuberculin units;
Connaught Laboratories, North York, Ontario, Canada).
Contacts were visited again 72 hours later to read the TST.
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During that visit any household contact who had not been
present on the first visit was also interviewed, subjected to
TST and revisited 72 hours later to read the result. NonBCGvaccinated household contacts of an index case were
considered M. tuberculosis infected if the skin induration
was > 10 mm at 72 hours post TST. For BCGvaccinated
household contacts, a cut-off value of > 15 mm at 72 hours
post TST was used as an indication of M. tuberculosis
infection, otherwise the contact was regarded as non-M.
tuberculosis-infected.20
The participation rate was nearly 100% when the
contacts were explained the benefits of TST and when it
was followed by appropriate free prophylactic or curative
TB therapy.

Statistical Analyses
Data were processed using software Epi-Info version
6.04 (CDC, Atlanta, GA, USA). All the analyses were
performed using SAS software (SAS Inc, Cary, NC, USA).
The summary statistics were generated by computing means
(±SD) for continuous variables and frequencies for
categorical variables. We used generalised estimating
equations (GEEs) to arrive at a marginal multivariate
logistic regression model predicting positive M.
tuberculosis infection status as detected by TST. The GEE
corrects for correlation and lack of independence of
responses for contacts with an index TB case in common
(clusters within households) using quasi likelihood methods
and robust variance estimators. Univariate GEE analyses
were carried out to evaluate each variable of interest for its
unadjusted association with the infection status of contacts.
A multivariate GEE model was then used to estimate the
independent effect of each variable on the infection status of
the contact. All independent variables significantly (P <
0.1) related to an outcome variable in univariate analyses
were considered for inclusion in the multivariate GEE
model.21 The variables meeting the above selection criteria
were all entered in a multivariate model. We arrived at the
final model by the backward elimination method. The
adjusted ORs and their 95% confidence intervals (9%CIs)
were computed using the parameters' estimates of the final
GEE model and used for the interpretation of the results.

Table 1: Demographic characteristics of household contacts
of the smear-positive tuberculosis cases recorded during a
cross-sectional study of risk factors associated with tuberculin
skin test positivity among household contacts of index cases,
Umerkot, Pakistan, August–September 1999 (n=385)
Variables
Age of household contact
4 months–4 years
5–14 years
15–24 years
25 years
Sex
Male
Female
Education (years of schooling)
Nil
1–5
6–10
>10
Marital status
Never married
Ever married
BCG scar
Present
Absent
Relationship of contact with index case
Husband
Wife
Child
Sibling
Father
Mother
Grandparent
Uncle/aunt
Others

n (%)

68 (17.7)
83 (21.6)
103 (26.8)
130 (33.9)
205 (53.2)
180 (46.8)
277 (71.9)
36 (9.4)
45 (11.7)
27 (7.1)
236 (61.3)
149 (38.7)
57 (14.8)
327 (85.2)
28 (7.3)
34 (8.8)
184 (47.8)
23 (6.0)
8 (2.1)
8 (2.1)
1 (0.3)
2 (0.5)
97 (25.2)

with index case and BCG scar status is given in Table 2. In
general, the prevalence of M. tuberculosis infection was
higher among the contacts who were of male sex, had no
formal schooling, had never married, were children of index
patients, or who did not have a visible BCG scar. There was

Results
The means (±SD) and median number of contacts
per case interviewed and tested for TST positivity were
respectively 5.4 ± 3.1 and 4.0. The prevalence of M.
tuberculosis infection among household contacts was 49.4%
(95%CI 46.9-51.9%). Their demographic characteristics are
given in Table 1. The distribution of M. tuberculosis
infection status as assessed by TST positivity with respect to
age, sex, marital status, education, relationship of contact
S-11

Figure: Distribution of Mycobacterium tuberculosis-infected household contacts of acidfast bacilli smear-positive index patients by household size in Umerkot, Sindh, 1999.

J Pak Med Assoc (Suppl. 1)

Table 2 Univariate GEE analysis of risk factors from a cross-sectional study of TST positivity among household contacts of smear-positive
tuberculosis cases, Umerkot, Pakistan, August–September 1999 (n 360)*
Variables

Infected contacts‡ 179 (%)

Age of contact
4 months–4 years
14 (7.8)
39 (21.8)
5–14 years
15–24 years
46 (25.7)
80 (44.7)
25 years
Sex
Female
90 (47.4)
100 (52.6)
Male
Education
Illiterate†
142 (79.3)
37 (20.7)
Literate
Marital status
Ever married
87 (48.6)
Single
92 (51.4)
Relationship of contact with index case‡
41 (22.9)
Spouse
First degree
103 (57.5)
Second degree
35 (19.6)
BCG scar in contact
34 (19.0)
Present
145 (81.0)
Absent
Sleeping site relative to index case
Same bedroom
118 (65.9)
Different bedroom
61 (34.1)
Sharing of utensil with index case
130 (62.0)
Yes
47 (26.6)
No
Intensity of AFB sputum-smear positivity of index case
< ++
111 (62.0)
> ++
68 (38.0)

Non-infected contacts‡ 180 (%)

Odds ratio

95%CI

46 (25.6)
36 (20.0)
53 (29.4)
45 (25.0)

1.0
2.7
2.3
3.5

—
1.4–4.9
1.3–3.9
2.0–6.0

90 (46.4)
104 (53.6)

1.1
1.0

0.7–1.5
—

117 (65.0)
63 (35.0)

1.2
1.0

0.8–1.8
—

56 (31.1)
124 (68.9)

1.3
1.0

0.7–1.9
—

21 (11.7)
112 (62.2)
47 (26.1)

2.0
1.2
1.0

1.1–3.6
0.8–1.9
—

21 (11.7)
159 (88.3)

1.8
1.0

1.2–2.5
—

93 (51.7)
87 (48.3)

1.9
1.0

1.3–2.8
—

102 (58.0)
74 (42.0)

1.6
1.0

1.1–2.4
—

147 (81.7)
33 (18.3)

1.0
3.2

—
1.7–5.9

*A contact was considered to be M. tuberculosis infected if the skin induration was 10 mm without BCG vaccination and 15 mm with BCG vaccination at 72 hours post
tuberculin test; otherwise the contact was regarded as non-M. tuberculosis-infected.
† Illiterate: had no formal school education; literate: had one or more years of schooling.
‡ Relationship of contact with index case: spouse (husband or wife); first degree (child, sibling, and parents); second degree (uncle, aunt, brother-in-law, and sister-inlaw, others).
GEE = generalised estimating equations; TST = tuberculin skin testing; CI = confidence interval; AFB = acid-fast bacilli.

also a direct linear relationship between the household size
and the number of M. tuberculosis infected contacts
(Figure).
For further GEE analysis, contacts from household
size of nine or fewer were used. Six households of size 10
or more were dropped, as by their inclusion the GEE model
did not converge for parameter estimation owing to sparse
data. In the univariate analysis, factors associated with M.
tuberculosis infection status included contact age (P =
0.022), relationship with index case (P = 0.028), BCG scar
status (P = 0.003), sleeping site relative to index case (P <
0.001), sharing of utensils with index case (P = 0.026), and
intensity of AFB sputum smear positivity in the index case
(P = 0.002) (Table 2). No association was found between M.
tuberculosis infection status and the variables sex, marital
status and education.
The final multivariate GEE model (Table 3) revealed
that compared to non-infected contacts, M. tuberculosis
infected contacts were more likely to be older by 5 years or
Vol. 59, No. 4 (Suppl. 1), April 2009

Table 3 Multivariate GEE analysis results of risk factors for TST
positivity among household contacts of smear-positive tuberculosis
cases, Umerkot, Pakistan, August–September 1999 (n = 360)
Variables

Adjusted OR

95%CI

Age of household contact
4 months–4 years
1.0
—
3.0
1.6–5.8
5–14 years
15–24 years
4.9
2.4–10.0
25 years
6.7
3.5–12.8
Sleeping site relative to index case
Different bedroom
1.0
—
2.5
1.5–4.0
Same bedroom
Intensity of AFB sputum-smear positivity of index case*
1.0
—
< ++
1.6–4.8
2.8
< ++
BCG scar
1.0
—
Absent
Present
1.6
1.1–2.6

P value

0.001

0.0003

0.0003

0.0276

* Intensity of sputum-smear-positivity: + = 1–10 AFB in the whole slide; + + =
1–10 AFB per microscopic field (x 1000); + + + = more than 10 AFB per
microscopic field.
GEE = generalised estimating equations; TST = tuberculin skin test; OR = odds
ratio; CI confidence interval; AFB = acid-fast bacilli.

S-12

more (5-14 years vs. 4 months-4 years, adjusted OR 3.0,
95%CI 1.6-5.8; 15-24 years vs. 4 months-4 years, adjusted
OR 4.9, 95%CI 2.4-10.0; _25 years vs. 4 months-4 years,
adjusted OR 6.7, 95%CI 3.5-12.8), to have slept in the same
bedroom (adjusted OR 2.5, 95%CI 1.5-4.0), to have lived with
an index case with an AFB sputum smear positivity index of
2 or more (adjusted OR 2.8, 95%CI 1.6-4.8) or to have had a
visible BCG scar (adjusted OR 1.6, 95%CI: 1.1-2.6).

Discussion
This cross-sectional study demonstrated that in this
study population in Umerkot, Pakistan, 49.4% of household
contacts of smear-positive index TB cases were M.
tuberculosis infected as assessed by TST. To our knowledge
no similar data from the study area or other areas of
Pakistan are available for comparison. However,
comparable data on the prevalence of M. tuberculosis
infection among household contacts of index cases have
been reported from other countries. For example,
prevalences of M. tuberculosis infection among contacts of
TB patients of as high as 44% in Spain and 55% in Peru
have been reported.22-24 Also, in another study in an area
with high TB incidence, 34% of children under the age of 5
years living in the same household as an index TB case were
diseased and 14% were infected.25 Therefore, the results of
the present study corroborate the findings of previous
studies and show that contact with AFB sputum
smearpositive index case poses a substantially higher risk of
acquiring M. tuberculosis infection. We could not assess the
sputum smear status of the TST-positive contacts, but one
could speculate that considerable numbers of these could
have active TB and contribute to the continued spread of M.
tuberculosis infection in their households and in the
community.
Consistent with previous findings, a trend of
increasing odds of TST positivity with increasing age was
observed in this study.23 Plausible explanations for this
result may include the extended duration and frequency of
contacts with an index case and/or that contacts with
increasing age might have been exposed to other AFB
smear-positive TB cases in this neighbourhood with a high
burden of TB.
The intensity of sputum smear positivity of the index
case was associated with increased odds of TST positivity
of the contact in this study. It has previously been shown
that the number of contacts infected by a person with TB
also depends on the severity of disease in the index case,11
and on the number of organisms excreted in the sputum.26
In this study M. tuberculosis infected contacts were
significantly more likely than non-infected contacts to have
had slept in the same bedroom as the index case. This type
of behaviour seemed to result from over-crowding, as most
S-13

of the housing units in the study area are one bedroomed,
with an average household size of 5.4. The presence of BCG
scar in contacts was also associated with positive M.
tuberculosis infection status. BCG may induce crossreactions for a prolonged period after vaccination.27
However, the recommended cut-off value of > 15 mm skin
induration on TST was used as an indicator of M.
tuberculosis infection in the study. Furthermore, BCG
vaccination reportedly does not prevent infection but
protects against the consequences of infection.28 Recently, a
prevalence of M. tuberculosis infection of 7.5% among
those with BCG scar was reported in another Asian
population.29
Several limitations of our study need to be
acknowledged. Firstly, the study is limited by its crosssectional design, so temporality (cause-and-effect
relationship) can not be established. Second, the first
subject from a given household registered for treatment at
the UATA clinic was assumed to be the index case. We are,
however, uncertain whether this is indeed the first person to
be infected or whether it is a secondary contact of another
infected member in the household who exhibited disease
earlier than the other infected household member. Third,
after exposure to M. tuberculosis the ability of TST to detect
delayed type hypersensitivity reaction is on average 4-12
weeks.30 Therefore, some infected household contacts
might have been incubating M. tuberculosis but were not
detected by TST and were labelled as non-infected, thus
directing the results towards null. Fourth, the duration of
contact of each household member with the index case
could not be ascertained, since the exact dates of diagnosis
of M. tuberculosis infection in most of the index cases were
not available. Fifth, as all the index cases were AFB smearpositive, we cannot draw any inference regarding the risk of
M. tuberculosis transmission in the household of AFB
sputum smear-negative index cases. And finally, in this
study we could not assess the intra-observer and interobserver variability of reading the TST results. However,
we believe that such variation was probably minimal
because all the interviewers were medical graduates and
their training before the start of the actual study should have
given them sufficient experience to conduct TST and
objectively measure the results.
We could not evaluate whether or not index patients
were suffering from multidrug-resistant TB. The evaluation
of such TB patients and the treatment required should be
prioritised to help shrink the pool of infectious individuals.
Evaluation of TST-positive household contacts for the
presence of pulmonary TB, followed by prophylactic or
supervised therapy as appropriate, may contribute to the
prevention of further spread of M. tuberculosis infection.
We recommend an awareness programme for household
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contacts about the possibility of acquiring M. tuberculosis
infection from AFB sputum smear-positive pulmonary TB
cases. Future research may be focused on the evaluation of
intervention programmes aimed to improve the knowledge
and awareness of TB patients and their contacts about the
disease and its complications in this and other similar
settings.
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Is there a value of Mantoux test and erythrocyte sedimentation
rate in pre-employment screening of health care workers for tuberculosis
in a high prevalence country?
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Abstract
Setting: Pre-employment screening of health care workers
(HCWs) is practiced widely. Research needs to be carried
out to evaluate the screening procedure in developing
countries.
Objective: To evaluate the efficacy of Mantoux test and
erythrocyte sedimentation rate (ESR) for the diagnosis of
active tuberculosis (TB), in pre-employment screening of
HCWs, in a high prevalence country.
Design: Pre-employment screening of all new employees
was reviewed from June to September 2000. The
screening consisted of history, physical examination,
blood and urine tests, Mantoux test and a chest
radiograph. Patients with clinical, laboratory or
radiological features suggestive of active TB were
referred to a specialist.
Results: Out of 207 employees, a Mantoux reaction of >10
mm and ESR of >25 mm/first hour was noted in 90 (43.5%)
and 21 (10.1%), respectively. One person had symptoms
suggestive of TB and was already on anti-tuberculosis
therapy at the time of screening. All other employees were
asymptomatic. Based on radiographic findings, four (2%)
cases were referred and one was given anti-tuberculosis
therapy. An additional 48 (23.1%) employees were referred
on the basis of positive Mantoux or elevated ESR; none
were found to have active TB.
Conclusion: In high prevalence countries use of Mantoux
test and ESR in pre-employment screening of HCWs is not
recommended for detection of active TB.

Introduction
The last decade has seen an upsurge in the global
prevalence of tuberculosis (TB), including multidrugresistant (MDR) strains. Health care workers (HCWs) are at
high risk of acquiring the disease during the course of their
occupation, and once infected they can spread it further to
their patients.1 The Centers for Disease Control and
Prevention recommends regular skin testing and appropriate
follow-up care for all HCWs.2 Measures used in
industrialized countries to screen HCWs and to control
nosocomial TB transmission are beyond the resources of
low-income countries. Research needs to be carried out to
evaluate the feasibility and cost-effectiveness of measures
S-15

aimed at preventing TB transmission among workers in
high-risk settings.
Screening of HCWs at the time of employment is
practiced widely in order to identify asymptomatic cases.
Hospitals vary widely in their pre-employment screening
practices depending on resources, risk of nosocomial
transmission and prevalence of TB in the community. Third
world countries, where the risks are highest, unfortunately
have the least resources available to them. In a small study
from British Columbia, HCWs were not found to be at
increased risk of TB.3 In Africa, on the other hand, 79% of
512 HCWs in Abidjan had a tuberculin reaction of >10
mm.4 In Malawi, 3.6% of 3042 HCWs had active TB with a
case fatality rate of 24%, and compared with the general
population the relative risk (95% confidence interval [CI])
in HCWs of all types of TB was 11.9 (95%CI 9.8-14.4).5
Similarly, in Asia, the HCWs had a high rate of TB
infection.6
Pre-employment screening programmes for
HCWs are mostly developed in western countries, often
based on consensus among experts rather than clinical
evaluation, expensive, and may lack local relevance. The
aim of our study was to evaluate the efficacy of the
Mantoux test and erythrocyte sedimentation rate (ESR)
in pre-employment screening of HCWs for the diagnosis
of active TB.

Study Population and Methods
The study was conducted at the Aga Khan University
Hospital, a teaching hospital located in Karachi, Pakistan.
All employees referred for pre-employment screening over
a period of 4 months (June-September 2000) were
evaluated. Pre-employment screening consisted of history
and physical examination, blood hemoglobin and ESR
levels, detailed urine report, Mantoux test and a chest
radiograph. Patients with clinical or laboratory features
suggestive of active TB were referred to a specialist
(pulmonary physician). The outcome of the referral and
details of further investigations were recorded. The medical
records of all the screened employees were reviewed in
November 2001, after a follow-up period of 14-18 months,
to detect any new case of active TB that might have been
missed on initial screening.
The Mantoux test was administered as an
J Pak Med Assoc (Suppl. 1)

intradermal injection of 0.1 ml of purified protein derivative
(PPD) containing five tuberculin units. The injection was
given with a hypodermic needle into the anterior aspect of
the forearm to produce a bleb, and a circle was drawn
around it. The test was read after 72 hours by measuring the
induration and not the erythema. A result of 10 mm or more
was taken as positive.
The data were double entered and verified using EpiInfo Version 6.04 (CDC, Atlanta, GA). The analysis was
done using SPSS Version 10.0 (SPSS Inc, Chicago, IL).
Frequencies of individual variables and crosstabulation
between outcome variable and independent variables were
also performed. The mean distribution of variables was also
performed where appropriate.

Results
A total of 207 employees (52% males and 48%
females) were screened (Table). A history of bacille
Table: Characteristics of health care workers at pre-employment
screening visit (n = 207).
Mean (range)
Age (years)
Height (cm)
Weight (kg)
Systolic blood pressure (mm Hg)
Diastolic blood pressure (mm Hg)
Hemoglobin (gm/dl)
Hematocrit (%)
Random blood sugar (mg/dl)
Erythrocyte sedimentation rate
mm in first hour)
Mantoux test (mm induration)

Abnormal chest radiograph
Mantoux test result
10 mm or above
15 mm or above
20 mm or above
Sputum smear/culture-positive

26.7 (18-54)
163.7 (142-193)
60.8 (33.5-132.0)
113.7 (90-170)
75.3 (50-100)
13.2 (8.1-16.5)
40.3 (25.9-50.4)
100.8 (80-160)
11 (0-46)
7.6 (0-28)
n (%)
5 (2.4%)
90 (43.5%)
45 (21.7%)
15 (7.2%)
None

Calmette-Guérin (BCG) vaccination was obtained in only
54 (26%) cases. History of TB in the family or contact with
a TB patient was denied in 204 (99%) cases, but three were
unsure about it. One patient had been investigated for fever
and pleural effusion 3 months before her pre-employment
screening. She was diagnosed with TB pleural effusion and
was receiving appropriate therapy. The remaining 206
employees were asymptomatic at the time of presentation
and had a normal physical examination.

Mantoux, ESR and chest radiograph findings
A Mantoux skin reaction of >10 mm and blood ESR
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of >25 mm after the first hour was noted in 90 (43.5%) and
21 (10.1%) employees, respectively. Only four of the 90
cases with a >10 mm reaction had an abnormal chest
radiograph and were referred for further evaluation. None of
the HCWs with a Mantoux >20 or ESR of >25 had clinical
or radiological evidence of active TB.
Chest radiograph was abnormal in five (2.4%)
cases. One was receiving anti-tuberculosis therapy for
previously diagnosed pleural effusion and had pleural
thickening on radiograph. One had hilar prominence, two
had minimal linear scarring and one had linear and
nodular infiltrate and loss of volume of the right upper
lobe. Of the five cases with an abnormal chest
radiograph, four had a Mantoux result of >10 mm and
one had a result of 0 mm.

Referral to chest physician
At pre-employment screening one employee was
already on anti-tuberculosis therapy and was referred to a
specialist. All of the other employees were asymptomatic,
with a normal physical examination, and would have not
needed referral on a clinical basis. Based on chest
radiograph findings four (2%) asymptomatic cases were
referred. One with hilar prominence was investigated with
computed tomography (CT) scan and was found to have a
bronchial cyst. One with infiltrates and loss of lung volume
was started on tuberculosis treatment on radiographic
grounds; sputum smears and cultures were negative. Further
investigations were not recommended for two patients with
minimal linear scarring.
Based on the results of positive Mantoux and/or
elevated ESR, 48 (23.1%) additional employees were
referred to a specialist. The vast majority (77%) were young
females below the age of 30 years. All had normal physical
examinations and chest radiographs. The specialist
recommended no further investigation, and none were
diagnosed with active TB.
Based on chest radiograph only five cases would
have been referred for pulmonary opinion and the only case
of suspected active TB would have been picked up. When
Mantoux and ESR were added to the screening process a
ten-fold increase in the number of referrals was seen (total
52), with no extra case of active TB being detected.

One-year follow-up
Medical records of all screened employees were
reviewed after a 14-18 month period following preemployment screening. The outcome of physician
encounters, laboratory investigations and radiographic
studies were recorded. None of the employees was
diagnosed with active TB during the follow-up screening.
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Discussion
Our study suggests that in a high TB prevalence
country the Mantoux test is not a useful diagnostic tool for
pre-employment screening of HCWs. Of the employees
screened, 44% had a positive test of >10 mm and half of
these (22%) had a reaction of >15 mm. Such high rates of
positive skin reaction among HCWs have earlier been
reported in other studies from the US (40%)7 and Mexico
(70%).8 The only case of active disease in our study had
symptoms and signs suggestive of TB. Based on the result
of Mantoux testing, a large number of referrals were made
to the chest clinic with no further detection of active cases.
At the 1-year follow-up none of these HCWs had developed
active disease. In Pakistan, the use of Mantoux testing for
screening resulted in delays in the recruitment process and
extra costs for consultation. Similarly, an elevated ESR of
>25 mm/first hour was seen in 10% of the employees, and
in the absence of symptoms none of these were found to
have active TB.
Mantoux testing is used widely for identification of
infected cases. In high prevalence countries a large
proportion of the population is expected to have a positive
reaction, which limits the specificity of the Mantoux test as
a screening tool for active disease.9 Furthermore, skin
reaction may not correlate with disease severity, and has
been shown to decrease with disease severity. Therefore,
tuberculin response in a BCGvaccinated TB-endemic area
cannot be used as a diagnostic marker for active
tuberculosis, particularly in advanced disease.10
Due to epidemiological differences between the
industrialised and the developing countries, strategies for
the diagnosis of TB need to be developed that are cost
effective and take account of local factors. An International
Union Against Tuberculosis and Lung Disease (IUATLD)
task force, with members from 10 countries, developed a
scoring system for screening children for TB and for
selecting suspects for further investigations.11 In a low
prevalence country heavy reliance was placed on history of
close contact and on a positive skin test. In high prevalence
countries case contact and skin test was found to be less
important, with symptoms being more indicative of active
TB. The results of our study would support the development
of a scoring system that relies more on symptoms than on
skin test to screen adults and to select those who need
further investigation.
The effectiveness of occupational health screening
and surveillance procedures was evaluated in a study from
the west Midlands region of the UK.12 Most cases of active
TB presented with symptoms, and no occupational health
unit knew of any extra case that was not notified by the
registry. An emphasis on prompt reporting of suspicious
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symptoms both before and during employment was
recommended. Another 9-year study from a regional
pediatric hospital in Cincinnati, Ohio, had evaluated the
mandatory employee tuberculin skin test programme.13
Despite intense active surveillance among thousands of
hospital employees with >97% annual compliance,
tuberculin conversion rates were low, and no cases of active
TB were identified during the 9 years of follow-up. Rates of
TB in that community were low, and the application of
guidelines appeared excessive and costly. The results of our
study also indicate that the current screening programmes
should be evaluated regularly and made relevant to the
needs of the region.
The ESR is a non-specific test used by many
physicians for screening patients with active diseases like
TB. A recent study in children found that one-third of cases
with active TB had a normal ESR at the time of diagnosis,
and that ESR was of little value as a diagnostic test.14 Our
study results show that ESR was elevated in 10% of
apparently healthy individuals, and that despite living in a
high prevalence country none of these developed active TB
over a 1-year period.
Based on the result of our study, we have
discontinued performing Mantoux testing and ESR for
preemployment screening of HCWs. Clinical assessment
and chest radiograph is performed on each individual, and
no further test is performed for asymptomatic individuals
with a normal chest radiograph. Those with clinical and/or
radiological abnormalities have three sputum samples tested
for acid-fast bacilli and are referred to a specialist. We
recommend that for pre-employment TB screening of
HCWs in high prevalence countries, the main emphasis
should remain on history and physical examination. Chest
radiograph should be performed, when available, to detect
early or asymptomatic cases. Further studies are needed to
assess whether chest radiograph can be avoided altogether
in asymptomatic individuals. The sample size of our study
was small for an endemic region, and the results need to be
validated with larger studies.

Conclusions
In a high TB prevalence country such as Pakistan,
the use of Mantoux testing and ESR for pre-employment
screening of HCWs is not cost-effective. Greater emphasis
should be placed on symptoms to detect active cases.
Despite a positive tuberculin reaction in 44% and an
elevated ESR in 10% on initial screening, none of the
HCWs developed active TB over a one-year follow-up.
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Abstract

Key Words: tuberculosis; prevalence; rapid village survey.

Setting: The Shimshal Valley, a remote village in Northern
Pakistan, is one of the seven Pamirs of Central Asia, widely
known as the roof of the world.

Introduction

Objective: To investigate the prevalence of pulmonary
tuberculosis (TB) in the Shimshal Valley.
Design: The Rapid Village Survey Method (RVS) was used to
investigate the prevalence of pulmonary tuberculosis. The
selection criteria were chronic cough, hemoptysis, past history
of TB and close contact with a tuberculous patient. After
clinical examination, a chest radiograph was done and a single
spot sputum sample was obtained for smear examination.
Results: The total population of the village was 1077, of
whom 231 cases were studied. Overcrowding affected 75%
of the study population. The prevalence of smear positive
pulmonary TB in the village studied was 554 per 100 000
population, and the prevalence of active smear-negative TB
was estimated at 1949/100 000. The prevalence of active
pulmonary TB increased with age and the only risk factor
for active TB was age over 45 years. Of the 21 cases with a
past history of pulmonary TB, only 38% had completed a
full course of chemotherapy.
Conclusion: Pulmonary TB is a very serious health issue in
the rural community (Shimshal Valley) of Pakistan. This
study highlights the lack of efficacy of national tuberculosis
control programs in the country.
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There has been a global resurgence of tuberculosis
(TB) in the last decade and the vast majority of these TB
cases occur in the impoverished countries of Asia, Africa
and South America.1
Pakistan is a developing country with a population of
130 million people. In this country 1.5 million people suffer
from TB, and more than 210 000 new cases occur each
year.2 At present, only 1 per cent of central government
expenditure is spent on health care, and over half the
country has little or no access to health care. Until recently
there were no official guidelines for tuberculosis control in
Pakistan, and there is serious concern that drug resistance is
likely to increase at an alarming rate.
Shimshal Valley is a remote village in the Northern
Areas of Pakistan, situated in the neighborhood of the
Peoples' Republic of China, the former USSR, India and
Afghanistan. The eight great mountain ranges including
Karakuram, Hindukush, Himalaya and Pamir converge on
this land of rocks and glaciers. Shimshal Pamir is one of
the seven Pamirs of Central Asia, well known as the roof
of the world. It is at an elevation of 7800 feet above sea
level and at a distance of 45 kilometers from Karakuram
highway, which links Pakistan to the other Central Asian
States. The hardship endured by the people of the region
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The objective of our study was to investigate the
prevalence of pulmonary TB in Shimshal Valley using the
Rapid Village Survey method.

The basic demographic data were provided by the
village school research group. Data about symptomatic and
high risk populations were gathered from the records of
health workers. The demographic data were recorded by the
medical health workers and the history and physical
examination were done by a general surgeon and a family
medicine resident. A portable chest radiograph was
performed and a single spot sputum sample was obtained in
the clinic. Free medicines were distributed for common
illnesses, and difficult cases were referred to tertiary care
centers in other parts of the country. The RVS team departed
on the sixth day of the visit.

Material and Methods

Selection criteria

can be illustrated by the fact that there is not a single road
to Shimshal Valley that is traversible on horseback. One
therefore has to walk for 36 hours through the rocky
mountains to reach the valley. According to a survey in
1996, pulmonary TB was the leading cause of death
among adults in this region, whereas pneumonia was the
leading cause of infant mortality (School research group.
Mortality, morbidity and birth rate in Shimshal Valley.
Unpublished data).

Planning and organization
Before starting field activities, a series of meetings
was held with members of the Aga Khan Health Services,
Pakistan (AKHSP) and the Government Health Department,
Northern Areas of Pakistan (GHDNAP), to assess feasibility
of the survey and funding. The funding for X-ray films and
laboratory supplies was provided by AKHSP, a portable Xray machine by GHDNAP, and the Aga Khan Foundation
provided transportation by helicopter between the nearest
town (Gilgit) and Shimshal Valley. The fuel for the electric
generator, food and accommodation was arranged by the
village volunteer service.
The final study design was approved after discussion
with an epidemiologist and a pulmonologist. The work was
carried out by a team consisting of a general surgeon, a
resident family physician, three laboratory technicians, two
lady health visitors, two health workers and a group of
dedicated volunteers.

Rapid Village Survey method (RVS)
The study design was based on the experience of
RVS for case finding in the control of pulmonary
tuberculosis and leprosy by Elink Schuurman3 and
Tumbelaka.4 This method is cost-effective and the overall
accuracy is similar to the total village survey (TVS) method.
The RVS team reached the village on 26 June 1996, and a
meeting was held with the village president, health workers
and volunteer services. The survey was planned over a fiveday period. The health workers performed a door-to-door
visit in the village, identified the villagers who fulfilled the
selection criteria (as defined below) and invited the
villagers, via a standard message, to report to the RVS
center. Information about the schedule of the study was also
conveyed by the radio broadcasting services. There was no
registered medical practitioner in the village, and thus the
survey provided the villagers with a unique opportunity to
see a qualified physician.
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The selection criteria used in the survey included:
history of chronic cough (more than three weeks' duration),
history of hemoptysis, past history of pulmonary TB, and
close contact with a TB patient.
All subjects who had one or more of the above
selection criteria were identified during door-to-door visits
by the health workers and invited to attend the RVS center.
At the end of day four, the lists of suspected cases were
checked and the volunteers visited the houses of those who
had not yet presented voluntarily to the RVS center. In this
remote village we were able to screen all the suspected
cases identified by the health workers.

Definitions
Smear positive pulmonary TB: A person with a
smear positive for acid-fast bacilli (AFB), on a single spot
sputum examination.
Smear negative pulmonary TB: A person with
upper lobe infiltrates and/or cavitation on chest radiograph,
in the absence of a positive sputum smear
Healed pulmonary TB: A person with evidence of
fibrosis and/or calcification on chest radiograph in the
absence of the above criteria for active TB.
Adult: A person aged 15 or over.

Statistical analysis
The database was completed after the sputum AFB
smears had been read by a consultant pathologist and the
chest radiographs by a consultant pulmonologist. The data
were coded and entered into a commercially available
program, Excel 7.0. Statistical analysis was done with the
help of an epidemiologist using a statistical software
package (SPSS 4.0). The data were analyzed for evaluation
of active and healed tuberculosis. Univariate analysis was
done to assess the significance of risk factors for active
pulmonary TB such as age, sex and overcrowding. The level
of statistical significance was set at P < 0.05.
J Pak Med Assoc (Suppl. 1)

Table 2: Characteristics of patients with active TB.

Results
The total population of the village was 1077, of
whom 49.7% were male and 54.5% were adults. The overall
literacy rate was 18.4%, 25.9% in males and 10.9% in
females. The source of income was agricultural produce and
livestock in 94%, and 6% were in service or business. The
crude birth rate was 4.93% and crude mortality rate was
1.02% per annum.
The characteristics of the study population are
summarized in Table 1. The majority of the population
Table 1: Characteristics of the study population in Shimshal
Valley, 1996. (Total population = 1077)
Characteristic
Population studied
Sex: Male
Female
Age: 15 years
15–45 years
45 years
Past history of TB
Close contact with TB patient
Chest radiograph
Normal
Active infiltrates/cavitation
Fibrosis/calcification
Poor quality/not obtained
Single sputum smear examination
Smear positive
Smear negative
Sputum not obtained

n (%)
231
98 (42)
133 (58)
18 (8)
134 (58)
79 (34)
21 (9)
159 (69)
40 (17)
23 (10)
149 (65)
19 (8)
6 (2.5)
103 (44.5)
122 (53)

(75%) lived in overcrowded conditions (more than three
persons per room). Chronic cough was present in 82% of
the study population, of whom two-thirds had productive
cough. A history of hemoptysis was obtained in 35% of
cases. Physical examination revealed crepitations in 38
(17%), bronchial breath sound in 26 (11%), rhonchi in 17
(7%) and cervical lymphadenopathy in three (1%) cases. Of
the 231 study subjects, a satisfactory chest radiograph was
obtained in 212 (92%) and a single spot sputum sample in
109 (47%) cases.
Six sputum samples were smear positive and the
prevalence of smear positive pulmonary TB in the village
studied was 557/100 000. A further 21 cases had features of
active TB based on radiological appearance, and the
prevalence of smear negative active pulmonary TB was
estimated at 1949/100 000 (Table 2). Based on radiological
findings of pulmonary fibrosis and/ or calcification compatible
with TB, the prevalence of healed TB was estimated at 13
835/100 000 population. The prevalence of active pulmonary
TB increased with age: the only significant risk factor for
active pulmonary TB was age > 45 years. Only 8% of the study
population were in the pediatric age group, and no case of
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Total number
Sex: Male
Female
Age: 15 years
15–45 years
45 years
Close contact with a TB patient
Past history of TB
Chest radiograph
Active infiltrates/cavitation
Fibrosis/calcification

Smear
positive

Smear
negative

6
1
5
0
3
3
5
3

21
9
12
0
5
16
12
3

3
3

21
0

active pulmonary TB was found among them. In this village,
82% of children had received BCG vaccination.
Of the 21 subjects with a previous history of
pulmonary TB, three (14%) were still sputum AFB positive on
a single smear and 28% were symptomatic with active
infiltrates and/or cavitation on chest radiograph. Only eight
(38%) cases had completed a full course of anti-TB treatment.

Discussion
The results of our survey confirm that in this remote
village, where 75% of the population lives in overcrowded
conditions, pulmonary TB is a major health problem. The
prevalence of smear positive pulmonary TB (557/100 000) and
smear negative TB (1949/ 100 000) is considerably higher than
in other developing countries.5-7 These smear positive patients
continue to be a source of infection in the village, and when no
treatment is provided each patient is expected to survive for
about 2 years and to infect 10 to 15 further individuals each year.8
During the period 1994 to 1996, 70% of the 24 adult deaths in
the village were related to diagnosed or suspected cases of
pulmonary TB. There was increased prevalence of pulmonary
TB with increasing age, consistent with other studies from Asia.9
Our study also highlights the problem of poor
compliance with treatment among patients known to have
pulmonary TB. Only 38% completed a full course of anti-TB
treatment. The reasons for poor compliance were unavailability
of anti-TB medications, lack of a surveillance program for
tuberculosis control, poor socio-economic conditions and low
literacy rate. These partially treated patients remain a
continuous source of TB infection, and could potentially
promote the emergence of multidrug-resistant strains. In
addition, as suggested by the Bangalore study, each year 10%
to 15% of smear negative patients would be expected to
progress to become smear positive.10 The overcrowding
observed in the study population would also be a strong risk
factor for the spread of TB bacilli in the community.
Our study design using the RVS method has been
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validated for case finding in the control of pulmonary TB.3
Shimshal Valley was considered a suitable site for RVS, and the
local factors that contributed to the validity and success of the
survey were: 1) a village isolated from the rest of the country
where all the people lived closely together; 2) a preliminary
survey was available about the suspected and high risk
population; 3) a strong village organization, dedicated health
workers and volunteer service ensured a successful survey, and
health workers were able to visit each house in the village to
invite people to participate in the survey; 4) in the absence of a
qualified medical practitioner in the village, the RVS was a rare
opportunity for people to be examined by a qualified doctor and
obtain free medicine for common medical ailments.
Our study differed from that of Elink Schuurman et al.3
in some aspects. We did not have the facilities to perform
cultures on the sputum samples obtained. Instead we depended
on radiographic findings to detect smear-negative active cases.
The sensitivity of chest radiograph in detecting active and
healed cases of TB has been described to be low in mass
radiography.11 Of interest is a follow-up study of nearly 300
Chinese subjects who were considered to have active TB on
clinical and radiological features but were sputum AFB
negative on five smear examinations. Over the next 30 months,
71% had active disease confirmed and another 15% had
evidence of changing lesions on serial chest radiographs,
indicative of active disease.12
Secondly, compared to only 5% in their study, we
screened nearly 20% of the entire village population, and
believe that the chance of missing further symptomatic patients
was small. Our study was, however, not followed by a total
village survey. The prevalence of smear-positive cases among
suspected individuals was similar in both studies, but the
overall prevalence of smear-positive TB in the village was
much higher in our study.
Our study has certain limitations. A single spot sputum
sample was used for smear examination, potentially leading to
an underestimation of disease prevalence. Ideally, three early
morning sputum samples should have been collected, and this
might have resulted in an even higher prevalence rate.
However, in a study of smear-positive patients, 90% were
found to be positive on their initial smear.13
Secondly, TB culture was not performed on the sputum
samples obtained. Had resources been available, this would
have helped us to define more accurately the prevalence of
smear-negative, culture-positive cases, and to identify drug
resistance patterns.
Thirdly, radiological features were used to define active
and healed TB. We accept that a number of infectious,
inflammatory, neoplastic and occupational diseases can mimic
TB. Furthermore, patients with TB may have atypical
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presentations, and differentiation between active and healed
TB may be difficult on radiological features alone. However, in
a high prevalence region such as the Shimshal Valley, the
commonest feature of reactivation TB is upper lobe infiltrates/
cavitation,14 and pleural/pulmonary fibrosis and calcification in
the upper zones is usually secondary to remote TB infection.
Fourth, very few children were included in the study
and this, coupled with difficulties in the interpretation of
radiograph and smear examinations in children, may have
resulted in a failure to identify any cases with active TB. The
prevalence of active TB in children in the village remains
unknown. Similarly, the prevalence of extra-pulmonary TB
was not studied.
Finally, our study may have underestimated the
prevalence of active TB due to sample selection (exclusion of
asymptomatic cases, failure of some symptomatic cases to
report to the RVS center).
In order to prevent the spread of disease and to decrease
TB related mortality, we made the following recommendations
to the AKHSP. 1) Urgent treatment of smear positive and
treatment failure cases. The success of treatment should be
monitored carefully according to WHO recommendations,15
and the target of successful treatment should be 80-90%
compliance. 2) Treatment should be fully supervised by the
health care workers. 3) Health care workers from the same
village should be trained to monitor short course
chemotherapy, to record patient data and to perform sputum
AFB smears. 4) Treatment failure and relapses should be
screened for multidrug-resistant bacilli. 5) Smear-negative
cases with radiological features of active TB should also be
treated. 6) New cases of pulmonary TB should be detected by
a regular screening program, and all persons with productive
cough should have three sputum smears for AFB examination.
7) BCG vaccination should be continued and its efficacy
evaluated. 8) Chemoprophylaxis should be given to high risk
cases who do not have active TB.
The successful implementation of a pulmonary
tuberculosis control program in Shimshal Valley is possible
through close collaboration between AKHSP and GHDNAP,
but community participation will be the key to success.
Implementation of our recommendations for control of
pulmonary tuberculosis in Shimshal Valley was started in May
1997, and the program will strictly follow the WHO guidelines
with emphasis on directly observed treatment and short course
chemotherapy.
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Do private doctors follow national guidelines for managing
pulmonary tuberculosis in Pakistan?
S.K. Shah, H. Sadiq, M. Khalil, A. Noor, G. Rasheed, S.M. Shah, N. Ahmad
National Tuberculosis Control Programme, Rawalpindi, Pakistan.

Abstract
As private medical practitioners play a major role
of in providing care to pulmonary tuberculosis (TB)
patients, a survey was made of knowledge and practice in
2 cities in Pakistan. Only 1 of the 245 physicians was aware
that cough > 3 weeks alone is the main symptom
suggesting pulmonary TB. The majority diagnosed (80%)
and treated (83%) cases themselves without referral. Less
than 1% relied on sputum microscopy alone for diagnosis.
None of the practitioners were following National TB
Control guidelines for prescribing drugs and none ensured
compliance with anti-TB treatment under supervision of a
doctor/health worker. Only 3% kept records of
pulmonary TB patients. None of the physicians assessed
the effectiveness of treatment with sputum microscopy
alone; the majority (76%) used only clinical assessment.

Introduction
Tuberculosis (TB) is the largest single infectious cause
of death among young people and adults in the world,
accounting for nearly 2 million deaths a year; about a third of
the world's population harbours the infection.1 This large pool
of infected people means that TB will continue to be a major
problem in the foreseeable future.2 While they belong to all
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socioeconomic strata, the great majority of TB patients are
poor.3 Due to these and many other relevant factors, the TB
epidemic was declared a global emergency by the World
Health Organization (WHO) in 1993.4
TB remains one of the major public health problems in
Pakistan. Moreover, WHO has identified Pakistan as among
the countries with a high burden of disease.5 According to the
Pakistan national TB survey in 1987-886 the prevalence of
sputum- positive or open cases of pulmonary TB was
estimated to be 0.17 per 1000 population. These open cases
form a reservoir of infection in the community and are the
source of person-to-person transmission.
In Pakistan where only 36% of the population is
literate and 28% is living below the absolute poverty line,7 the
private sector makes a major contribution to providing health
care for all kinds of health problems including the
management of TB cases.8 Private medical practitioners in
Pakistan, as in other developing countries, comprise a wide
range of health care providers, ranging from unqualified and
unskilled practitioners to highly qualified medical
postgraduates. However, a large number are in the former
category, who are readily available and accessible especially
in the rural settings where 70% of Pakistan's population lives.
The absence of any effective regulatory mechanism further
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worsens the situation. In India it has also been noted that the
private health sector in developing countries tends to be a
relatively amorphous, unorganized and dynamic entity
comprising various provider types of different sizes and
characteristics.9
There is increasing interest in many countries about
the role of the private health sector in TB care.7 In a study of
health-seeking behaviour in Pakistan,10 it was found that 90%
of TB patients had initially contacted a private practitioner
before visiting a TB centre. Similarly, another study in a
different setting also established that 80% of hospitalized TB
patients had first consulted private practitioners.11 Moreover, a
study in India observed that 86% of TB patients had first
consulted a private practitioner.12 Yet TB patients attending
the private sector may not be receiving the correct treatment
according to the National Tuberculosis Control Programme
guidelines.
The present study was carried out to determine the
knowledge and practices of private general medical
practitioners towards diagnosis, treatment and follow-up of
pulmonary TB patients in 2 cities of Pakistan. In addition, we
intended to collect baseline information to plan future
interventions to involve the private sector in the National TB
Programme.

Methods
The study design was a descriptive crosssectional
survey. The study participants were selected from all formally
qualified medical graduates who were practising medicine on
a full- or part-time basis outside the government (public)
sector in the 2 largest cities of Pakistan: Rawalpindi and
Lahore. The basic criterion for inclusion in the study was that
the private medical practitioners had managed at least 1
pulmonary TB patient during the previous year.
Out of a total population of 884 private general
medical practitioners, 245 were randomly selected to be
included in the study. This sample size was estimated at a
confidence level of 95%, at 20% expected frequency of
consistency with National TB Programme guidelines, and a
power of 80%.
A standardized questionnaire on the relevant themes
and issues was used in this study. Questions were mostly
dichotomous choice with some rating scale questions.
Questions were asked about diagnosis (knowledge about
symptoms suggestive of TB, diagnostic and referral practices,
diagnostic facilities), treatment (usual prescribing practices,
knowledge about how to categorize patients for treatment,
frequency of dispensing treatment), follow-up (ensuring
compliance, record-keeping, assessing effectiveness of
treatment, defaulter tracing and family contact tracing), and
awareness of National TB Control Programme guidelines.
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The responses were analysed by city and by
qualification status of the general practitioner, i.e. medical
graduate only or postgraduate qualification. A 95% confidence
interval was calculated where relevant. The responses were
compared for significant differences using Pearson
chisquared. Data were analysed using Epi- Info, version 6.04c
and SPSS, version 10.0.5. Frequency tables were prepared for
most of the variables.
Table 1 Knowledge of private practitioners about duration of cough
before suspecting tuberculosis by city and by qualification
Duration of
cough

Graduates
No. %

Postgraduates
No. %

Total
No. %

Rawalpindi
2 weeks
3 weeks
4–6 weeks
7–9 weeks
Lahore
2 weeks
3 weeks
4–6 weeks
7–9 weeks

(n = 83)
14 17
21 25
45 54
3
4
(n = 125)
15 12
23 18
45 36
42 34

(n = 17)
2 12
4 24
10 59
1
6
(n = 20)
2 10
3 15
9 45
6 30

(n = 100)
16
16
25
25
55
55
4
4
(n = 145)
17
12
26
18
54
37
48
33

P-valuea

0.923

0.945

n = total number of respondents.
aGraduates versus postgraduates.

Results
The mean age of the 245 private practitioners was 38
years, ranging from 23 to 70 years. A total of 232 of them
(95%) were below the age of 60 years; female practitioners
comprised 20% (48). All of the sample were medical
graduates; the year of graduation ranged from before 1960 to
2001. A postgraduate degree or diploma was held by 37
(15%): 6 (2%) had a postgraduate qualification in medicine
and 31 (13%) had other qualifications (none of them had a
postgraduate diploma or degree in chest diseases). There were
100 practitioners in Rawalpindi and 145 in Lahore. The
proportion holding a postgraduate degree or diploma was 17%
and 14% in Rawalpindi and Lahore respectively.
Of the respondents, 58% from Rawalpindi and 41%
from Lahore had provided care to 1-5 pulmonary TB patients
during the previous 3 months, compared with 34% and 41%
respectively who had seen 6-10 patients.

Diagnosis
Knowledge about symptoms
In response to the question "In your opinion, what are
the main symptoms that suggest pulmonary TB in adults?",
only 1 out of 245 private practitioners mentioned cough for
more than 3 weeks. Nearly half (45%) of the physicians
described a combination of cough, haemoptysis, weight loss,
night-sweating and lymph node enlargement, whereas 30%
considered cough and weight loss as the main symptoms
J Pak Med Assoc (Suppl. 1)

suggestive of pulmonary TB.
The knowledge of physicians in the 2 cities about the
main symptoms suggestive of pulmonary TB was
significantly different (P = 0.010). More practitioners in
Lahore considered cough and weight loss as the main
symptom, whereas in Rawalpindi it was cough, haemoptysis
and weight loss. There was no significance difference between
graduates and postgraduates in Rawalpindi (P = 0.529) or in
Lahore (P = 0.335) about knowledge of symptoms. None of
the postgraduates mentioned cough more than 3 weeks as the
main symptom suggestive of pulmonary TB.
On prompting for the duration of cough before
suspecting pulmonary TB, only 21% of doctors (25% in
Rawalpindi and 18% in Lahore) mentioned cough of 3 weeks
in suspecting TB. Of the 37 postgraduates, only 7 stated that
cough for 3 weeks is suggestive of TB. However, 45% of
respondents overall stated that cough for 4-6 weeks and 14%
that cough for 2 weeks is suggestive of TB. In both the cities,
like graduates, the majority of postgraduates were also of the
opinion that a cough for 4-6 weeks should be suspected for
pulmonary TB. There was no difference in knowledge about
duration of cough between graduates and postgraduates in
Rawalpindi (P = 0.923) and Lahore (P = 0.945).

Diagnostic practices
Questions about their practices when they suspected a
patient is suffering from pulmonary TB showed that 80% of
respondents diagnosed the patient themselves, 11% diagnosed
the patients themselves and then referred them to a TB centre
or consultant and 8% referred the patient straight away.
However, a significant difference (P < 0.0001) was noted
between the 2 cities in relation to patient referral. In Lahore
the majority of practitioners (90%) diagnosed cases
themselves, whereas in Rawalpindi 66% relied on their own
diagnosis and 24% initially diagnosed themselves and then
referred the patients. In Rawalpindi 82% of postgraduates
compared with 95% in Lahore diagnosed the patients
themselves (Table 2). Graduates referred more patients than
the postgraduates in Rawalpindi (P = 0.013), whereas in
Lahore no difference (P = 0.923) was observed between
graduate and postgraduate referral practices.
For diagnosis of pulmonary TB only 1 private medical
practitioner (a graduate) out of 245 relied on sputum
microscopy alone. In response to the question, "While
diagnosing a suspected case of pulmonary TB, what actions
do you usually take?" the majority of respondents (45%)
reported using a combination of tests, i.e. clinical examination,
tuberculin test, sputum microscopy, blood erythrocyte
sedimentation rate (ESR), and chest X-ray. Table 3
summarizes the responses by city and by qualification. In
Rawalpindi, the difference among graduates and
postgraduates was significant (P = 0.044), since more
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Table 2 Practices of private practitioners for action taken on
suspecting pulmonary tuberculosis by city and by qualification.
Graduates
No. %

Action taken

Rawalpindi
Diagnose themselves
Diagnose themselves
then refer
Refer immediately
Lahore
Diagnose themselves
Diagnose themselves
then refer
Refer immediately

Postgraduates
No. %

Total
P-valuea
No. %

(n = 83)
52 63

(n = 17)
14 82

(n = 100)
66 66

0.013

22 27
9
11
(n = 125)
112 90

2
12
1
6
(n = 20)
19 95

24 24
10 10
(n = 145)
131 90

0.923

4
9

3
7

1
0

5
–

5
9

3
6

n = total number of respondents.
aGraduates versus postgraduates.

Table 3 Practices of private practitioners for actions taken to
diagnose a suspected case of pulmonary tuberculosis by city.
Diagnostic
method

Rawalpindi
(n = 100)
No. %

Sputum
Clinical
Clinical + sputum
Clinical + X-ray
X-ray + ESR
Clinical + sputum +
X-ray + ESR
Clinical + sputum +
X-ray + ESR + TT
Othersb

Lahore
(n = 145)
No. %

Total
P-valuea
(n = 245)
No. %

1
3
0
11
11

1
3
–
11
11

0
2
1
6
38

–
1.4
0.7
4
26

1
5
1
17
49

0.4
2
0.4
7
20

26

26

22

15

48

20

45
3

45
3

64
12

44
9

109 45
15 6

0.009

Sputum = sputum microscopy, clinical = clinical examination,
TT = tuberculin test, ESR = erythrocyte sedimentation rate.
aRawalpindi versus Lahore.
bSerology, polymerase chain reaction, urine or blood tests.
n = total number of respondents.

graduates preferred clinical examination and chest X-ray, but
the difference was not significant in Lahore (P = 0.717).

Diagnostic facilities
Only 5 out of 245 private medical practitioners had
facilities for sputum examination. Responding to the question,
"Which facilities do you have for diagnosing pulmonary TB
patients at your clinic?" 92% of doctors in Rawalpindi and
86% in Lahore stated that they did not have any facility at their
clinics. Only 8% had the facility to perform ESR. Similarly, 1
respondent in Rawalpindi and 3 in Lahore had X-ray facilities.
Among the 5 who had sputum examination facilities, only 2
had used sputum microscopy in the process of diagnosis.
Among the postgraduates, only 1 had a facility for blood ESR
in Lahore and 1 had a chest X-ray facility in Rawalpindi.
In response to the question, "If none, where do you
usually send your patients for laboratory investigations?" 61%
of private medical practitioners in Rawalpindi and 76% in
S-24

Lahore referred their patients to private laboratories.
Respectively, 13% and 19% stated that they sent their patients
to a public laboratory, whereas 26% and 5% did not
recommend any specific laboratory. Among the postgraduates,
53% in Rawalpindi and 90% in Lahore referred their
suspected TB patients to a private laboratory for
investigations. A small proportion of them (18% and 10%
respectively) sent their patients to public facilities. In both the
cities, the difference between graduates and postgraduates was
not significant (Rawalpindi P = 0.723, Lahore P = 0.250).

Treatment
Referral practices
After the diagnosis was established, 83% of the private
medical practitioners treated the pulmonary TB patients
themselves; only 17% referred the patients (10% to a TB
centre, 7% to a consultant or other non- specified referral).
However, a significant difference between physicians in the 2
cities was found regarding referral to a TB centre or consultant
(14% in Rawalpindi and 10% in Lahore) (P < 0.0001). When
comparing the responses by qualification, it was observed that
significantly more graduates and postgraduates in Rawalpindi
(75% and 88%, P = 0.014) than in Lahore (89% and 90%, P =
0.758) treated patients themselves.

Information gathering
In response to the question "If you have to treat a new
case of pulmonary TB, what information would you like to
have before prescribing treatment?", none of the doctors
mentioned inquiring about the history of any previous anti-TB
treatment. A total of 28% of private practitioners in each of the
cites admitted that they did not know what to do. Information
on family history and socioeconomic status was considered
important in Rawalpindi, whereas liver function tests and
patient's weight was believed to be essential in Lahore. These
responses were significantly different between the cities (P <
0.0001). Among the postgraduates, 12% in Rawalpindi and
20% in Lahore admitted that they did not know what
information was required. However, 35% of postgraduates in
each of the cities considered family history and
socioeconomic status to be of importance. The difference by
qualification was significant in Lahore (P = 0.043) but not in
Rawalpindi (P = 0.156).

Knowledge about categorization
In response to the question, "If you have to treat a new
case of pulmonary TB, how do you categorize a patient based
upon history and results of sputum microscopy, to select a
treatment regimen?" most practitioners (97%) admitted that
they did not know about the system of categorizing pulmonary
TB patients (98% in Rawalpindi and 96% in Lahore). Among
the postgraduates, 82% in Rawalpindi and 95% in Lahore
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were unaware of how to categorize pulmonary TB patients for
treatment. In Rawalpindi, more postgraduates were aware of
categorization than were graduates (P = 0.040), whereas in
Lahore being a postgraduate did not have any effect on
knowledge about categorization (P = 0.835).

Practice of national treatment guidelines
None of the private practitioners in either of the cities
were following the National TB Control Programme
guidelines for prescribing treatment. For the initial phase, the
majority (68%) prescribed a fixed-dose combination of 4
drugs, whereas 12% prescribed combinations of 4 separate
drugs and 15% 3 separate drugs. About 2% of practitioners
also prescribed separate combinations of 5 drugs. These
practices were significantly different in the 2 cities (P =
0.001).
When asked about the duration of the initial phase,
87% of respondents said they did not divide treatment into
initial and continuation phases and kept the patients on
continuous treatment with the same drugs until considered
cured. Only 6% overall used an initial phase of 2 months
duration (9% in Rawalpindi and 3% in Lahore, P = 0.27)
(Table 4).
During the continuation phase, 42% of practitioners
reported prescribing a fixed- dose combination of 4 drugs and
29% a fixed-dose combination of 3 drugs, whereas 15% and
10% prescribed a combination of 4 and 3 separate drugs
respectively. The difference was significant (P < 0.0001)
between the 2 cities: in Lahore 58% of respondents preferred a
fixed-dose combination of 4 drugs whereas in Rawalpindi 53%
Table 4 Practices of private practitioners in initial and
continuation phases of anti-tuberculosis treatment by city.
Treatment
duration

Initial phase
2 months
3 months
5 months
6 months
Continuous
(until cured)
Don’t know
Continuation phase
< 5 months
6 months
7 months
8 months
9 months
Continuous
(until cured)
Don’t know

Rawalpindi
(n = 100)
No. %

Lahore
(n = 145)
No. %

Total
P-valuea
(n = 245)
No. %

9
5
0
0

9
5
–
–

5
1
1
3

3
0.7
0.7
2

14
6
1
3

81
5

81
5

132
3

91
2

213 87
8
3

0
5
6
0
1

–
5
6
–
1

2
1
2
1
0

1.4
0.7
1.4
0.7
–

83
5

83
5

136
3

94
2

2
6
8
1
1

6
2
0.4
1

1
2
3
0.4
0.4

0.27

0.27

219 89
8
3

aRawalpindi versus Lahore.
n = total number of respondents.
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prescribed a fixed-dose combination of 3 drugs. Even some of
those who recognized the initial phase of treatment did not
follow any fixed duration of continuation treatment and thus
89% overall continued the treatment until the patient was
considered cured (Table 4). Only 6 physicians (2.4%) prescribed
anti-TB drugs for 6 months. It was noted that, irrespective of
drug combinations used, all the private practitioners prescribed
rifampicin during the continuation phase of treatment.

Dispensing treatment
In response to the question "How do you give anti-TB
medicines to patients?" 97% of respondents (96% in
Rawalpindi and 98% Lahore, P = 0.305) revealed that they
only prescribed the medicines and did not dispense them at
their clinics. Only 2 out of 245 physicians called their patients
daily to dispense medicines.
When asked "How often do you dispense/ prescribe
anti-TB medicines to the patients?" 62% revealed that they
prescribed medicines on a fortnightly basis whereas 30% did
it on a monthly basis. These practices were significantly
different between the 2 cities (P = 0.003); in Rawalpindi more
doctors prescribed on a fortnightly basis than did those in
Lahore where a monthly system was more common (Table 5).
Table 5 Practices of private practitioners in frequency of prescribing
anti-tuberculosis drugs by qualification and by city.

treatment, short course].
In responding to the question, "Do you ensure that the
patients take all the prescribed/ dispensed anti-TB medicines
regularly?" 15% of private medical practitioners in both the
cities admitted that they did not do anything about ensuring
the intake of medicines, whereas 85% in both the cities simply
stated that they ensured it. While answering the question,
"How do you ensure that the patients take medicines?" 38% of
respondents in Rawalpindi and 31% in Lahore stated that they
ensured it through relatives of the patients (Table 6). The other
Table 6 Practices of private practitioners in ensuring compliance
with anti-tuberculosis drugs by qualification and city.
Overall responses
%
95% CI

Method of ensuring
compliance
Rawalpindi
Personal counselling
Clinical assessment
Relatives
Others
Lahore
Personal counselling
Clinical assessment
Relatives
Others

33
9
38
20
30
22
31
17

(n = 85)
24 to 43
3 to 15
28 to 48
12 to 28
(n = 123)
23 to 37
15 to 29
23 to 39
11 to 23

n = total number of respondents.

Treatment
frequency

Graduates
% 95% CI

Postgraduates
% 95% CI

Total
% 95% CI

means employed were clinical assessment (17%) and personal
counselling (31%).

Rawalpindi
Daily
Weekly
Fortnightly
Monthly
Other
Lahore
Daily
Weekly
Fortnightly
Monthly

(n = 83)
1
–1 to 3
7
2 to 12
72 62 to 82
16 8 to 25
4
0 to 8
(n = 125)
1
–1 to 3
4
1 to 7
55 46 to 64
40 31 to 49

(n = 17)
–
–5 to 17
29 to 77
12 to 58
–5 to 17
(n = 20)
0
–
0
–
70 50 to 90
30 10 to 50

(n = 100)
1
–1 to 3
7
2 to 12
69 60 to 78
19 11 to 27
4
0 to 8
(n = 145)
1
–1 to 3
3
0 to 6
57 49 to 65
39 31 to 47

Assessing treatment effectiveness

0
6
53
35
6

n = total number of respondents.

None of the postgraduates and only 1 graduate in each city
ensured they dispensed the medicines on a daily basis. The
practices regarding frequency of prescribing/dispensing
medicines between graduates and postgraduates were similar
in Rawalpindi (P = 0.399) and Lahore (P = 0.599).

Follow-up
Ensuring compliance
None of the medical practitioners in either city ensured
the intake of anti-TB medicines under the supervision of a
doctor or a health worker, i.e. none of the private medical
practitioners observed the DOTS strategy [directly observed
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None of the private medical practitioners assessed
the effectiveness of anti-TB treatment through sputum
microscopy alone. Responding to the question, "How do
you assess the effectiveness of your treatment?" 76% stated
that it was through clinical assessment, followed by those
who preferred X-ray and laboratory investigations. The
difference between the cities was highly significant (P <
0.0001); 88% in Rawalpindi compared with 65% in Lahore
said that they assessed it clinically. Ways of assessing
treatment effectiveness were similar comparing graduates
and postgraduates in Rawalpindi (P = 0.210) and in Lahore
(P = 0.726).
Most of the private medical practitioners in
Rawalpindi (48%) and Lahore (55%) assessed treatment
effectiveness on a fortnightly basis, while 25% in Rawalpindi
and 37% in Lahore assessed it quarterly. The majority of
postgraduates in Rawalpindi (53%) assessed treatment
monthly and in Lahore (60%) fortnightly, followed by 29%
and 40% respectively on a quarterly basis. The difference
between graduates and postgraduates for frequency of
assessment was significant in Rawalpindi (P = 0.010) but not
in Lahore (P = 0.350).
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Record keeping
In response to the question, "Do you keep records of
TB patients at your clinic?" most of the private medical
practitioners (97%) did not maintain records for pulmonary
TB patients; only 3% (n = 7) said they kept records. Practices
in the 2 cities were the same (P = 0.373). Among the
postgraduates, only 1 in Rawalpindi and 2 in Lahore had any
records for the TB patients.

Patient tracing
Only 2% of private medical practitioners traced
defaulters. In response to the question, "What action do you
take if the pulmonary TB patient on treatment does not come
back for the next appointment?" a majority (98%) in both the
cities admitted that they did not take any action. Similarly,
94% postgraduates in Rawalpindi and 100% in Lahore
admitted that they did not take any actions if a patient
defaulted on treatment.
In response to the question "In case of a new
pulmonary TB patient, do you take any action towards his/her
close family contacts?" 41% of private medical practitioners
in both the cities admitted that they did not take any action. Of
those who said that they do take an action, 98% in both the
cities would enquire about the symptoms of pulmonary TB
and 2% relied on either sputum tests or chest X-ray. Similar
patterns were observed comparing graduates and
postgraduates.

Awareness of national guidelines
When asked "Are you aware of the National TB
Control guidelines?", 96% of private medical practitioners in
Rawalpindi and 99% in Lahore admitted that they did not
know about the guidelines. Among the postgraduates, only 1
in Rawalpindi was aware of these guidelines. The status of
awareness regarding the guidelines was the same for graduates
and postgraduates in Rawalpindi (P = 0.664) and Lahore (P =
0.668).
In response to the offer, "Would you like to attend any
training on National TB Control Guidelines?" a majority
(94%) of physicians in both the cities showed a willingness to
participate in such activities. Similarly, among the
postgraduates, 88% in Rawalpindi and 95% in Lahore desired
to participate in training.

Discussion
TB remains a major public health problem in Pakistan
with a high prevalence of open cases who are the main source
of personto- person transmission. In Pakistan, the private
sector makes a major contribution to providing health care for
all kinds of health problems including TB.
The present study showed that the knowledge and
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practices of formally qualified private medical practitioners
were not in line with the National TB Control Programme
guidelines. A majority of respondents (79%) incorrectly stated
the duration of cough that is suspicious for pulmonary TB,
giving a duration of either 4 to 9 weeks or 2 weeks. There was
no significance difference between graduates and
postgraduates in the 2 cities, Rawalpindi and Lahore.
For diagnosing a suspected case of pulmonary TB,
none of the practitioners perform sputum microscopy alone.
This finding is similar to a study conducted in India, which
found that treatment practices of private practitioners were
inadequate and only a small proportion of private medical
practitioners suggested sputum examination.12 Contrary to the
findings of Marsh,13 this study found that more than 90% of
the private medical practitioners perform one or multiple
laboratory tests in the process of diagnosis.
After private medical practitioners establish the
diagnosis, 83% of them would start treatment themselves and
only 10% would refer the patient to a TB centre. None of them
take the history of any previous anti-TB treatment and most of
them prefer to rely on family history and socioeconomic status
to help them prescribe medication. A small percentage also
perform liver function tests and record the weight of the
patient. However, a significant difference was noted in relation
to patient referral practices in the 2 cities. Graduates in
Rawalpindi refer more patients than do postgraduates,
whereas in Lahore no difference was observed between
graduates and postgraduates.
Overall, 97% of the practitioners admitted that they
had no knowledge of the categorization system for TB
patients to select a treatment regimen. Even the postgraduates
in Rawalpindi (82%) and in Lahore (95%) were unaware of
the categories. It is therefore unlikely that a patient will
receive appropriate treatment based upon categorization of
his/her illness.
None of the private medical practitioners followed
National TB Control Guidelines in prescribing medicines. The
majority prescribe a fixed-dose combination of 4 drugs (a
famous brand in Pakistan) or 3 drugs. A significant difference
was observed between the preferences of practitioners for 4or 3-drug fixed-dose combinations in the 2 cities. However,
more important is the fact that there was no concept of initial
and continuation phases of treatment and the majority of
practitioners prescribe fixed or separate combination of drugs
until the patient is considered cured. Interestingly, rifampicin
is very popular and 100% of practitioners continue with it
during the entire course of treatment. The practices regarding
frequency of prescribing/ dispensing medicines were similar
between physicians in the 2 cities and those who were
graduates or postgraduates.
A majority (85%) of respondents said that they ensure
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the intake of anti-TB medicine; however, none of them had a
system for ensuring compliance under the supervision of a
doctor or a health worker. Instead, the majority relied on
personal counselling or on relatives to help with ensuring
compliance. Graduates and postgraduates had similar
practices in both cities. Almost all the private practitioners
(98%) said they did not take any action if a patient on anti-TB
medication does not return (defaults on treatment).
While the majority of practitioners prefer to continue
the treatment until the patient is cured, none of them
performed sputum examination alone to assess the
effectiveness of anti-TB treatment. Most (76%) assessed the
treatment effectiveness only clinically and the remainder
depended on X-ray chest and laboratory investigations such as
ESR, etc. The frequency of assessing the treatment
effectiveness also varied. Most of them assess treatment on a
fortnightly, quarterly or monthly basis.
In new cases of pulmonary TB, only 59% of the
doctors would take action with the patients' close contacts and
most of these (98%) would simply enquire about symptoms.
The facilities to investigate a suspected case of
pulmonary TB were also rare at the private practitioners'
clinics. Only 5 respondents had a facility to perform sputum
examination. Interestingly, only 2 out of those 5 practitioners
performed sputum microscopy in order to establish the
diagnosis. Thus it is not only laboratory facilities that are
scarce, there is also a lack of awareness among all cadres of
private medical practitioners.
Only 3% of all the private medical practitioners were
maintaining records for their TB patients.
Among all the respondents, 98% admitted that they
had not heard of the National TB Control Programme
guidelines and the other findings of the study suggest that even
the 2% of practitioners who claimed to be aware of them do
not follow the guidelines in practice.
It is concluded that, while a few of the private medical
practitioners in 2 major cities in Pakistan are following some
isolated components of the national guidelines, none of them
(graduates or postgraduates in either city) are
comprehensively following the guidelines in establishing a
diagnosis, treating or following-up pulmonary TB patients.

Recommendations
The findings of this study strongly suggest the following:

Programme guidelines.
u A functional collaboration needs to be established
between private medical practitioners and the National TB
Control Programme to provide quality TB care services.
u Mass public awareness should be raised to identify
the main symptoms of pulmonary TB.
u Further studies are needed to assess the baseline
knowledge of newly qualified doctors/ final year students, and
of practitioners holding postgraduate qualification in chest
diseases, and to determine the curriculum needs of medical
colleges.
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Abstract
We investigated gender differences in knowledge of
and attitude towards tuberculosis (TB) in urban and rural
communities in Sindh province, Pakistan. Knowledge of
symptoms was generally deficient, particularly in rural
females. Regarding TB prevention, 22.4% of rural and
14.4% of urban males said completing treatment was
important; only 9.8% of rural and 7.1% of urban females
agreed. Doctors were an important source of information
in rural areas and 60.9% of rural males said they would
only stop treatment on a doctor's advice. In contrast, >
65% of respondents in urban areas said they would stop
treatment when symptoms ended. Our study highlights the
need to increase population awareness about TB in Sindh.

Introduction
Tuberculosis (TB) is one of the most important
infectious causes of mortality in the developing world.
Estimated annual global incidence is 8 million cases and there
are 2 million deaths yearly.1,2 The total number of TB cases is
predicted to increase in all regions up to 2005, with the
expected increase 3% per year on average. Pakistan has the
6th highest TB burden globally and accounts for 44% of the
TB burden in the WHO Eastern Mediterranean Region [2]. It
is currently estimated that there are around 1.5 million TB
patients in Pakistan, while every year 250 000 people develop
the disease.3 In Sindh province, 88 000 persons get this
disease every year, including 44 000 smear-positive cases.3,4
Tuberculosis kills more women than all causes of
maternal mortality combined.5 In 1998, about three-quarters
of a million women died from TB and over 3 million
contracted the disease, accounting for about 17 million
disability adjusted life years.6 A number of studies have shown
that in high prevalence countries women in their reproductive
years (15-40 years) have higher rates of progression to disease
than men of the same age. This may be related to the
physiological changes associated with reproduction.7-9 As TB
affects women mainly in their economically and
reproductively active years, the disease has a severe impact on
their children and families.10 Women also face obstacles to
gaining access to diagnostic facilities, investigation of the
disease and completing treatment. In addition, the added
burden of housework, childcare and employment allows them
very little time to access health care and TB care for
themselves.10-12
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Gender, culture and personal experience are generally
said to influence healthseeking behaviour. Several authors
agree that the human element in TB control has often been
overlooked and suggest that there would be significantly
better control if more attention were given to the health culture
of the population.13-15 Local surveys on knowledge and
attitude towards TB greatly benefit the planning, health
education and implementation of TB control programmes.
Research has shown that several health interventions have
failed because they were designed without ascertaining any
knowledge of the health behaviour of the target population.16
For successful TB control, it is important to target women and
to elicit the beliefs and knowledge of women regarding TB as
well as their health-seeking behaviour.
To help in the baseline assessment of the differences in
knowledge about TB in males and females, we conducted a
study in urban and rural areas of Sindh province in Pakistan
with the following objectives: to study the differences in
knowledge of cause, spread and treatment of TB; to compare
male and female health-seeking behaviours; and to compare
urban and rural perspectives regarding knowledge of and
attitude towards TB.

Methods
This was a cross-sectional, descriptive study. The
study was conducted in 1 urban site in Karachi known as
Baldia Town and 1 rural site in Hyderabad division known as
Tando Jam. Two hundred households (100 urban and 100
rural) were selected from the data-base of voters using a table
of random numbers. All family members 20-45 years were
included in the study. The questionnaire was given to every
adult male and female between 20 and 45 years of age living
permanently in these households. Anyone who had been
staying for less than 6 months was not interviewed. In the
urban area, 455 individuals (229 males and 226 females) were
interviewed, while in the rural area 299 individuals (156 males
and 143 females) were interviewed, giving a total of 754. The
mean number of persons per household in the urban area was
9.6, while in the rural area it was 8.4. Consent was obtained
from the respondents before administering the questionnaire
and there were no refusals.
Data were collected using semistructured
questionnaires having both closed and open-ended questions.
Questionnaires were translated into the national language,
Urdu, and the local language, Sindhi. The household
questionnaire included questions on age, sex, literacy and
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socioeconomic status of the respondents. The individual
questionnaires contained questions regarding knowledge of
TB, including causes and factors responsible for its spread,
signs and symptoms of TB, parts of the body affected,
investigations needed in such cases, reasons for stopping
treatment and sources of information. Health-seeking
behaviour was also determined for both males and females.
Open-ended questions were asked concerning the
individual's attitude towards TB and the sociocultural stigmas
associated with the disease. The community's attitude towards
females who develop TB was also elicited. The questionnaire
was administered by interviewers who underwent a 2-day
training on questionnaire administration techniques. In the
case of male respondents, a male interviewer was used and for
females, a female interviewer. The entire questionnaire was
completed in 40 minutes. The raw data from open-ended
questions was categorized into open codes. These open codes
were applied by 2 independent researchers and the results
were discussed with the whole team. P-values were calculated
using chi-squared.

Results
Of the 754 people interviewed, 385 were male, 62% of
them married, and 369 were female, 74.3% of whom were
married. The greatest proportion of the households (42% in
urban and 43% in rural areas) had an income of 2000-5000
Pakistan rupees per month (US$ 33-83). Radio and television
ownership varied from 50% to 70% in urban areas and 45% to
65% in rural areas. Nearly 78% of women in rural areas were
illiterate compared with 51% in urban areas. Male literacy was
higher, urban 88% and rural 45%.
Observations were made regarding the symptoms of
TB as perceived by males and females. In the urban area,
cough was the most commonly cited symptom for both males
(67.2%) and females (76.5%). Blood in sputum was again
cited by both males (17.9%) and females (18.6%). Prolonged
fever was most commonly reported by females (29.6%).
Anorexia and night sweats were not reported by either males
or females. In the rural area, a significant difference was seen
between male and female perceptions of symptoms; 57.7% of
males cited cough as a predominant symptom compared to
21% of females. Again, 25.6% of males gave blood in sputum
as an important symptom compared with only 5.6% of
females. Prolonged fever was cited by 19.2% of males but
only 4.9% of females. Neither males nor females reported
night sweats, anorexia or weight loss as symptoms before
probing (Table 1).
Very few people were aware of the causative agent of
TB, especially rural females. In the urban area 30% of males
and 35% of females cited "germs" as causing TB, while in the
rural areas 18.6% of males and 9.8% of females mentioned
"germs". X-ray as a diagnostic test for TB was indicated by
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Table 1 Male and female (urban and rural) perceptions
regarding symptoms of TB.
Symptom

Urban
Male Female P-value
%
%

Rural
Male Female P-value
%
%

Cough
Blood in sputum
Weight loss
Prolonged fever
Persistent cough
Anorexia
Night sweats
Other

67.2
17.9
7.9
7.4
7.0
0.4
0
1.3

57.7
25.6
4.5
19.2
1.3
3.8
0
1.3

76.5
18.6
8.8
29.6
0.4
1.3
0
8.0

> 0.05
> 0.05
> 0.05
< 0.01
< 0.05
> 0.05
–
> 0.05

21
5.6
1.4
4.9
0
1.4
0
0

<0.001
<0.001
>0.05
<0.0001
<0.0004
>0.05
–
–

nearly 51% of males and females in the urban area, 69% of
males in the rural area and 30% of rural females. Sputum
testing, however, was not well known, with only 24% of urban
males, 28.8% urban females, 23.1% of rural males and only
6.3% of rural females being aware of it.
We investigated the knowledge of the participants
regarding spread of TB (Table 2). In the rural area, 37.2% of
Table 2 Male and female (urban and rural) perceptions
on how TB is spread.
Spread of TB
Male
%
Droplet
Spitting
Utensils
Dirty water
Sexual relations
Syringes

38.9
9.2
0.9
2.6
3.1
0.4

Urban
Female
%
28.8
11.5
0.9
4.9
14.2
0

Rural
Male
Female
%
%
37.2
29.5
22.4
3.2
1.3
7.7

24.5
4.2
6.3
0.7
0.7
2.1

males and 24.5% of females said that TB is spread by droplets
while in the urban area this was cited by 38.9% of males and
28.8% of females. Spitting as a means of spreading TB was
given by 29.5% of males and only 4.2% of females in the rural
area. In the urban area, only 9.2% of males and 11.5% of
females said that TB is spread by spitting. More rural males
(22.4%) than females (6.3%) said that using the same eating
utensils as a TB patient can facilitate the spread of TB. In the
urban area, 14.2% of females and 3.1% of males felt the same.
Other reasons for the spread of TB included drinking dirty
water, reusing syringes and sexual relations (Table 2).
Regarding protective measures against TB, there were
significance differences between urban and rural groups
(Table 3). In the urban area knowledge about bacille CalmetteGuérin (BCG) was negligible in males, 1.7% compared to
32.7% in rural males. About a quarter of all respondents said
that staying away from a TB patient was the best protective
measure; while in men the difference between the urban and
rural areas was significant (P = 0.002), it was not so for
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women (P = 0.6). Only 7.1% of the urban females said that
completion of treatment at home was the best protective
measure. This figure was 22.4% for rural males (Table 3).
Table 3 Male and female (urban and rural) perceptions on
protective measures against tuberculosis (TB).
Measures to protect
Male
Female
Urban Rural P-value Urban Rural P-value
against TB
%
%
%
%
Stay away from
patient
Complete treatment
at home
Use anti-TB drugs
Have separate utensils
for TB patient
Use boiled water
bacille
Calmette-Guérin
Other

27.9

22.4

0.002

23.9

25.2

0.6

14.4
6.1

22.4
4.5

< 0.0001
< 0.0001

7.1
10.6

9.8
0.7

< 0.0001
< 0.0001

5.7
3.5

8.3
3.2

< 0.0001
< 0.0001

13.7
3.5

2.1
0

< 0.0001
< 0.0001

1.7
0.4

32.7
0.6

< 0.0001
–

4.9
1.6

8.4
0.7

0.0002
–

Table 4 Male and female (urban and rural) perceptions regarding
which part of the body tuberculosis affects
Body part
affected

Chest
Lungs
Kidney
Digestive system
Anywhere
Neck
Bones
Skin
Ribs
Reproductive organs
Liver

Male
Urban
Rural
%
%
59.8
39.9
10.5
2.6
2.6
1.3
0.4
0.4
0.4
0
0

45.5
26.9
0
2.6
6.4
0.6
0
10.9
1.3
0
0.6

Female
Urban
Rural
%
%
41.2
47.8
12.8
8.8
31.7
0
3.1
0
2.1
0
0

19.6
13.3
3.5
2.1
4.2
2.1
2.1
3.5
11.9
0
1.4

Urban-rural disparity was evident in gauging
knowledge as to which part of the body TB affects (Table 4).
More urban males (39.9%) than rural males (26.9%) said the
lungs were involved. Some men, 59.8% urban and 45.5%
rural, said that TB affects the chest. Urban females were more
knowledgeable than rural; 47.8% said that lungs were
involved compared with only 13.3% of rural females. Around
41.2% of females in the urban area said the chest was involved
compared with 19.6% in the rural area (P < 0.05). In both
areas, neither males nor females were aware that kidneys,
bones, the digestive system and the reproductive system could
also be affected.
In the urban area, 81.4% of females preferred to go to
a private clinic for treatment of minor illnesses compared to
21.7% of rural females. The majority of the rural females
(62.9%) preferred to visit the tertiary care hospital compared
to only 13.3% of urban females (P < 0.05). In males, a similar
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pattern was seen with 84.7% of urban males preferring to go
to a private clinic compared with only 39.7% of rural males.
The most favoured type of health facility for rural males was
the tertiary care hospital (50.6%). Rural males also went to the
hakim (traditional healer) and homeopath more often than
women (rural and urban) and urban males (Table 5).
Table 5 Male and female (urban and rural) health-seeking behaviour.
Health facility

Urban areas
Male
Female
%
%

Rural areas
Male
Female
%
%

Private clinic
Tertiary hospital
Government dispensary
Hakima
Homeopathic
NGO clinic

84.7
7.9
3.9
2.6
0.9
0

39.7
50.6
10.9
5.1
0.6
0.6

81.4
13.3
4.0
0
0.4
0.9

21.7
62.9
21.0
1.4
0.7
0

aTraditional healer.
NGO = nongovernmental organization.

When asked about stopping treatment, the majority of
urban respondents (> 65%), males and females, said that they
would stop treatment when the symptoms ended. This view
was also expressed by 43.4% of rural females but only 32.1%
of rural males. In rural males, 60.9% said they would follow
the advice of the doctor on when to stop the treatment but in
the urban areas < 25% of the respondents emphasized the role
of the doctor in this respect. A very small percentage said they
would stop treatment if they could not afford it (Table 6).
Table 6 Male and female perceptions (urban and rural) about when
to stop antituberculosis treatment.
When to stop
treatment

When symptoms end
When doctor advises
Cannot afford it

Male
Urban
Rural
%
%
65.5
23.6
0

32.1
60.9
1.9

Female
Urban
Rural
%
%
66.8
23.0
1.3

43.4
21.0
0.7

When asked with whom they would visit the health
facility, only 28.7% of rural females said they would go
alone while 53.0% said they would go with their husband or
a family member (35.0%). The majority (72.0%) of rural
males said they would go alone. In the urban area, only
35.8% of females were willing to go alone but 33.6% said
that they would need to be with their husband while 55%
said they could be accompanied by any family member. A
majority of the urban males (77%) also said that they would
go to the health facility alone.
To ascertain if it would be possible to get to hospital to
get treatment for TB on a regular basis, nearly 30.5% of urban
females said that they would not be able to go to the hospital,
while 90% of males said they would go. In the rural areas,
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65% of males said that they would be willing to go to the
hospital to get treatment, while 70% of females did not agree
to go to the hospital to get treatment. Only 27% of males and
38% of females in the urban area said that they would allow
an outsider to come and give the medicine to a TB patient. Of
these, half said that only a doctor could come, while nearly a
quarter said that only a female could come. In contrast, in the
rural area nearly 63% of males and 86% of females said that
an outsider could come and provide the TB medicines.
However, 80% of them said it should be a doctor or a woman.
Only 12%-14% of the respondents (except rural males,
34.8%) had received information about TB from either the
radio or television (Table 7). About 15% of men, both urban
and rural, had received information from newspapers. Very
few rural women (3.5%) received any knowledge about TB
from newspapers. However, 66.0% of rural men acquired
knowledge about TB from their local doctor, compared with
31.0% of urban men. Friends were also an important source of
information in urban areas (Table 7).
Table 7 Sources of information on tuberculosis (TB) stated by males
and females in urban and rural areas.
Source of
information

Doctor
Friends
Newspaper
Radio/television
TB patient
School
Leader/religious man

Male
Urban
Rural
%
%
31.0
27.5
15.3
14.8
6.1
1.7
0

66.0
3.8
14.7
34.6
1.3
0
0

Female
Urban
Rural
%
%
12.8
16.8
12.8
14.6
15.9
0.9
0

25.9
1.4
3.5
11.9
1.4
0
0.7

Discussion
Overall knowledge regarding TB has been found to
be extremely deficient in both sexes, but especially in
rural females. The respondents' perceptions about the
disease indicate the sociocultural trends prevalent in
society as well as lack of correct information on the
disease. Several important trends regarding basic
knowledge as well as the social perceptions pertaining to
gender differences and urban-rural disparity have been
highlighted through this study.
The perceived causes of TB varied from "germs" to
dirty water, many respondents, however, also associated
TB with drug addiction, which is an interesting
observation. Smoking and alcohol consumption have also
be cited in several other studies conducted in Kenya,
Philippines and Bombay.17-19 Rural males were more
concerned about the sharing of utensils than rural females.
Most respondents were aware that TB is a contagious
disease and "sharing with a TB" patient was considered a
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major factor in its spread. This finding is supported in
studies from Kenya and India.17-19
Knowledge about BCG vaccination as a preventive
measure was very limited, except in rural men (32.7%).
Again, a substantial proportion of rural men (22.4%) and
some urban men (14.4%) said that completing the treatment
helped in preventing others from developing TB. Rural
females generally had less knowledge on means of
protection against TB than the other 3 groups.
The disparity in health-seeking behaviour between
the urban and rural population was quite apparent in this
study; the urban respondents generally frequented private
clinics while the rural respondents, especially males, visited
government public hospitals more frequently. Females were
found to be more likely to discuss their medical problems
with their husbands or other family members while the
males were found to chiefly discuss these issues with their
doctors. It was seen that rural males followed the advice of
the doctor regarding when anti-TB treatment should be
stopped. This health-seeking behaviour explains the better
knowledge level of the rural males. Doctors appear to play
a limited role in providing health education in urban areas.
In the urban area, males and females frequently visit private
practitioners and in slum areas, many private practitioners
are unqualified health care providers. Even if qualified, they
do not participate in continuing medical education
programmes and are unaware of the recent trends in disease
and they do not have time to give health education messages
to their patients. Since public health programmes such as
directly observed treatment short-course (DOTS) are not
implemented through the private system, many are not even
aware of these strategies. Hence, in the urban areas,
knowledge of males as well as females was limited.
In the rural areas, most public health strategies are
implemented at the public health facilities, where the
doctors are well versed in the public health programmes and
provide health education messages to all patients. Since
rural males visit these public health facilities, they have a
better perception of the disease and are more knowledgeable
about various issues pertaining to TB. Rural females are not
allowed to venture out of the house freely, hence their
exposure is limited, and not only do they have a narrow
vision of the disease implications, their understanding and
perception of the disease are also very limited. They tend to
view TB as a "punishment from God" and strongly
stigmatize the disease. These observations are further
strengthened by the finding that the media (radio, television,
newspapers) were not an important source of information
on TB except for rural males. This is a manifestation of
groups of rural men watching television in hotels in
villages. In the case of rural males (66%), the doctor plays
an important part in imparting knowledge. Hence, contrary
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to the general belief, it was the rural males who were more
aware of the disease implications of TB.
The DOTS strategy is the recommended treatment
for TB in Pakistan. This strategy involves supervised
administration of TB drugs and may require daily visits of
the TB patient to a health facility for administration of the
drug or supervised drug administration at home in the
presence of the health worker. We found that both rural and
urban females were generally reluctant to visit health
facilities alone, more so rural females. Rural women would
not be allowed to visit the health facility unless
accompanied by husbands or other family members. Rural
respondents were, however, more open to allowing
outsiders to come to the house to provide medicines.
Health-related beliefs and practices play a very
important role in the success of any health intervention
strategy. For the success of DOTS in Pakistan, it is
important ascertain the willingness of the patients to take
the TB medicines in the presence of health personnel. Our
study outlines the constraints that females, especially rural
females, may face in regular visits to the health facility. The
urban restraint, i.e. unwillingness to allow outsiders into the
house, should also be taken into consideration. Female
health workers, either lady health workers or female
community workers, could be employed in this capacity.
However, this would need to be strengthened by forceful
motivation from the Government.
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Abstract
Jail inmates may be at increased risk of contracting
tuberculosis (TB). We studied 386 detainees (mean age 17.7
years) in Karachi juvenile jail to determine the prevalence
of TB and possible risk factors for contracting TB. We
found a 3.9% prevalence of TB among the inmates,
significantly higher than the estimated 1.1% prevalence in
the general population of Pakistan. Positive family history
of TB was a significant risk factor for TB. Poor adherence
of previously diagnosed patients to anti-TB treatment was
found. Our study highlights the vulnerability of inmates to
TB owing to the presence of highly infectious cases, along
with environmental conditions such as overcrowding and
poor ventilation. This study strongly indicates the need for
an effective treatment programme in the jails as well in the
general community.

Introduction
Available data around the globe suggest that jail
inmates are at increased risk of contracting pulmonary
tuberculosis (TB).1-3 Factors such as overcrowding,
malnutrition and limited access to health care services
put prison inmates at high risk. Children and adolescents
are even more vulnerable. There is increasing recognition
that the high risk of TB in settings such as prisons,
remand centres, police stations, detention centres for
asylum seekers, penal colonies, and prisoner-of-war
camps poses a problem for those imprisoned and for the
wider society.2 A study conducted in Mwanza, Tanzania,
revealed that 40.7% of the prisoners studied had smearpositive TB.3
Pakistan contributes 43% of the disease burden in
the Eastern Mediterranean Region of the World Health
Organization, and thus ranks sixth among the countries
with the highest burden of disease for TB,4 but
unfortunately there are limited data available regarding
prevalence of TB among jail inmates in general, and
juvenile detainees in particular. Through this study we
proposed to determine the prevalence of pulmonary TB and
the associated risk factors among juvenile detainees in
Karachi in order to complement national and international
efforts to control TB in the community in general and in
prisoners in particular. The city of Karachi was selected for
the study because it is the most populous city of the
country, with a population of more than 10 million, and has
residents from all parts of the country. The juvenile prison
Vol. 59, No. 4 (Suppl. 1), April 2009

in Karachi reflects the same characteristics as the city,
housing prisoners from all parts of the country and even
from neighbouring countries.
The proposal for this study was approved by the
Ethical Research Committee of Sindh AIDS control
programme, Karachi, Pakistan. Study participants were
recruited after obtaining informed written consent and all
study participants diagnosed with TB were provided with
free treatment through the government of Sindh directly
observed treatment short course (DOTS) programme.

Methods
A cross-sectional study was conducted in the
juvenile prison in Karachi during the calendar year 2002.
The medical officer of the prison and technicians were
trained in laboratory techniques, clinical diagnosis and
management of TB with the DOTS strategy at Ojha Institute
of Chest Diseases, Karachi, for 2 weeks. The technician and
the prison dispenser also received training in sputum
microscopy at the Institute of Chest Diseases.
All participants were interviewed using a structured
questionnaire
which
included
questions
on
sociodemographic characteristics, past and family history of
TB, and other risk factors. They were then clinically
examined by the medical officer.
Prisoners were suspected of having TB on the
grounds of clinical findings, past history of diagnosis of TB
infection and family history of the illness.
Individuals identified as suspected TB cases were
investigated for acid-fast bacilli (AFB) in their sputum. A
TB suspect was defined as any person who presented with
symptoms or signs suggestive of TB, in particular cough of
long duration (more than 2 weeks).5
Three specimens of sputum were then collected form
the suspects and examined by microscopy using the ZiehlNeelson method of staining. The first specimen from a
suspected inmate was obtained on the first day of
examination after coughing and clearing the back of throat
(1st spot). The inmates were given a container to bring the
second (overnight) specimen next day. The third and final
specimen was collected on the second day (2nd spot).
Individuals with at least 2 positive smear results
were diagnosed as sputum smear-positive active pulmonary
TB cases, and were registered for the DOTS programme
with Sindh TB control programme.
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Diagnostic criteria for sputum smearnegative
pulmonary TB cases were: at least 3 sputum specimens
negative for AFB, no response to a course of broadspectrum antibiotics and a decision by a clinician to treat
with a full course of anti-TB chemotherapy.
Neither X-ray nor culture facilities were available in
the jail and were therefore not included in the case
definition.
This programme was carried out under the auspices
of the government of Sindh with the assistance of the World
Health Organization. Efforts were also made to transfer
patients to the nearest DOTS programme after their release
from prison.
Risk factors for contracting TB infection in prison
were studied by random selection of 60 controls among
non-suspect individuals and comparing them to the 15
cases.
The Z-test was used to compare the prevalence of
TB in prisoners and in the general population. Univariate
and multivariate analyses of risk factors for contracting TB
in prisons was performed by calculating the odds ratio and
95% confidence interval. Data management was carried out
using Epi-Info, version 6.04 and SPSS, version 10.0
statistical packages.

Results
We enrolled 386 single male juvenile detainees in
the study. Mean age ± SE was 17.7 ± 1.3 years (range 15-23
years) though the official age limit for juvenile jail inmates
is 18 years. Pakistanis accounted for 357 (92.5%) detainees.
The rest were from India or Myanmar (Table 1). Most (87.9)
were residents of Karachi. The average family size for the
detainees was 8 (range 1-25). They were all imprisoned in
10 barracks, averaging 35.0 ± 11.7 prisoners per barrack
(range 10-59 prisoners).
In 14.7% (53) of cases, the father of the inmate was
dead. In the rest of the cases 25.4% (98) of the fathers were
labourers, 18.9% (73) self-employed, 12.7% (49) in public
or private service, 24.4% (94) had other professions and
4.9% (19) were unemployed. Of the inmates themselves,
1.0% (4) were unemployed, 47.7% (184) were labourers,
17.1% (66) were selfemployed, 13.2% (51) were in service,
and the remaining 21.0% (81) had other professions. About
60% (228) of participants were illiterate, and none had
higher secondary school or above education (Table 1).
The period of imprisonment was 1-6 months for
52.3% (202) of jail inmates, 6- 12 months for 20.2% (78),
more than 1 year for 16.3% (63) and less than 1 month for
11.1% (43). In addition, 12.7% (49) of inmates had a
previous record of imprisonment. We found that 42.6%
(164) of jail inmates were smokers and 21.5% (83) were
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Table 1: Sociodemographic characteristics of juvenile
jail detainees (n = 386).
Characteristic
Age
15–16 years
17–18 years
18 + years
Education
Uneducated
Primary
Secondary
Nationality
Pakistania
Non-Pakistani
Residence
Karachi
Outside Karachi
Father’s occupation
Died
Unemployed
Labourer
Government service
Private service
Self employed/business
Driver
Farmer
Fisherman
Other
Detainee’s occupation
Unemployed
Labourer
Service
Self employed/business
Fisherman
Student
Other
Family members in the household
1–4
5–8
9–12
> 12

No.

%

58
239
89

15.0
61.9
23.1

228
79
79

59.1
20.5
20.5

357
29

92.5
7.5

320
66

82.9
17.1

53
19
98
23
26
73
29
26
31
8

13.7
4.9
25.4
6.0
6.7
18.9
7.5
6.7
8.0
2.2

4
184
51
66
38
30
13

1.0
47.7
13.2
17.1
9.8
7.8
3.4

50
187
123
26

13.0
48.4
31.9
6.7

aArea of origin: Karachi (82.9%); interior Sindh (1.3%); Punjab (4.1%); NorthWest Frontier province (2.6%); Balochistan (1.3%); northern
areas (0.3%).
s = standard deviation.

drug users. Among the drug users, 83.6% were inhaling the
drugs and only 1.4% had a history of injecting (Table 2).
Nine jail inmates had previously been diagnosed
with TB; 3 had received the full 6 months treatment, 2 did
not receive any treatment, and 4 received irregular
treatment, but all of them were symptomatic on clinical
examination during our study (Table 3). One of the 3 cases
who had received 6 months treatment was also positive for
AFB. All had been symptomatic for TB for more than a
month. Among the 6 patients who received no or irregular
treatment, 3 complained of cough, fever, weight loss and
haemoptysis. One had a history of fever and cough while
the other 2 were suffering from chronic cough.
J Pak Med Assoc (Suppl. 1)

Table 2: Risk factors for tuberculosis (TB) among
juvenile jail detainees (n = 386).
Characteristic
Duration of stay in jail
< 1 month
1–6 months
> 6–12 months
> 1 year
Past history of imprisonment
Yes
No
Family history of TB
Yes
No
Don’t know
Smoking history
Smoker
Non-smoker
History of drug use
Drug user
Non-drug user
Method of drug use
Inhalation
Ingestion
Inhalation + ingestion
Inhalation + ingestion + injection
Didn’t reply

Table 4: Rates and clinical features of tuberculosis (TB) infection
among juvenile jail detainees (n = 386).

No.

%

43
202
78
63

11.1
52.3
20.2
16.3

49
337

12.7
87.3

29
347
10

7.5
89.9
2.6

164
222

42.6
57.5

83
303

21.5
78.5

61
9
2
1
10

15.8
2.3
0.5
0.3
2.6

Table 3: Aspects of previous treatment for tuberculosis (TB) among
juvenile jail detainees (n = 386).
Characteristic
History of TB
Yes
No
History of treatment for TB
Yes
No
Course of treatment
Completed
Not completed
Duration of incomplete treatment (months)
3
3.5
5
Duration of interruption to treatment (months)
<1
>1

No.

%

9
377

2.3
97.7

7
2

1.8
0.5

3
4

0.8
1.0

2
1
1

0.5
0.3
0.3

1
3

0.3
0.8

Forty-eight (12.4%) prisoners had been suffering
from 1 or more symptoms (cough, fever, weight loss
and haemoptysis) for more than 1 month (Table 4).
Seventy-three jail inmates (18.9%) were
initially suspected for TB on the basis of clinical
symptoms, family history and past diagnosis of TB.
Of these, 48 had clinical signs and symptoms
suggestive of TB, 33 had a family history of TB,
while 8 had symptoms suggestive of TB in addition to
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Characteristic

No.

%

Registered for DOTS
Symptoms suggestive of TB
Cough > 4 weeks
Cough + fever > 4 weeks
Cough + fever > 4 weeks
+ weight loss
Cough + fever > 4 weeks
+ weight loss + haemoptysis
Cough + fever > 4 weeks
+ haemoptysis
Cough > 4 weeks
+ haemoptysis
Fever > 4 weeks
Weight loss + haemoptysis
Haemoptysis
Sputum smear microscopy
Specimen 1
Positive sputum
Negative sputum
Fresh blood
Saliva
Specimen 2
Positive sputum
Negative sputum
Fresh blood
Saliva
Specimen 3
Positive sputum
Negative sputum
Fresh blood
Saliva

15

3.9

20
10

5.2
2.6

1

0.3

4

1.0

1

0.3

2
4
1
5

0.5
1.0
0.3
1.3

1
17
5
50

0.3
4.4
1.3
13.0

3
16
4
50

0.8
4.1
1.0
13.0

3
16
4
50

0.8
4.1
1.0
13.0

family history of the disease.
For the AFB smear test, of 73 suspected cases, in 19
(26.0%) cases we were able to obtain sputum while the rest
had saliva and blood in their specimen but no sputum. Of
the 19 whose sputum was tested, 5 (26.3%) showed AFB on
microscopy.
On the basis of the AFB smear results, previous
diagnosis of the disease and signs and symptoms strongly
suggestive of TB, 15 (3.9%) jail inmates were identified
as suffering from TB and selected for the DOTS regimen.
Inmates who had tested negative for AFB and had no
history of earlier diagnosis were selected for the DOTS
regimen mainly on the clinical judgement of the treating
physician.
Table 5 shows the risk factors for contracting TB.
There was elevated risk among patients who were illiterate,
Karachi residents, those whose father was unemployed,
smokers or drug users; the results were not, however,
statistically significant. However, there was a 7-fold
increased risk among those reporting a family history of TB,
and this was statistically significant.
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Table 5 Risk factors for contracting tuberculosis (TB) infection in prison.
Risk factor

Education
Uneducated
Educated
Nationality
Pakistani
Non-Pakistani
Residence
Karachi
Outside Karachi
Father’s occupation
Died or unemployed
Employed
Number of family members in household
>6
6 or less
Duration of stay in jail (months)
>6
<6
Past history of imprisonment
Yes
No
Family history of TB
Yes
No or don’t know
Smoking history
Yes
No
History of drug use
Yes
No

Cases
(n = 15)
%
No.

Controls
(n = 60)
No.
%

Crude
OR

95% CI

Adjusted
OR

95% CI

10
5

66.7
33.3

36
24

60.0
40.0

1.33

0.35–5.24

1.33

0.36–5.60

15
0

100
0

57
3

95.0
5.0

ND

14
1

93.3
6.7

52
8

86.7
13.3

2.15

0.23–50.6

2.14

0.25–102.3

3
12

20.0
80.0

7
53

11.7
88.3

1.89

0.23–10.20

1.87

0.27–9.84

9
6

60.0
40.0

45
15

75.0
25.0

0.50

0.13–1.94

0.51

0.13–2.03

5
10

3.3
66.7

18
42

30.0
70.0

1.17

0.29–4.53

1.16

0.27–4.42

0
15

0
100

11
49

18.3
81.7

ND

4
9

30.8
69.2

3
55

5.2
94.8

8.15

1.22–58.59

7.78

1.12–62.48a

9
6

60.0
40.0

29
31

48.3
51.7

1.60

0.44–5.96

1.59

0.44–5.37

7
8

46.7
53.3

20
40

33.3
66.7

1.75

0.48–6.42

1.74

0.43–6.40

ND

ND

OR = odds ratio.
CI = confidence interval.
aYates corrected chi-squared = 5.21; Fisher exact P-value = 0.018.
ND = not determined.

Discussion
We found a 3.9% (15/386) prevalence of TB among
the prisoners in Karachi juvenile jail. This high prevalence
of the disease in the inmate population may be related to
overcrowding, poor ventilation and malnutrition in the jail
environment. Furthermore, poor health care facilities
jeopardize adequate treatment of the infection and could
possibly result in the development of resistant strains in
prisons.
Our study highlights one of the important aspects of
M. tuberculosis infection in the community-a high rate of
poor compliance and the possible emergence of multidrug
resistant strains. Of 9 cases diagnosed with TB, 4 had
received partial treatment and only 3 had completed their
treatment. But all these cases, irrespective of whether they
received treatment or not, were symptomatic. The detection
of 5 AFB positive cases during our study suggests a high
vulnerability of jail inmates to TB. The presence of AFB in
the sputum suggests a high level of infectivity. Coughing,
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overcrowding and poor ventilation produce conditions
which allow the bacteria which cause TB to remain viable
for a long time, thus exposing everyone who comes into the
barracks, whether a prisoner, member of staff, visitor or an
investigator, to infection.
Family history was identified as a major risk factor
for TB, with 33 (8.5%) prisoners reporting history of TB in
the family. Of these, 8 (24%) were initially suspected of
having TB on the basis of signs and symptoms. Later, 4
(50%) were selected for the DOTS programme; 2 of them
were AFBpositive and 2 had a history of cough, fever, and
haemoptysis for more than 1 month.
Poverty was stated as a major reason for not
receiving treatment following diagnosis in 14% (17) of
previously diagnosed, but not treated, prisoners. Similarly,
in 14% (17) ignorance of the consequences of the disease
may have been the reason, as those prisoners failed to give
any explanation for not receiving treatment. Poor
compliance to the anti-TB regimen appeared to be
J Pak Med Assoc (Suppl. 1)

responsible for treatment failure in 42% (37) of cases,
circumstances which may favour the emergence of
multidrug resistance.

The finding of this study that jail inmates are at
increased risk for TB infection is in line with earlier studies
conducted in prisons in other parts of the world.1-3

Our study identified a limitation in using the AFB
test as the sole criterion for diagnosing TB infection. It
certainly improves the specificity of the diagnosis, but at the
cost of poor sensitivity. No AFB-positive prisoner was
found asymptomatic, suggesting no false positive diagnosis,
using this criterion. Many patients suffering from TB
infection were, nevertheless, AFB-negative, suggesting the
possibility of some false negative results, perhaps due to
undetectable levels of AFB in the smears, or poor quality of
specimen collection, staining and microscopy. This may be
related to indiscriminate use of antibiotics, including
antimycobacterial drugs.

It is suggested that a TB control programme be
introduced in the jail environment, ensuring regular
screening of prisoners for TB infection and the early and
effective management of cases. Special attention should be
given to those reporting a positive family history of TB as
they have proved to be more likely to be infected. There is
also a need to ensure that all prisoners who were receiving
DOTS during their prison term continue to do so after their
release until the course of treatment is completed.
Overcrowding and poor sanitation and ventilation provide
M. tuberculosis an opportunity to persist for long periods
and infect others. There is a need to improve ventilation,
sanitation and overall living conditions in the jail
environment.

Another limitation noted in the study was the
language barrier. There were prisoners from the whole of
south-east Asia, speaking different languages and dialects.
This may be the reason that compliance of the prisoners
with regard to sputum collection was poor, even among the
prisoners who were complaining of a productive cough.
Difficulty was also noted in taking the clinical history of the
patients. It was also noted that 2 weeks training of
technicians with regard to AFB staining and microscopy
may not be sufficient to carry out these procedures
independently.
In our study, owing to the absence of radiological
support and culture facilities in the jail environment, the
treating physician was left with no option but to use his
clinical judgement and start the DOTS regimen for 7
previously diagnosed patients who had symptoms and for 3
clinically suspect cases who tested negative for AFB and
had no history of the disease. For the effective and rational
use of DOTS in prisons, it may be appropriate to have
facilities for radiography and microbial culture in clinically
suspected but AFB smear-negative cases before making any
judgement regarding treatment.
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Abstract
Objectives: To study the differences in presentation of
pulmonary tuberculosis in young adult and elderly
patients.
Design: A prospective study was conducted between
December 1999 to May 2000, which included all the
patients presenting with pulmonary tuberculosis at the
Department of Thoracic Medicine, Jinnah Postgraduate
Medical Centre (JPMC), Karachi.
Patients and Methods: here were 67 young adult (mean
age 30.63 yrs) and 36 elderly patients (mean age 65.92
yrs) with pulmonary tuberculosis. The difference in
presentation of two groups were analyzed for statistical
difference. Chi-square test was used for testing
difference of percentage. The students t-test was used for
testing difference of mean. The P < 0.05 level of
significance was adopted.
Results: he elderly patients were more likely to have
dyspnoea (73% vs 23.9% P<0.001) and non-specific
symptoms (62.2% vs 17.9% P<0.001) but less
haemoptysis (21.6% vs 46.3% P<0.01). The chest
radiograph in elderly patients more commonly had
extensive bilateral infiltration (32.4% vs 14.9%
P<0.03) and lower zone infiltration (37.8% vs 3%
P<0.001).
Conclusion: he result of our study suggests that elderly
patients with pulmonary tuberculosis were more likely to
present with dyspnoea, non-specific symptoms and
atypical radiographic appearance (JPMA 53:321;2003).

Introduction
Tuberculosis is one of the important
communicable diseases world wide. 1 The incidence of
tuberculosis has been increasing globally, almost 2
billion people (one third of the world's population)
around the globe are infected with M. tuberculosis. 2 It
is the world's biggest killer by a single pathogen
causing the death of three million people every year,
which is equal to approximately 6% of all the deaths
worldwide. 3 Some studies have shown that the
diagnosis of TB in elderly is frequently delayed or
found at autopsy. 4-11 However others suggested that
the pattern of TB in the elderly is so characteristic,
that it should be given a separate classification. 12 In
this prospective study we tried to evaluate, whether
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there is any difference in presentation of young and
elderly patients with pulmonary tuberculosis, as the
incidence of tuberculosis in our population is very
high.

Patients and Methods
This study was conducted between Dec, 1999 to
May, 2000 in newly diagnosed patients of pulmonary
tuberculosis, at the Department of Thoracic Medicine,
JPMC, Karachi. Demographic data, presenting
symptoms, radiographic appearance, weight of the
patients, AFB smear either sputum of gastric lavage
(those who failed to produce sputum) were collected. The
patients were divided into two groups (1) younger (<60
years) and elderly (>60 years) age groups. The difference
in presentation of the two groups were analyzed for
statistical differences, chi-square test was used for testing
difference of percentage and student's t-test was used for
testing difference of means. The P<0.05 level of
significance was adopted.

Results
Demographic data for the patients are presented in
Table 1, consisting of 67 young and 36 elderly patients
with pulmonary tuberculosis. The diagnosis was made by
positive AFB smear. The mean age in the younger group
was 30.63 years and in the elderly group 65.92 years. The
mean body weight of elderly patients was greater than
that of younger patients (47.83kg vs 45.69kg P not
significant). There were greater number of smokers
amongst elderly patients (38.88% vs 23.9, P not
significant) (Table 1).
The presenting symptoms are listed in table-2
patients with younger age group were more likely to have
night sweats (56.7% vs 8.1% P<0.001), fever (98.3% vs
83.8% P<0.01). haemoptysis (46.3% vs 21.6% P<0.01)
and weight loss (74.6% vs 51.4% P<0.02). However the
elderly patients were more likely to have dyspnoea
(73.0% vs 23.9% P<0.001), chest pain (40.5% vs 14.9%
P<0.002) and non-specific symptoms (62.2% vs 17.91%
P<0.001) such as dizziness, body aches and abdominal
pain. The symptoms of cough, sputum, anorexia and
malaise were not significantly different between the two
groups (Table 2).
Radiographic finding are given in Table 3. The
patients in the younger age group had a greater frequency
J Pak Med Assoc (Suppl. 1)

Table 1: Demographic data of patients with pulmonary tuberculosis.
Young
(n=67)

Elderly
(n=36)

P Value

30-36
18-55

65-92
61-80

P<0.001

35 (54%)
32 (43.2%)
45.69
64
3
16 (23.9%)

20 (52.2%)
16 (47.8%)
47.83
33
3
14 (38.88%)

NS P>0.92
NS P>0.70
NS P>0.25
NS P>0.25
NS P>0.25
NS P>0.11

Patient
Charecterstics
Age
Mean
Range
Sex
Male
Female
Body weight (kg)
Sputum AFB smear
Gastic lavage AFB smear
Smoker

Table 4: Associated medical problems in patients with pulmonary
tuberculosis.
Medical
problems

NS = not significant

COPD
Asthma
Pneumonia
Malignancy
Bronchiectasis
Diabetics
Cirrhosis
Peptic Ulcer
Hypertension
Psychiatric
Others
Total

Table 2: Presenting symptoms in patients with pulmonary
tuberculosis.
Young
(n=67)

Elderly
(n=36)

P Value

38 (56.7%)
66 (98.3%)
57 (85.1%)
66 (98.3%)
31 (46.3%)
50 (74.5%)
49 (73.11%)
23 (34.3%)
10 (14.9%)
12 (17.91%)

3 (8.1%)
34 (94.4%)
37 (73.0%)
31 (83.8%)
8 (21.6%)
19 (52.4%)
23 (62.2%)
11(29.7%)
15(40.5%)
23 (62.2%)

P<0.001
P<0.56*
P<0.11*
P<0.01
P<0.01
P<0.02
P<0.21*
P<0.69*
P<0.002
P<0.001

Presenting
symptoms
Night sweats
Cough
Sputum
Fever
Haemoptysis
Weight Loss
Anorexia
Malaise
Chest Pain
Non-Specific

* Not-significant

of upper zone infiltration only (31.3% vs 5.4% P<0.002).
The as elderly age group patients tended to have more
extensive lesion of both lungs (32.4% vs 14.9% P<0.03).
The lower zone infiltration was also seen more
frequently in elderly group patients (37.8% vs 3%
P<0.001) (Table 3).
Associated medical problems are listed in Table 4.
They were more commonly seen in elderly patients
(80.55% vs 25.37% P<0.001).
Table 3: Major radiographic finding in patients with pulmonary
tuberculosis.
Presenting
symptoms
Upper Zone inflatration Only
Middle Zone inflatration Only
Lower Zone inflatration Only
Wide Spread infilatration of
one lung
Wide Spread nflatration of
both lung
Cavitation
Miliary shawoding

Young
(n=67)

Elderly
(n=36)

P Value

21 (31.3%)
7 (10.4%)
3 (4.5%)

2 (5.4%)
2 (5.4%)

P<0.002
P<0.81*

21 (31.3%)

5 (13.5%)

P<0.05

10 (14.9%)
12(17.9%)
2 (3%)

12 (32.4%)
2 (5.4%)
2(5.4%)

P<0.03
P<0.011*
P<0.80*

*NS = not significant
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Young
(n=67)

Elderly
(n=36)

P Value

2 (3%)
3 (4.5%)
1 (1.5%)
6(9%)
1 (1.5%)
1 (1.5%)
2 (3%)
1 (1.5%)
17 (23.37%)

9 (24.3%)
2(5.4%)
2 (5.4%)
4 (10.8%)
2 (5.4%)
6(16.2%)
4 (10.8%)
29 (80.55%)

P<0.001
P<0.81*
P<0.082*
P>0.01
P>0.08*
P<0.001

* Not-significant

Discussion
The diagnosis of tuberculosis in elderly is
frequently made only at autopsy. 4-11 The delay in
diagnosis has often been attributed to atypical clinical
and radiological presentation. 13 Many studies have
compared the clinical presentation of pulmonary
tuberculosis in young adults versus the elderly.8,16-20
Morris went on to state that elderly patients with
pulmonary tuberculosis had a different disease.12
In the present study we have found that nonspecific symptoms are more commonly present in
elderly patients. They may therefore be treated for other
medical illness initially. There may be a considerable
delay before the diagnosis of TB is finally made.
Dyspnoea is more common in patients in the
elderly age group, and could be due to the higher
incidence of smoking, COPD and more extensive
lesions.
Haemoptysis is more common in patients with
younger age group and is probably related to a higher
incidence of cavitation.
Cough was a common presenting symptom in
both groups. Although many elderly patients have other
associated medical problems which may give rise to
cough, such as chronic bronchitis, emphysema, asthma
and malignancy, this symptom should be evaluated
seriously particularly if it prolonged and not responding
to treatment.
With respect to the difference in radiological
findings between the two groups, Some studies found
there was no difference.16 Teale C, et al suggested that in
the elderly there is a shift toward less common
presentations such as lower zone and miliary
shadowing.21 In our study lower zone infiltration only,
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occurred more frequents in elderly patients.
The findings of our study are consistent with
most of international studies.
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Conclusion
Our study showed that elderly patients with
pulmonary tuberculosis were more likely to present with
dyspnoea and non-specific symptoms. Similarly
radiographic appearance were atypical viz lower zone
infiltration and bilateral extensive lesions were more
common in this age group.
On the other hand younger patients presented
with classical symptoms of TB, and also had greater
frequency of upper zone infiltration on chest radiograph.
A knowledge of these differences should help make an
earlier diagnosis of pulmonary TB, especially in the
elderly in whom it may be often delayed.
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Cost of DOTS for Tuberculous Patients
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Abstract
Objective: To determine the cost of DOTS (directly
observed therapy short course) incurred by the patients.
Methods: A hospital based cross-sectional study was
conducted at Nazimabad Chest Clinic and Ojha Center
for Chest Diseases from January 2005 to July 2005. Two
hundred and twenty tuberculous patients with acid-fast
bacilli positive in their sputum were analyzed. Variables
for cost were assessed with respect to money and time.
Results: Most of the tuberculous patients (68%)
registered during the data collection period were females.
Thirty seven percent of the patients belonged to families
S-41

with 8-10 family members living under one roof. The
expense of direct cost for two months treatment was Rs.
3060-3600 (if patient was not buying the antituberculous drugs). Most of the patients who were on
DOTS spent more than 4 hours per day in obtaining the
therapy. The disease was found to be common in poor
families (75% of patients had total monthly income less
than Rs. 2000).
Conclusion: Tuberculosis was common in poor and
large-sized families. Time consumption on travel for
DOTS was a deterrent for compliance. DOTS coverage
should be modified to reduce time and financial cost for
the patients.
J Pak Med Assoc (Suppl. 1)

Introduction
Tuberculosis is a disease that has a major impact on
a global scale.1 Tuberculosis causes death of nearly 3
million people every year.2 Tuberculosis eradication has
become a matter of greater concern among the national,
international and local health authorities. Contributing 85%
to the total global burden, 22 countries have been identified
and labeled as highly endemic countries by W.H.O.3 Due to
the emergence of H.I.V., increased migration and the
deterioration of the health services in many countries, the
incidence has risen so drastically in recent years, that T.B.
was declared a global emergency by W.H.O. in 1993.4
Without increased investment in intervention strategies, the
global tuberculosis situation is expected to worsen in the
near future.5
There is little reliable epidemiological data
available for Pakistan, although TB is considered to be a
major cause of ill health.6 According to World Health
Organization (W.H.O.) report of the year 2000, Pakistan
stands at number " 6" behind China, India, Bangladesh
and Indonesia in the list of 22 highest burden TB
countries of the world.7. There are estimated 268,000 new
cases and 64,000 deaths from TB each year in Pakistan;
which bears 44% burden of TB cases in the W.H.O.
Eastern Mediterranean Region (E.M.R.O.).8 The annual
incidence of infectious T.B. cases is estimated to be
between 85-100 / 100,000 persons. Annually around
120,000 new TB cases are being added to the existing
number of infectious individuals. Based on burden of
disease estimates, TB represents 5% of the total DALYs
(disability adjusted life years); which indicates that the
burden of tuberculosis in Pakistan, is substantially higher
than the world's average of 3%.9
Tuberculosis is especially prevalent in the
population undergoing stresses of poor nutrition,
overcrowding, inadequate health and displacement.10
Government of Pakistan endorsed DOTS strategy and in
1994, in collaboration with W.H.O., revised the TB control
policy and technical guidelines.11
In DOTS patient swallows the medicines under
the watchful eye of the doctor, a health worker,
community volunteer, mohalla molvi, pharmacist, or
even any entrusted family member.12 The TB patient is
almost always cured if these medicines are taken
regularly for the entire period of time. The antituberculous drugs in this short-course chemotherapy are
Isoniazid, Rifampicin, Pyrazinamide and Ethambutol or
Streptomycin.
DOTS stops TB bacteria at the source. Curing a
contagious patient is the best way to prevent TB bacteria
from spreading to others.13
Vol. 59, No. 4 (Suppl. 1), April 2009

In Pakistan low treatment adherence prevails.14 In
the sixties Sloan and Sloan observed dropout rates of
66% in Sindh15, similar reports were found in the recent
Rawalpindi cohort study.16 Several studies have shown
financial factors contributing to non-adherence to
treatment. Research has shown irregularity of attendance
during the initial phase to be a major determinant for
treatment adherence not only in the initial phase but also
in the continuation phase.17 This study was conducted at
Karachi Medical and Dental College on tuberculous
patients to identify the barriers in the implementation of
DOTS.
The other objective of the study was to determine the
cost on DOTS incurred by the patients and the factors
responsible for non-compliance.

Patients and Methods
A cross-sectional study was conducted at Iqbal Yad
Chest Clinic (O.P.D.) of Ojha Center and Nazimabad Chest
Clinic. A sample of 220 was estimated assuring compliance
of 50% with a level of significance of 5%. All the
consenting patients attending the TB O.P.D. between 9:00
a.m. till 1:30 p.m. were registered between January and June
2005. Non-probability convenience sampling technique was
used.
A questionnaire was prepared keeping in mind the
information needed regarding DOTS with respect to money
and time. The variables for money were in terms of direct
cost spent in traveling and buying the O.P.D. slip. The cost
on buying anti-tuberculous drugs was not included as those
were given free at the centers. Indirect cost on DOTS was
the time spent in traveling and waiting in O.P.D. Cause of
previous incomplete treatment was also asked from the retreatment cases.
The questionnaire consisted of twenty close-ended
questions. For each question a code was assigned and data
was collected by face-to-face interaction through verbal
communication. Sputum was tested for acid-fast bacilli.
Pre-testing was carried out three days before the actual
study in O.P.D.

Results
Most of the patients registered in the TB center
(82%)(180/220) were the new cases. Nine percent were
relapses and 9% were defaulters (Figure 1). Sixty eight
percent (150/220) patients registered in the T.B. O.P.D. were
females, among them 40% (87/220) were in the age group
of 11 to 20 years and 21% of the males (45/220) were in the
age group of 31 to 40 years (Table 1).
Thirty seven percent (81/220) of the T.B. patients
belonged to those families where total family members
S-42

Table 1: Association of sex with the age of the TB patients.
Age in years

Male
No.

Patient
%

Female
No.

Patient
%

Total
No.

Total
%

11-20

3

1

87

40

90

41

21-30

15

7

30

13

45

20

31-40

45

21

15

6

60

27

41-50

3

1

15

6

20

9

> 50

4

2

3

1

5

3

Total

70

32

150

68

220

100

p-value

0.000

Table 2: Relationship of reasons for previous incomplete treatment with the total monthly income of the patients.
INCOME IN RUPEES

CAUSES
N=220
<2000
n=170
1. Expensive
medicine
n=5
2. Prolonged
treatment
not necessary
n=5
3. Long
distance
n=30
4. No cause
as new cases
n=180

2000-4000
n=31
No.
%

p-value

4000-6000
n=10
No.
%

No.

%

2

40

1

20

1

1

20

2

40

20

67

5

147

82

23

>6000
n=9
No.

%

20

1

20

0.0001

1

20

1

20

0.001

17

3

10

2

6

0.006

12

5

3

5

3

0.0003

** Expensive drugs was the cause of discontinuation of treatment when tuberculosis was first diagnosed.

9%(20)

9% (20)

New Patients
Relapse Cases
Defaulters

82% (180)

Figure : Distribution of the categories of the TB patients

were between 8 to 10 living under one roof. Sixty one
percent (135/220) patients spent Rupees 41 to 60 on
traveling. The mean daily expense was Rupees 42 and for
two months intensive therapy it was Rs.2520. Forty four
S-43

percent (96/220) patients stated that more than 4 hours were
spent (including traveling both ways and waiting in the
O.P.D.) on DOTS practice, mean time spent was 3 hours and
15 minutes.
Table 2 shows the causes of previous incomplete
treatment compared with the total monthly income of the
T.B. patients. Eleven percent (25/220) of the patients were
those who stopped treatment as it was expensive. Seventy
five percent (167/220) of the patients belonged to the
families where total monthly income was less than Rs.
2000. The relationship between the total monthly income
and the causes of previous incomplete treatment was
statistically significant (p=0.001).
The distance in kilometers traveled by the patients
compared with the categories of the patients, revealed that
57% (124/220) patients came from a distance more than 15
J Pak Med Assoc (Suppl. 1)

kilometers and among them most were new cases i.e., 43%
(95/220) The relationship between the categories of the T.B.
patients with the distance was statistically significant (p=
0.0038).

Discussion
Various studies in U.K. have established
overcrowding and socioeconomic deprivation as major
factors for the rise in tuberculous cases.18 A study in Lahore,
Pakistan showed that majority (71%) of the tuberculous
patients were members of the poor, deprived and lower
social class 19. In our study also majority of the patients
were from lower socioeconomic group (monthly income
less than Rs.2000) and having large families. Overcrowding
in small enclosed spaces with close and prolonged contact
with other family members provides an opportunity of
infection to spread from one individual to the other through
droplets or coughing.20 Most of the patients spent Rupees
51- 60 daily and for two months intensive therapy amounts
to Rs. 3060-3600, which the poor patients could not afford.
With poverty also comes malnutrition leading to weakening
of body defences. With the expense of treatment and the
lengthy therapy involved for tuberculosis, majority of the
patients could not afford to buy medicines and bear
traveling expenses when their basic needs are not being met.
Most of the male patients in our study group were found to
be in the age group when their families were dependent on
them for earning and providing financial support. This
would simply perpetuate the vicious cycle of poverty
leading to lower defences. Females from illiterate families
in general have a lower status in the family, and are deprived
of better quality of food leading to poor nutritional status. In
addition early marriages and multiple pregnancies put extra
burden on their defence system leaving them more
vulnerable to tuberculosis.
From our study it appears unlikely that medical
advances alone can control tuberculosis. As the powerful
tools for treatment and prevention which are currently
available have made little impact, so any new methods
would have little impact unless there is global political
willingness to address gross inequalities of wealth and
health care provision in society.21
While tuberculosis can affect anyone, the greater
burden of disease falls on the poor.22 The director of W.H.O.
Global TB Program has stated, "epidemic is no longer an
emergency only for those who care about health, but for
those who care about justice".23

communities and despite increased coverage of DOTS the
disease continues to increase in younger females and males
in their prime productive ages. DOTS coverage should
reach TB patients at home as time and travel cost are major
deterrents to compliance.
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Abstract
Objective: To assess knowledge of patients with
tuberculosis; about their disease and misconceptions
regarding TB.
Methods: A cross sectional study was conducted at Outpatient clinics of two teaching hospitals (private and
public) in Karachi, Pakistan. A questionnaire was filled
for the purpose.
Results: A total of 170 patients were interviewed, 112
from private and 58 from a public sector hospital. Cough,
fever, bloody sputum and chest pain were recognized as
the common symptoms of TB. Eleven (7%) patients
thought TB was not an infectious disease and 18 (10.6%)
did not consider it a preventable disease. Contaminated
food was considered the source of infection by 81
(47.6%) and 96 (57%) considered emotional
trauma/stress the causative agent of TB. No counseling
about preventing spread was received by 81 (50%)
patients and 97 (57%) considered separating dishes as an
important means of preventing spread. Thirty one (18%)
patients would have discontinued their medications
following relief of symptoms. Thirty nine (23%) of the
respondents thought that TB could lead to infertility and
66 (38.8%) believed that there were reduced chances of
getting married following infection.
Conclusion: Misconceptions concerning TB are
common in Pakistani patients. Lack of knowledge on
Tuberculosis is alarming.

Introduction
Tuberculosis (TB) has reached epidemic
proportions in many developing countries, with a third of
world population being infected. Every year there are 8
million new TB cases that results in 2-3 million deaths
worldwide, making TB the leading killer amongst all
infectious diseases. Pakistan ranks 6th in the world
among countries with the highest prevalence of TB. It
has an annual incidence of around 300,000 new TB
cases.1
Deficiencies in National TB Control Program are
compounded with widespread misconceptions and false
beliefs among TB patients. These myths have turned TB
into a social stigma. This stigmatization can play an
S-45

important role in reluctance of patients in seeking
treatment.2 Very few studies have been conducted in
Pakistan regarding awareness of TB among patients. No
programme for TB control can be effective unless
erroneous beliefs amongst the masses are identified and
removed. Future education has to be based on existing
scientific knowledge and presented in a manner that can be
easily comprehended and accepted by the patients. Social
and cultural factors have to be taken into account as they
play an important role in compliance of TB patients.3
The objectives of this study were to assess
knowledge of TB patients about their disease, and to
identify their misconceptions and social stigmas
associated with TB.

Methods
A cross sectional study was conducted at the outpatient pulmonary clinics in two teaching hospitals of
Karachi, which has a population of about 14 million. Aga
Khan University Hospital (AKUH) is a private sector
hospital, while the Jinnah Postgraduate Medical Centre
(JPMC) is a government sector health facility.
A total of 170 patients were interviewed.
Unselected adult patients (aged above 16 years) who
were suffering from TB or had suffered from TB in the
past were included in the study. Convenience Sampling
was used to recruit participants. They were questioned
about knowledge, attitudes and misconceptions
concerning TB.
A multiple choice questionnaire comprising a total
of 36 questions was designed in English. The
questionnaire was first pilot tested. After a few
modifications the questionnaire was implemented. The
questionnaire was translated in Urdu (the national
language of Pakistan) and administered to the patients by
trained research officers.
The questionnaire data was entered and analyzed
using SPSS version 11.0.

Results
A total of 170 patients were interviewed at two
tertiary care hospitals in Karachi. The demographic
J Pak Med Assoc (Suppl. 1)

variables are presented in the Table. Forty one (24%)
Table: Patient characteristic of TB cases from the Aga Khan
University Hospital (AKUH) and Jinnah Post Graduate
Medical Centre (JPMC), Karachi.
Variables

AKUH

JPMC

Total

112

58

170

72

20

92

40

38

78

None

17

24

41

Below matriculation

24

23

47

Past matriculation

54

11

65

Graduate

14

-

14

3

-

3

Total number of patients
Gender: Males
Females
Level of education

Post Graduate
Monthly income (in Pak. Rupees)
< 5000

30

49

79

5000-10,000

25

10

35

10,000-15,000

15

2

17

15,000-20,000

19

-

19

> 20,000

20

-

20

respondents had not received formal education of any kind,
whereas seventy nine (46.5%) were either unemployed or
earned less than Rupees 5000 ($85) a month.
Forty seven (27.6%) had not heard of TB before they
were diagnosed themselves and 16 (9.4%) thought that it
was a rare disease in Pakistan. Eleven (7%) did not consider
TB as an infectious disease. Inhaled droplets were
recognized as the common source of infection but eating
contaminated food (47.6%), use of blood products (32.9%)
and inheritance (27%) were also considered important
modes of transmission. Lung was considered as the only
organ affected by TB by 39 (23%) patients and 96 (57%)
thought that stress and emotional trauma could lead to
tuberculosis.
The four most commonly recognized symptoms of
tuberculosis were thought to be cough (83.5%), fever
(54.7%), chest pain (24.7%) and bloody sputum (24.7%).
Twenty eight (17%) responders thought that TB occurred
only once in a life-time and did not recur for a second time
after treatment. Thirty one (19%) patients believed that the
total duration of treatment was less than 6 months; while
31(18%) were of the view that treatment should be stopped
following control of symptoms.
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TB was not considered a preventable disease by 18
(10.6%) patients and 97 (57%) considered separating dishes
as the most commonly used method for preventing the
spread of TB. Thirty seven (22%) were not aware of
availability of vaccine against tuberculosis.
Fifty six (33%) patients were not concerned about
spreading TB infection to their family members. Eighteen
(10.6%) patients sought treatment approximately six
months after onset of symptoms. In the first instance, 94
(55.3%) patients first consulted their general practitioners in
private sector for treatment. In 18 (10.6%) patients it took
over 6 months from the time they first consulted a doctor
and were diagnosed with tuberculosis.
Diagnosis of TB was kept hidden from family and
friends by 70 (41%) patients and 66 (39%) thought that
there were less chances of getting married if one was ever
infected with tuberculosis. Thirty nine (23%) patients
believed that pulmonary tuberculosis could lead to
infertility.
Health care workers were the main source of
information about tuberculosis in 127 (75%) cases but 81
(50%) patients claimed to have received no counseling by
their physicians about how to prevent spread of infection.

Discussion
This study showed that misconceptions regarding
tuberculosis were widespread in Pakistani patients. Poor
knowledge of TB patients concerning their disease may
contribute to the high burden of TB disease in the country.2
The level of knowledge and awareness about TB is known
to correlate with seeking health care and time of
presentation.4,5 By educating the patients and removing
their misconceptions, patient compliance with therapy and
spread of disease is likely to improve.6
Diagnosis of TB was associated with anxiety and
sense of isolation. TB patients are exposed to a great deal of
ostracism from the community.7,8 Those infected have fear
of social aversion.2 Such stigmatization of TB patients in
the society can lead to reluctance in seeking treatment. In
this study, nearly 40% patients did not reveal their disease
to their relatives and friends. A majority of patients and their
relatives feel that the dishes of TB patients should be kept
separate from rest of the family members thus isolating
them further from their families. These misconceptions
were compounded by the fact that the patients received
inadequate education from their physicians; half of patients
received no information about ways to prevent the spread of
disease. Majority were unaware that TB was not infectious
after few weeks of treatment. Many patients felt that
preventive measures should be practiced for an indefinite or
long period of time.
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Despite the fact that these patients were visiting a
pulmonary clinic in teaching hospitals, and were on
treatment or had received treatment for TB, it could not be
assumed that they had received enough insight into their
disease. This study has highlighted serious deficiencies in
the knowledge of TB patients about their disease. In a
similar study from India Singh et al. reported that only 2.3%
of their respondents knew that TB was caused by a germ.8
More than half of the patients in our study were of the
opinion that TB may result from stress and emotional
trauma and 20% were of the view that treatment can be
stopped after control of symptoms. Clinical improvement,
unavailability of drugs or cost of drugs were reported to be
the main reasons for defaulting treatment in earlier
studies.9,10 Poor drug compliance could contribute multidrug resistance (MDR) TB in the country.
Another important aspect noted in this study was
that more than half of TB patients in Pakistan first
presented to their general practitioners in private sector and
up to 10% delayed seeking treatment for more than six
months after the onset of illness. A person suffering from
TB infects an average of 10-15 people in a year and
therefore the community should be made aware of TB
symptoms and the need for early treatment. Early
diagnosis, prompt treatment with compliance are necessary
to control the incidence of TB.
Coupled with poor patient knowledge, general
practitioners in high burden countries like Pakistan do not
have sufficient knowledge on TB therapy. Low compliance
with WHO guidelines makes the situation worse.11,12 The
physicians themselves were also prone to myths and
misconceptions concerning tuberculosis.13 It has been
shown that the method of diagnosis, treatment and
monitoring of treatment carried out by general physicians
was not satisfactory.14 Health care workers face the
challenge of changing behaviours in the community to
ensure that people with symptoms present early for
screening and that people diagnosed as having tuberculosis
comply with treatment.15 Health care workers must also
learn about local beliefs that may influence presentation and
adherence of patients.16 Therefore in order to make the TB
control programmes effective, not only the communities but
also health care providers must be educated.
Diagnosis of tuberculosis is associated with social
stigma in many countries. Almost half of the TB patients in
our study were of the view that being infected with TB
reduced their chances of getting married. Even though 95%
knew that TB was treatable, almost 40% claimed they
would not marry their children to someone who was
currently diseased, or had been infected in the past and has
now been cured of tuberculosis. In Ethiopia evil spirit and
S-47

sexual intercourse have been found to be incriminated as a
cause for TB. Their community also exhibits a great deal of
ostracism towards TB patients.7 "Cold" has been cited as a
cause of TB in Ethiopia.9 Belief in an association between
HIV and TB has been found in Zambia and Ethiopia.7,17
Alienation of TB patients has also been found in relatively
developed countries like South Africa.15 In the different
communities, different cultural beliefs like tuberculosis
resulting from sex after the death of a family member and
after a woman has a spontaneous abortion are prevalent.
People also believe that the resulting disease can only be
treated by traditional healers. There is also a belief in a
'western' type TB that can spread from sufferers or is due to
environmental pollution or to smoking or alcohol
excesses.16
To remove misconceptions about TB community
based awareness strategies should be designed, information
and education on TB must be disseminated out.7,8 Studies
conducted in Bangladesh, which faces similar social and
cultural background, have shown that well conducted
community health education campaigns can affect level of
knowledge and produce favorable attitudes towards
tuberculosis.18
In conclusion, poor knowledge and misconceptions
concerning tuberculosis are rampant in Pakistani patients.
Public awareness programs using the electronic media and
literature are crucial in educating the masses and removing
misconceptions. TB control program will remain ineffective
unless myths and fears of TB patients are addressed
simultaneously.
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Abstract

current DOTS strategy.

Purpose of the Study: Pakistan is among the high-burden
countries for tuberculosis. One of the fundamental problems
in TB control is a high defaulter rate among the registered TB
cases in the public sector. In 1999, a cross-sectional study was
designed to identify the determinants of low compliance for
the TB treatment in two rural districts in Sindh.

Introduction

Methods: Before the actual data collection, a pilot testing
was planned in a secondary level care hospital. Fourteen
defaulters for TB treatment were identified but none could
be contacted due to incomplete addresses. Other alternatives
were explored with the health facility team to reach them
including a field-based search through Lady Health Workers
of the National Health Program but all endeavors went into
vain. The pilot testing propelled us to postpone the crosssectional study but we continued scrutinizing the follow up
problem for TB patients in other health facilities. Not
surprisingly, more or less a similar picture was found in
those health facilities.
Principal Conclusions: The study concludes that the public
health care system in Pakistan lacks even the basic
requirements for an effective TB control program, that is, a
viable information system and the functional integration of
program with rest of the health care delivery system. A DOTS
strategy to control TB was initiated in the public sector in
Pakistan just one year prior to this study. The Ministry of
Health requires re-visiting the program to ensure that the
lacunae identified in this study are being taken care of in the
Vol. 59, No. 4 (Suppl. 1), April 2009

Pulmonary Tuberculosis is among the major killer
diseases. About one third of the world's population is
infected with the disease, 95% of which are in the
developing countries and 98% of all TB related deaths occur
in these regions. The burden of TB is greater in adults, more
than three-quarters of cases occur in the 15-59 age groups.1
Situation in Pakistan is not different from that in other
developing countries. In Pakistan, an estimated 260,000
new cases occur annually and more than 50,000 individuals
die due to TB.2 With a very high defaulter rate for the
completion of TB treatment, the incompletely cured patients
return to the community to further infect 10-14 people in the
course of a year. R. Liefooghe3 et al. cited results of a follow
up of 3950 TB patients, registered in Bethania Hospital
Sialkot, Pakistan between January 1988 and December
1990. The study revealed that 72% of the patients did not
complete their prescribed treatment course. Tuberculosis is
a disease which requires not only uninterrupted long-term
treatment but also, continuous monitoring of the patients in
order to ensure treatment compliance. Non-availability of
drugs, financial and physical accessibility to the health
centers and a lack of awareness regarding consequences of
incomplete treatment are the known causes for low
compliance for the TB treatment. Inconsistent treatment
policy with poorly managed, under funded and incorrectly
conceptualized TB control programs are the added factors.4
Non-compliance of a course can lead to relapse, possibly
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with drug-resistant bacilli.5 A larger part of the resources
within developing countries is likely to be used in near
future for diagnosis and treatment of TB, thus rendering it a
growing economic and financial burden.6
Control of tuberculosis is often given as a classical
example of a public health activity that is important for the
whole society and in which it is appropriate for the state to
play a dominant role.7 WHO recommends that each country
should analyze treatment results through cohort studies
based on a national recording and reporting system? Data
obtained from the Department of Health (DoH), Sindh
(Table 1)8 depicts the seriousness of the problem in the
Table 1: Summary of treatment outcome for TB patients in Sindh,
during 1995-99.

Registered Patients
Regular Patients
Defaulters
Cured
Deaths

1995

1997

1998

1999

524545
167727
356818
(68%)
9386
48

41959
8911
33040
(79%)
4213
122

27470
12185
15285
(56%)
5469
72

76408
42241
34167
(45%)
8470
151

Source: Directorate Tuberculosis Control, Department of Health,
Sindh, Hyderabad, 1999.

public sector, showing a very high percentage of defaulters
of all diagnosed registered TB cases, ranging from 45% in
1999 to 79% in 1997. It is better to understand the dynamics
involved in this dismal situation. A descriptive study was
therefore planned in 1999, in order to: 1) identify and
contact defaulters for TB treatment, registered at the
government health facilities. 2) find out the reasons for low
compliance for the treatment and, 3) determine the present
status of treatment and the disease among the identified
defaulters.
A provincial directorate of TB control manages the
National TB Control Program (NTP) in Sindh. The office of
the directorate is situated at Hyderabad. A district TB
Coordinator oversees the program in each district. The
program is part of an overall provincial and district health
system but operates as a vertical program, parallel to the
existing health services through their TB clinics and
microscopy centers. There are 161 TB clinics and 108
microscopy centers in Sindh.9 The program has its own
information system. The information gathered at the facility
level is sent to the District TB Coordinator who compiles
the report and forward it to the Director, TB control.

Methods and Results
Study design and study population
A descriptive study was designed to evaluate
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defaulters for the TB treatment at the government health
facilities in Sindh. Districts Mirpurkhas and Khairpur,
reporting the highest number of defaulters in 1998 (637 and
3116 respectively),8 were selected for the study. Based on
the TB defaulter rates for 1999, a sample size of 400 was
calculated.
In order to obtain the concurrence of the Directorate
TB Control and also to involve them in the study, several
meetings were held with the program director and his team
at Hyderabad. A pilot testing was planned to enhance the
internal validity of the data collection tools and also to
examine logistical requirements and the feasibility in the
field. Taluka Hospital at Tando Allahyar in Hyderabad
district was chosen for this purpose to make it convenient
for the Director TB control and his team to participate in the
study.

Data collection
The study data was planned to collect identified
defaulters using a structured questionnaire. Besides socioeconomic and demographic variables, the questionnaire
included specific variables such as: history of TB treatment
at the government health facility, method of diagnosis, type
and duration of treatment and reasons for discontinuation of
treatment. To assess the current status of the disease,
collection of three consecutive sputum smears according to
the WHO guidelines, was also planned.

Pilot Testing
The pilot testing was planned to identify the
defaulters for TB treatment who were registered at the
Taluka Hospital Tando Allahyar in Hyderabad district from
June 1998 to June 1999. Initial visits were paid to the health
facility to develop rapport with the health facility team and
also to give them an orientation about the study. The
Director of the TB control program and his assistant also
accompanied the principal investigator.
Available records were reviewed to identify TB
treatment defaulters. Fourteen defaulters were identified
through the TB register during the period June 1998 to June
1999. They could not be treated due to their incomplete
addresses. Other alternatives were explored with the health
facility team to reach the defaulters. Lady Health Workers
(LHWs) of Prime Minister's Program, now called as
National Program for Primary Health Care and Family
Planning, were considered to be the best option to reach
them*. Around 40 LHWs were contacted and requested to
find the reported defaulters. Again with the incomplete
addresses none of the 14 defaulters could be identified. With
this frustrating situation, another compromising strategy
was applied. All 40 LHWs were asked to provide addresses
of all TB cases known to them in their catchment area, in a
J Pak Med Assoc (Suppl. 1)

hope to find defaulters for the government health facilities
from their lists. Of 110 TB patients identified by the LHWs,
16 were reported to have discontinued their treatment
before the completion of the advised course. Among those,
12 were available for the interview and the collection of
their sputum smear. None of them had ever registered or
received any treatment for tuberculosis in a government
health facility. Mean age of the identified defaulters was
39.4 with a range between 25 and 54 years. Six were males
and 6 females. Sputum specimens were sent to the
collection point of Aga Khan Hospital's laboratory at
Hyderabad, and the final examination was done at AKUH's
main laboratory at Karachi. No sputum was reported
positive for acid-fast bacilli.

Further exploration after the pilot testing
The whole exercise appeared a futile one. It was
concluded that further efforts to pursue with the same
strategies would produce no results in the proposed study sites
viz. Mirpurkhas and Khairpur. This pilot testing however
brought up some very important operational issues and
problems attached with the health care delivery system in the
public sector. The most apparent and important finding was an
inefficient health management information system for the TB
control program. In a seminar, held in Cotonou, Benin,
organized by the International Union Against Tuberculosis
and Lung Diseases, it was stressed that a good notification
system is a key element for the success of National
Tuberculosis Programs (NTPs).10 A valid and credible
information system is a pre-requisite for instituting an
effective decision-making process. Owing to the importance
of this area for TB management, we shifted the focus of our
study to further explore the issue of proper registration of TB
cases in other health facilities in the province.
Pursuing further, we visited five more health care
facilities in Hyderabad, Dadu and Badin districts (Table 2) to
Table 2: List of health facilities in three districts
visited after the pilot study.
Location of
health facilities
Kotri
Talher
Nassar Pur
Tando Jam
Chumber

Type of health facility

District

Taluka Headquarter hospital
Rural health center
Rural health center
Rural health center
Rural health center

Dadu
Badin
Hyderabad
Hyderabad
Hyderabad

assess the TB management information system and its role in
the follow-up of registered TB cases. Of five health facilities
visited, one had discontinued its TB clinic due to nonavailability of a medical officer and irregular supply of antiTB drugs. Rest of the health facilities had the same problem
Vol. 59, No. 4 (Suppl. 1), April 2009

of inadequate addresses of the registered TB patients. One
medical officer explained that he had good relationships with
two local General Practitioners (GPs) and that they always
helped him find the TB cases whenever needed for follow up.
He further explained that since there was no formal setting of
households in the rural areas with proper addresses, one has
to find and live with such kind of alternate arrangements.
However, on request to demonstrate such mechanism, he
regretted that two GPs were only available in the evening
time at their clinics. In one health facility, we did not find a
single defaulter for the TB treatment during the whole
calendar year, an unexpected and startling finding despite
incomplete addresses in the TB register. The TB medical
officer explained that this was made possible only due to his
personal efforts. He further claimed that being a local doctor
he knew the whole catchments population of his health
facility. He, however, clarified that patients who came from
areas outside the catchment area of his health facility, were
not labeled as defaulters if they were lost during the course of
treatment. The other two health facilities also portrayed a
similar picture with inadequate addresses, no follow-up
mechanism, shortage of anti-TB drugs, and non-availability
of properly trained personnel for TB management.

Conclusion and Recommendations
A flawed assumption of tracing TB treatment
defaulters using the existing information system led to
premature cessation of the study during the pilot phase.
However, this pilot testing followed by a brief operations
research has identified certain important operational
problems that render the delivery of TB control program
less effective. The most striking discovery was the lack of
any meaningful management information system, which
can facilitate any follow up of patients. Moreover, there was
a serious lack of integration of the TB control Program with
the rest of the available health care services, particularly
with the field-based Lady Health Workers' National Health
Program. These findings indicate that the public sector
health care delivery system in Pakistan lacks even the most
fundamental elements of an effective health care system.
A DOTS strategy is being implemented in Pakistan
under the revised National Tuberculosis Control Program
(NTP). DOTS expansion began in earnest after 2000 when
the government rehabilitated provincial TB programs
through World Bank's Social Action Program Project II.11
This small-scale operations research was conducted just one
year prior to the country-wide launching of DOTS program.
The findings thus have several implications for an effective
DOTS strategy in the country. The ambitious target of
achieving 100% DOTS coverage by the year 2003 requires
the Ministry of Health to revisit current DOTS strategy in
order to assess the role of Lady Health Workers, the local
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communities and the General Practitioners in TB case
finding, and the use of information system for monitoring
the program activities. The existing Health Management
Information System in the public sector has tremendous
potential to deliver health services more effectively. Its
proper utilization in decision-making can improve the
quality of collected data. Just recording the complete address
of the registered TB patient would greatly facilitate followup to ensure completion of the prescribed treatment regimen.

Dr. Arif Soomro and his team for their assistance and
participation in the pilot testing at Taluka Hospital Tando
Allahyar. Special thanks for Dr. Anwar Islam, former Head of
Health System Division at Community Health Sciences
Department of the Aga Khan University for his inputs to the
initial draft of this article.
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Abstract
The World Health Organization estimates that up to 50
million persons worldwide may be infected with drug resistant
strains of TB. The fatality rate of MDR-TB is 20-80%.
Drug resistant tuberculosis cases are on the rise in
Pakistan. The reasons for this menace are multiple including
improper prescription, compliance and over the counter sale
of anti-TB drugs. The treatment cost of drug-resistant TB is
high, both to the individual patient and society.
This article is written to create awareness about the
available second line drugs and those in the pipeline.
Considering the fact that resistant tuberculosis is difficult to
manage, it is suggested that these drugs should only be used
after consultation with a physician experienced in the
S-51

treatment of drug resistant TB. The most frequent mistake
made by treating physicians is addition of one drug in the
failing regimen.
At present, 27 potential anti-TB drugs are at various
stages of development. The aim is that by 2010 at least one
of these molecules completes the journey and should come
in the market.

Introduction
Tuberculosis infects one third of world population
and every 15 second one patient dies of TB. Tuberculosis
takes global economic burden of $12 billion a year. During
the last thirty years no new anti-tuberculosis drug has been
introduced for clinical use. Now research is on going for
developing new drugs in this field. There is a great need to
J Pak Med Assoc (Suppl. 1)

win the war against tuberculosis. Some of the drugs have
been very effective against Mycobacterium Tuberculosis
like Rifamycin derivatives, combination of betalactum
inhibitor and betalactum agents and fluoroquinolones. The
purpose of this article is to discuss new emerging drugs and
their efficacy in the treatment of tuberculosis.

New Anti-Tuberculosis Drugs
Rifamycin derivatives: The rifamycins are a group of
antibiotics, which are synthesized either naturally by the
bacterium Amycolatopsis mediterranei, or artificially.
Rifamycin acts by binding specifically to the ß-subunit of
bacterial DNA-dependent RNA-Polymerase, RpoB.1
Rifamycins are particularly effective against mycobacteria,
and are therefore used to treat tuberculosis, leprosy and
mycobacterium avium complex (MAC) infections.
*
*
*

*

*

The rifamycin group includes the following drugs:
Rifamycin A, B, C, D, etc. (the "classic" rifamycin
drug)
Rifampicin
Rifabutin: an orally active, semi synthetic antibiotic
which is derived from Rifamycin S. It is used for the
prevention of disseminated Mycobacterium avium
complex.
Rifamide: a derivative of Rifamycin B is used against
gram-positive cocci causing respiratory tract infections
and against gram-negative and gram-positive
organisms in biliary tract infections.
Rifapentine: has a longer half-life than Rifampin and is
similar to it.

Rifabutin
Rifabutin is a semisynthetic spiropiperidyl
derivative. Rifabutin inhibit mycobacterial RNA
polymerase like Rifampicin. Its activity is better against
Mycobacterium Avium Complex (MAC). This lipophilic
drug after absorption from the GI tract is eliminated in the
urine and bile. In patients with renal impairment dose
adjustment is not needed. It has been shown that Rifampicin
sensitive M. tuberculosis strains were also sensitive against
Rifabutin and about one third Rifampicin resistant strains
still sensitive to Rifabutin.2
Therapeutic uses: It is effective for the prevention of MAC
infection in HIV-infected individuals. At 300 mg/day, it
decreases the frequency of MAC bacteremia by 50%.
Rifabutin is commonly substituted for Rifampicin in the
treatment of tuberculosis in HIV-infected patients due to its
less profound interaction with indinavir and nelfinavir.3 In
combination with clarithromycin and ethambutol, it is also
used in the treatment of MAC disease.
Side effects: Rifabutin is generally well tolerated. Reported
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side effects when used in HIV patients are rash (4%), GI
upset (3%), and neutropenia (2%).
There is a need to evaluate Rifabutin in randomized
controlled trials for the treatment of new smear positive
pulmonary tuberculosis and MAC pulmonary disease. Its
long half-life suggests that it would be useful in
intermittent therapy. It is suggested that before such trials
are initiated, it is important to determine the optimal dose,
lest failure to show effect be attributed to a sub therapeutic
dose. It is imperative that controlled studies of various
drug regimens that contain higher doses of Rifabutin be
undertaken for the treatment of patients with disseminated
MAC disease and AIDS.

Rifapentine
Rifapentine is a semi synthetic Ansamycin
antibiotic similar in structure to Rifampin. The in vitro
activity of Rifapentine is 2-4 times that of Rifampicin
against a variety of clinical mycobacterial isolates.
Rifapentine is bactericidal against actively growing
bacilli, with a rate of killing similar to that documented
for Rifampicin. Rifapentine half-life is ~4-fold greater in
humans than Rifampicin. The prolonged elimination halflife of Rifapentine is likely due to its higher lipophilicity,
which facilitates tissue penetration of the drug and lack of
biotransformation
to
antimicrobially
inactive
metabolites.4 Absorption is enhanced when the drug is
taken after a meal.
Mode of action: Rifapentine inhibits DNA-dependent RNA
polymerase activity in susceptible microorganisms.
Specifically, these antibiotics interact with bacterial RNA
polymerase interfering with initiation of biosynthesis but
not elongation. The mammalian enzyme is unaffected by the
Rifamycins.
Uses: Rifapentine is approved for the treatment of
pulmonary tuberculosis in combination with other effective
antituberculosis drugs. Initial results of a study5 of
Rifapentine in tubercular patients, indicated comparable
efficacy with Rifampin in producing negative sputum
cultures for M. tuberculosis. Higher relapse rates were
reported in the Rifapentine-treated group (10%) than the
Rifampin-treated group (5%) during follow-up.
In a TRC study6, of 103 strains of M. tuberculosis
tested, 52 strains were sensitive to both. The remaining 51
strains resistant to Rifampicin were also resistant to
Rifapentine, indicating complete cross- resistance. It was
interesting to note that among sensitive strains Rifapentine
has a 2 to 16 fold higher activity than Rifampicin.
The results of Rifapentine in pulmonary TB with
HIV are disappointing. A randomized trial4 compared
Isoniazid / Rifapentine (600mg once a week) with Isoniazid
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/ Rifampicin (600mg twice weekly) in 71 HIV-positive
people with TB. Four people on Rifapentine developed drug
resistance compared with none of the Rifampicin group. The
author was of the opinion that the once weekly Rifapentine /
Isoniazid should not be used among people with HIV.

against M. tuberculosis is proven in clinical trials. One of
the studies concluded that levofloxacin-containing regimen
resulted in a similar rate of adverse events compared with
conventional first-line regimens when used for treatment of
active tuberculosis.11

Adverse Reactions: The adverse reaction profile of
Rifapentine is similar to that of other Rifamycin antibiotics.
Rifapentine is an inducer of cytochromes P450 3A4 and
P450 2C8/9 isoforms and may increase the metabolism of
other drugs that are metabolized by these enzymes.

Ciprofloxacin

Dosage/administration: During intensive phase
600 mg with an interval of not less than three days between
doses is continued for two months. Rifapentine may be
given with food if stomach upset, nausea or vomiting
occurs. During continuation phase, treatment is continued
once weekly for four months in combination with Isoniazid
or an appropriate agent for susceptible organisms.

Fluoroquinolones
Fluoroquinolones(FRQs) have bactericidal activity
against M. tuberculosis.
FRQs inhibit the gyrase, an enzyme involved in
DNA replication.7 There is no cross resistance between
these agents and other antituberculosis drugs. Ofloxacin,
Ciprofloxacin, Lomifloxacin, levofloxacin, sparfloxacin
and Moxifloxacin have shown activity against M.
tuberculosis.

Ciprofloxacin12 is active against all strains of M.
tuberculosis sensitive to Streptomycin, INH, Rifampicin,
and Ethambutol and inhibited almost all strains showing
intermediate sensitivity or resistance to one or more of the
above agents. Nearly all isolates, including atypical one
were inhibited at a concentration of 3.2 mg/1. Efficacy of
Ciprofloxacin is proven in clinical trials.13 Other
fluoroquinolones like Lomifloxacin and Sparfloxacin have
also shown efficacy in appropriate clinical settings.

Moxifloxacin
ATS guidelines14 stress that among the new
fluoroquinolones, Moxifloxacin appears to be the most
promising in the treatment of resistant tuberculosis. In an
experimental study, Lounis15 proved that addition of
Moxifloxacin as a companion drug provide better protection
against development of drug resistance.
The most potent of the currently available FQNs in
descending order of in vitro activity against M. tuberculosis
are moxifloxacin, gatifloxacin, levofloxacin, ofloxacin, and
ciprofloxacin.16

Ofloxacin

Co-amoxyclav

Ofloxacin is a bactericidal drug. It is active in vitro
against M.tuberculosis as well as against M. kansasii, M.
xenopi, M. fortuitutum, and M. marinum. Mycobacterium
avium and most strains of M. chelonei are resistant to
ofloxacin.

Amoxicillin is a semi synthetic beta-lactam
antibiotic, with a broad spectrum of bactericidal activity
against many gram-positive and gram-negative
microorganisms. The addition of a beta-lactamase inhibitor
to amoxicillin greatly improves its in vitro activity against
M. tuberculosis.17 The beta-lactam inhibitors (i.e.,
clavulanic acid) possess no intrinsic antimycobacterial
activity, but they are able to inhibit the enzyme in part
responsible for the resistance of M. tuberculosis to betalactam antibiotics. There are no in-vivo studies using this
drug combination against M. tuberculosis. Beta-lactam
antibiotics penetrate poorly into mammalian cells, and this
characteristic may limit the effectiveness of these agents in
therapy for tuberculosis.

Natural resistance to Ofloxacin appeared to occur in
about 1 in 105 organisms, a proportion similar to that for
other drugs.8
The MIC for Ofloxacin is less than 4 mg/l and after
normal oral dose of Ofloxacin peak serum level attained is
10.7 mg/l, which is quite high.
Uses: Ofloxacin has an excellent activity against M.
tuberculosis in clinical investigations. In a recently reported
study from Hong Kong9, use of Ofloxacin in MDR TB
patients was associated with favorable outcome. The author
concluded that the presence of cavitation, resistance to
Ofloxacin in vitro and poor adherence emerged as variables
significantly associated with adverse outcomes.

Levofloxacin
It is less neurotoxic than Ofloxacin.10 Its efficacy
S-53

Tuberactinomycin
Tuberactinomycin18 (Enviomycin) resembles
Viomycin structurally as well as in its mode of action. It acts
by inhibiting protein synthesis.
Tuberactinomycin containing regimens have shown
good clinical response.19 Negative sputum culture at six
J Pak Med Assoc (Suppl. 1)

months ranged from 73% to 80% in the Tuberactinomycin
containing regimens compared to 63% in a similar Viomycin
containing regimen. In advanced cases, this ranged from
67% to 76% in the Tuberactinomycin containing regimens
compared to 59% in the Viomycin containing regimen. Thus
Tuberactinomycin was better than Viomycin.

Clarithromycin
The second generation macrolide, Clarithromycin, is
effective against Mycobacterium avium-complex, and other
NTM (Non-tubercular mycobacteria) including M.
paratuberculosis.12 It is also recommended in the treatment
of infections caused by Mycobacterium marinum and
Mycobacterium fortuitum complex. It has been shown to
cause a reduction in the bacillary load and clinical
improvement of M. avium disease in AIDS patients.20

Amikacin
Amikacin21, an aminoglycoside, is highly bactericidal
against M. tuberculosis. It is given five days a week in a dose
of 15 mg/kg/day as a single dose, usually by intramuscular
injection. The major side effect of Amikacin is nephrotoxicity
and vestibular damage. Hearing loss, hypocalcaemia,
hypokalaemia and hypomagnesaemia are other side effects. In
comparison to kanamycin, it is less ototoxic and less painful.

Capreomycin
Capreomycin21 is an aminoglycoside which is
bactericidal against M. tuberculosis. It is given in a dose of
15 mg/kg/day intramuscularly with maximum of 1 Gram. It
is toxic to the eighth cranial nerve, causing high frequency
hearing loss in 3.2 to 9.4% of patients before vestibular
dysfunction occurs. Renal toxicity is somewhat more
common with Capreomycin than with streptomycin, and it
may be associated with electrolyte disturbances secondary
to tubular damage. It is suggested that in elderly patients
when there is similar susceptibility to Capreomycin and
Amikacin, Capreomycin should be used since older patients
seem to experience more renal and ototoxic effects with
Amikacin than with Capreomycin.

Clofazimine
Clofazimine21 is a substituted iminophenazine
bright-red dye that inhibits mycobacterial growth and binds
preferentially to mycobacterial DNA causing inhibition of
transcription. The MlCs of clofazimine against M.
tuberculosis have not been published.
Adverse reactions include discolouration of the skin,
gastrointestinal upset, severe and life-threatening abdominal
pain and organ damage caused by clofazimine crystal
deposition, and asymptomatic discolouration of the eye.
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Potential compounds of the future
Nitroimidazopyran
A series of new compounds containing a
nitroimidazopyran nucleus that possess antitubercular
activity has been reported.22 This compound is related to
metronidazole. It seems that it will be available in future for
clinical evaluation. After activation by a mechanism
dependent on M. tuberculosis F420 cofactor,
nitroimidazopyran inhibited the synthesis of protein and cell
wall lipid. In contrast to current antitubercular drugs,
nitroimidazopyrans exhibited bactericidal activity against
both replicating and static M. tuberculosis. Lead compound
PA-824 showed potent bactericidal activity against multidrug resistant M. tuberculosis and promising oral activity in
animal infection models.
The nitroimidazopyran compound PA-824 has
bactericidal activity comparable to that of INH. However,
additional preclinical evaluation of PA-824 is needed before
clinical studies could begin.

Oxazolidinones
Oxazolidinones (eperezolid and linezolid) are an
appealing class of antimicrobials due to their unique
bacteriostatic mechanism of action, lack of cross-resistance
with other agents, good oral bioavailability, potential for
structural manipulation, and broad spectrum of activity. The
mechanism of action appears to be the ability to inhibit
protein synthesis by binding to the 50S subunit and
preventing the 30S complex from forming the 70S complex,
resulting in inhibition of translation.23 Eperezolid and
linezolid were shown to have activity against a wide variety
of organisms, including gram-positive cocci, gram-negative
anaerobes, and mycobacteria. Due to their predominantly
gram-positive activity, these agents were compared to
vancomycin, penicillins, macrolides, minocycline, and
similar antibiotics.23 Linezolid have shown activity against
M. tuberculosis in a murine model.24
Linezolid appear to be well tolerated when given
both orally and parenterally. Drug related adverse events25
occurred in 32.7% of patients, which were mild to moderate
in severity and which resolve on discontinuation of therapy.
They were nausea (5.4%), diarrhoea (5.2%), tongue
discolouration (2.5%), oral thrush (2.3%), taste perversion
(2.3%) and headache (2.3%). Thrombocytopenia (2.4%) is
related to duration of therapy.
Role of surgery: Recently few studies on the role of
surgery emerged as a light of hope in the management of
difficult to treat pulmonary tuberculosis. Pomerantz BJ26
reported in his patients with severe drug resistance (about 5
drugs) benefited from the resection of cavitary or badly
damaged lung tissue when compared with historical control.
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A recent study27 concluded that the use of resection lung
surgery was associated with overall improved outcome in
patients with highly resistant MDR-TB, with a trend toward
improvement for those taking fluoroquinolone antibiotics.
It is hoped that in future we will have more data on
the role of surgery but it is a disease, which can be managed
medically, and surgery is the last hope as an adjuvant not as
sole mode of treatment.

Immunotherapy for tuberculosis
Mycobacterium vaccae
M. Vaccae is found in the soil, first described in a
study from Uganda. It was found that prior sensitization of
animals with M. vaccae could optimize the protective effect
of subsequently administered BCG vaccine.28 A single
intradermal injection of 0.1 ml suspension of dead M.
vaccae containing 109 bacilli is administered a week or
more after starting effective chemotherapy. Following
effects have been noted: weight gain, rapid clearance of
tubercular bacilli from sputum and decrease ESR.29
Further work is needed to evaluate the role of M. vaccae in
the management of tuberculosis.

Interleukin-2
It is believed that immunity against M. tuberculosis
is mediated by T-lymphocytes that produce the type 1 (Th1)
helper T cell cytokines IFN and interleukin (IL)-2.30 In TB
patients, Th1 cytokines predominate at the site of disease,
but the systemic immune response in peripheral blood is
characterized by enhanced production of the type 2 (Th2)
helper T cell cytokine IL-4, and by reduced secretion of IFN
and IL-2 by peripheral blood T cells.31 The systemic Th1
response in TB patient is low which inclined researchers to
use IL-2 as an immunotherapeutic adjunct to treat
tuberculosis. IL-2 strongly induces IFN and is a potent
growth factor for CD4+ and CD8+ T cells, both of which
contribute to immunity against tuberculosis.30. Furthermore,
IL-2 stimulates expansion and enhanced functional capacity
of natural killer cells, which can eliminate intracellular M.
tuberculosis.32
Rapid sputum conversion was noted in a pilot study
from Bangladesh and South Africa, in which intradermal
IL-2 (225, 000 IU) twice daily was used during the first
month of TB therapy as an adjuvant.33 A later randomized
trial in South Africa comparing daily and pulsed IL-2 with
placebo in MDR TB found improved sputum clearance with
daily treatment.34 A recent study35 concluded that IL-2 did
not enhance bacillary clearance or improvement in
symptoms in human immunodeficiency virus-seronegative
adults with drug-susceptible tuberculosis.
It seems that we have again gone into an era similar
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to that of early forties when no cure for tuberculosis was
available and only hope was fresh air, rest, good diet and
sunlight. The present era when anti-TB drugs are available,
is more dangerous because of the development of MDR
tuberculosis due to irregular use of ATT, problems in
implementation of effective TB control programme in many
countries, over the counter sale of ATT and others. It is
hoped that effective implementation of TB control
programme under DOTS strategy, awareness of the mass as
well as the health care providers about tuberculosis,
judicious use of presently available medication, and control
over the counter sale of ATT would have an impact on the
control of MDR menace of tuberculosis.
Recently WHO published current drugs in pipeline
for the resistant tuberculosis.36 Diarylquinoline TMC207 is
bactericidal, and is currently in phase-IIa clinical trial.
Pyrrole LL-3858 is active against drug sensitive
mycobacteria and currently in phase-I clinical trial. Other
promising drugs are Pleuromutilins, Didiperidine SQ-609,
ATP Synthetase Inhibitor FAS20013 (FASgene),
Translocase I Inhibitor, InhA Inhibitors and Isocitrate Lyase
Inhibitors.
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Abstract

prescription.

Objective: In Pakistan, over 80% of the patients
suffering from TB consult a private practitioner for the
initial evaluation. A cross-sectional survey was
conducted in seven thickly populated urban communities
of Rawalpindi district to evaluate the adherence of
private practitioners with TB treatment guidelines as laid
down by National Tuberculosis Control Programme
(NTP) in Pakistan. The data was collected over 30 days.
Methods: A young lean man was simulated to act as a
TB patient and was provided with a chest X-ray
suggestive of TB and two Acid-Fast Bacilli (AFB)
positive sputum reports. Only those prescriptions were
included for analysis which either had recognized the
patient having TB or had any TB drug written in the

Results: A total of 77 practitioners were visited.
Prescriptions of 53 general practitioners fulfilled the
inclusion criteria and were analyzed. Only 2 (3.7%)
prescriptions out of 53 met the required standard for TB
patients as laid down by NTP. Eighty three percent (n =
44) favored a combination drug for the treatment while
the rest preferred individual preparations.
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Conclusion: The study reflects the lack of knowledge
about standardized TB treatment protocols amongst the
private practitioners in Pakistan. Public Private
Partnerships between government public health
departments and non-governmental organizations
working in public health can be a valuable tool in
generating mass awareness campaigns.
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Introduction
Tuberculosis (TB) is a major public health problem
and according to World Health Organization, (WHO)
Pakistan ranks 6th in the countries having high disease
burden.1 It contributes 26% of avoidable deaths among
adults and children in Pakistan.2 The present annual
incidence of open TB cases is between 85-100/100,000
persons and about 361,000 new cases of TB are added every
year in Pakistan.3
The International Union against Tuberculosis and
Lung Disease has estimated tuberculosis to be the cause of
one death every 10 seconds worldwide.4 Four out of 5 TB
patients in Pakistan still remain undetected, untreated and
inadequately managed.5 Lack of proper diagnostic
equipment and skills, irrational prescriptions and nonavailability of essential anti TB drugs are among the major
contributing factors of various complications including
emerging resistance. Multi Drug Resistant (MDR) TB is a
major cause of high costs, mortality and longer duration of
treatment. A simple TB case management incurs a cost of
3600 rupees for the treatment of 9 months while a MDR TB
case, which requires treatment for 2 years, costs about
250,000 rupees.6
Tuberculosis control in Pakistan is primarily the
responsibility of the government sector, which has not been
fulfilled for years. In Pakistan, over 80% of the patients
suffering from TB consult a private practitioner for the
initial evaluation.7 it is important to know the prescribing
habits of these doctors. Various national studies on the issue
have shown poor knowledge and prescribing behavior in
prescribers.8-10
In order to standardize the TB management in our
country National TB control Program (NTP) introduced
guidelines in 1995 which were revised in April 1999
containing diagnosis and treatment modalities for TB. This
study was conducted to evaluate the adherence of private
practitioners with TB treatment guidelines as laid down by
NTP in Pakistan.11,12

Subjects and Methods
A cross-sectional survey was conducted in seven
thickly populated urban communities of Rawalpindi district.
The study population comprised of private practitioners in
these areas and from each such area 10 practitioners were
selected at random. A total of 77 practitioners were visited,
over 30 days. A young lean man was trained to act as a TB
patient and was provided with a chest X-ray suggestive of
TB and two Acid-Fast Bacilli (AFB) positive sputum
reports. These positive investigation reports were given to
him so that he did not had to undergo investigations each
time to get prescriptions from the doctors. The
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patient was trained by anticipating the general questions
which he could come across during his encounter with the
doctor (Annexure I). Prescriptions generated as a result of
the simulated encounters were analyzed for the purpose of
the study. Only those prescriptions were included for
analysis which either had recognized the patient having TB
or had any TB drug written in the prescription. The
practitioners who were not qualified MBBS doctors, who
did not write any prescription or who prescribed treatment
other than TB were excluded from the study.
A standard prescription from a specialist doctor was
obtained for comparison, which followed national TB
control program guidelines and was validated by the
National Guidelines for Tuberculosis Control in Pakistan
(NTP). The prescriptions of 53 General Practitioners
fulfilled the criteria and were analyzed. Data collected was
entered on computer software and simple analysis was
carried out including percentages, means and averages.

Patient Presentation
A young lean man of 25 years age presents in front
of the doctor with the case history of 2-3 months lethargy,
low grade intermittent fever with spiking in the evening,
loss of appetite, weight loss and 4 weeks cough with
yellowish sputum usually, but brownish at times. The
temperature if noted was always between 100-100.50 F. He
feels that he is becoming weak. He is living with his 7
member family in a small flat in a poor sector of the city. He
did not receive any TB treatment as yet. He is working as a
sales man at a garments shop and on the suggestion of a
regular customer (who was a doctor) he got his chest x-ray
and sputum test done.

Results
The majority of doctors interviewed were males
(92.5%). Four (7.5%) practitioners were also working in the
government sector in addition to private practice. General
practitioners constituted 85% (n=45) of the practitioners,
whereas 3.7 (n=3) were specialists, 9.3% (n=5) did not
mention their status.
The patient record on the prescriptions showed that
age, weight and family history was recorded by 83%
(n=44), 18.9% (n=10) and 5.7% (n=3) respectively. Signs
and symptoms were described in only 13.2% (n=7) of
prescriptions, 17% (n=9) demanded further laboratory
investigations (Table 1). Only 24.5% (n=13) asked the
patient to come for a follow-up and advised a date.
Interestingly not a single prescriber mentioned any
categorization of the disease as desired by NTP guidelines
or kept patient records.
Only 2 (3.7%) of prescriptions out of 53 met the
required standard for TB patients as laid down by NTP.
J Pak Med Assoc (Suppl. 1)

Table 1:
17.0% (n=9)
11.3% (n=6)
5.7% (n=3)
7.5% (n=4
1.9% (n=1)
11.3% (n=6)

Any type of investigations requested
Blood CP
Liver function tests
X-ray chest
Sputum smear for AFB
ESR

Eighty three percent (n = 44) favored a combination drug
for the treatment while the rest preferred individual
preparations. Pyridoxine, an important supplement of the
treatment was correctly prescribed by only 2 doctors (3.8%)
(Table 2). None of the doctors prescribing individual
Table 2:
Doctors prescribing Fixed dose combination
Correct dose given
Correct dose timing
Correct duration of therapy
Doctors prescribing Individual drugs
Correct dose given
Correct dose timing
Correct duration of therapy
Doctors prescribing pyridoxine
Correct dose given
Correct dose timing

83%
43.18%
59.09%
43.18%
17%
0%
0%
0%
47.16%
3.8%
26.4%

(n=44)
(n=19/44)
(n=26/44)
(n=19/44)
(n=9
(n=0/9)
(n=0/9)
(n=0/9)
(n=25/53)
(n=2/53)
(n=14/53)

preparations could prescribe correctly. Seventy percent of
prescriptions also contained medicines other than those
required for treating newly diagnosed TB case. These
include brands of ciprofloxacin, doxycycline and
clarithromycin.

Discussion
This study in Pakistan is the first ever study that has
used a simulated subject as a patient. The advantage of a
simulated patient was that same pathophysiological
parameters were presented to every prescriber in the study.
The rehearsal of anticipated questions to the patient also
helped in presenting essentially same qualitative history to
every prescriber, without having any obligation of treatment
of the subject or any change of patient parameters during the
study period.
This study reflects the situation in only one
geographical area of the country however comparison of
results with other studies on prescribing behaviors show
similar situation and this can be used as an indicator of
current situation with regards to National Tuberculosis
Control Programme in Pakistan, that essentially is based on
WHO guidelines.
The National TB Control Programme (NTP) in
Pakistan was the result of WHO's emergency call to fight
the onslaught of TB in 1993, years after previously formed
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National Tuberculosis Control Board was liquidated due to
inadequate functioning. The NTP produced first set of
national guidelines for treatment of tuberculosis in 1995
that were revised again in 1999. There has never been any
mechanism for disseminating these guidelines to private
practitioners, even to those working in government
institutions. The NTP also adopted DOTS strategy to
combat ever increasing disease burden in 1994, it has taken
nine years for NTP to launch DOTS in 75% of districts of
the country that too only in the government owned
allopathic treatment centres, without any facilitative
systems that could link up with private practitioners.
Private healthcare system in Pakistan consists of
majority of General Practitioners (GPs) who work
exclusively in their privately owned clinical or hospital
setups, however a number of doctors working in
government managed healthcare setups also practice
privately in their off hours. A considerable number of
public sector paramedics, although legally not entitled,
work privately in parallel with registered physicians in
their off hours. We studied a cross section of different
settings of private practice in the seven most populated
regions of Rawalpindi city. It was expected that we'll come
across a few of these paramedics that were to be excluded
from the study.
The prescribing patterns of doctors in this survey as
well as in previous similar studies conducted show that
inappropriate prescribing is common amongst GPs.
Prescription analysis at a private teaching hospital in
Karachi showed that on an average, 53% dosages were
written correctly and not more than 79% doctors resorted to
the recommended four drug regimen of RHZE.13 Another
KAP survey of family physicians done in Karachi revealed
that of the 39% doctors resorting to four drug regimen, only
7.3% could write the correct dosages.14 Similar findings
could be quoted from studies done in Maharashtra India,
where results of one study gave 71% wrong prescriptions
amongst postgraduates15 and another indicated 79 different
prescriptions among 122 practitioners.16
Having 3% correct results reflects the quality of
healthcare system in Pakistan in combating TB. These
results also show the lack of effective collaboration between
the private sector and the National TB Control Programme.
The prescribing behaviour also indicates that the private
practitioners are not receiving continuing education and
training on TB case management guidelines. The effects of
such prescribing behavior can be interpreted in terms of its
negative effects of ineffective treatment, non-compliance
and emergence of drug resistance.
It is suggested that NTP guidelines should be widely
disseminated. Public private partnerships between
S-58

government health departments and non-governmental
organisations working in public health can be a valuable
tool in generating mass awareness campaigns, to fill the
gaps and to effectively utilize the existing public health
infrastructure.
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The Dynamics of Tuberculosis Treatment Adherence
R. Liefooghe,1 A. D. Muynck2
VLIR. IR project, Sialkot,1 HSA-SHAIP, Islamabad.2

Abstract
Aims: To establish various factors that affect TB treatment
adherence over time.
Design/Setting: Semi-structured questionnaire. All newly
diagnosed cases of TB at Bethamia Hospital, Sialkot were
interviewed at the beginning of treatment, one month of
therapy and at the end of intensive phase.
Results: Perception of TB as a stigmatizing disease was found
related to early defaulting and to a lesser degree to late
defaulting. Knowledge of TB in itself did not have a clear
impact on defaulting, but the attitude towards interruption of
treatment did. The strongest risk factor is irregularity of drug
intake and appointment keeping.
Conclusion: Strategies to improve treatment adherence
should concentrate on methods to increase patients motivation
for treatment.

Introduction
Low adherence to the treatment regimen has been of
the recognized as a major threat for tuberculosis (TB) control
program.1 A successful treatment plan consist of the daily
intake of a combination of drugs for a period of 6 to 9 months.
TB patients obviously face many constraints in order to adhere
to this treatment. To gain a better understanding of the process
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of treatment adherence it is necessary to identify its
determination factors and especially those that are vulnerable
to change.
The majority of studies have concentrated on
socioeconomics factors such as age, gender, education,
occupation, travel distance or knowledge of TB.2-5 Other
important behavioral factors described in more recent health
behaviour models6,7 such as intention to comply; perceived
barriers to TB treatment; attitudes towards the treatment and
social support, are often overlooked. TB is a major cause of ill
health in Pakistan.8 Several studies documented the problem
of low treatment adherence.9-11
Others have shown that behavioral factors,12 including
social stigma,13 contribute to non-adherence.
This study was carried out in Bethania Hospital (BH),
Sialkot. Annually, approximately 1000 TB patients receive
treatment in BH.14 Newly diagnosed sputum positive cases
receive daily four drugs during the intensive phase (2 months)
followed by two drugs daily for the continuation phase (6
months).1 To ensure treatment supervision during the
intensive phase, hospitalization was recommended for all
sputum positive cases. The study amide to understand the
barriers and problem areas in TB treatment compliance. An
attempt was made to identify the dynamics of the risk factors
in the intensive and continuation phases of treatment.
J Pak Med Assoc (Suppl. 1)

Patients and Methods
Risk factors for defaulting were assessed through
semi-structured interviews. For each patient information was
collected at the start of the treatment (T0), after one- month
(T1) and at the end of the intensive phase (T2)
Questions were based on previoud qualitative13,15 and
quantitative studies.16 Questionnaires were pretested and
adapted where necessary. All participants gave their informed
oral consent voluntarily.

Variables Measured
Intention to comply was measured by the question
"Are you confident you will finish the entire treatment" and
recorded on a 1-5-point scale (T0-T1-T2)ii. Perceived barriers
were measured at different points in time (T0-T1-T2). To
assess the attitude towards the curability of TB, patients were
asked to give their opinion on six statements on a 1-5-point
scale (T0-T1-T2) Perceived stigmatization score was
measured by the sum of patient's agreement on seven
statements (T0-T2).
Subjective social control was measured through two
questions on a 1-5-point scale. Patients were first asked to
what extent they believed their family, relatives or friends
were convinced that they should comply with the TB
treatmand secondly how strongly this opinion would affect
their own decision to comply (T0-T1-T2).
Social support was assessed by several questions
concerning the financial and material support (bringing food
to the hospital, looking after the children, helping in the fields)
given to the patient (T1-T2). For OPD patients, regular drug
intake was assessed twice (T1-T2) by the question "Did you
ever forget to take your drugs?"
Regularity of the treatment: A regular patient was
defined as a patient who was never more than 2 days late for
a check-up appointment in the intensive or for more than 7
days in the continuation phase. Assessment of knowledge of
TB consisted of questions concerning the transmission of TB
(T0-T2) and the duration of treatment (T0-T1-T2). The
attitude towards treatment adherence was measured by asking
patients to indicate their agreement, on a 5 point scale, with the
statement: "Do you believe that stopping your treatment
before completing the full course will be harmless or harmful
to your health?" (T1-T2).
Demographic profile included age, gender, tehsil of
residence and marital status. Socio-economic status was
measured by schooling (none, primary, or higher); #persons in
the family; dependency ratio (#persons in the family /
#persons economically active), occupation and whether the
patient was the sole breadwinner).
The outcome parameter was defaulting. A defaulter
Vol. 59, No. 4 (Suppl. 1), April 2009

was defined as a patient who interrupted treatment for more
than two consecutive months. Patients who defaulted in the
intensive treatment phase were defined as "early defaulters";
those who defaulted during the continuation treatment phase
as "late defaulter".

Data Analysis
Data were analyzed by SPSS-plus software. Risk
factors of patients' defaulting were assessed in two strata: the
intensive phase and the continuation phase for those who had
completed the intensive phase. The relative risk of defaulting
was used as the parameter of association; the alpha error was
put at a 0.05 level. Throughout the study, bilateral hypotheses
were tested. The association were tested through t-test for
equality of means, X2 test of association and X2 test of linear
trend; 95% confidence intervals (CI) around the rate ratios
(RR) are given.

Results
Study Population
Six hundred and fifty three sputum positive TB cases
were diagnosed between September 1996 and October 1997 at
BH. The criteria for eligibility was that the patients had to be
15 years or older, not critically ill and the follow-up to the
treatment carried out in BH. Patients who died (47) or were
transferred out (15) or failures (8) were eliminated from the
study. Fourteen initial Interview were missed (2.5%) and 3
patients refused to be interviewed, the remaining 563 patients
constitute the study population.
Of 563 patients 44% were females and 56% males.
More than 70% of the patients were between 15-45 years. The
educational level was very low; half of the patients had not
received any form of education. This was even more so for
women of whom only one third had had any schooling at all.
The majority (73%) of patients were residents of Sialkot
district. Almost all patients (90%) accepted hospital admission
initially but only 54% completed the full two months of
supervised treatment in the hospital. Overall 433 (77%)
complied with the entire treatment course and 130 (23%)
defaulted.

Defaulters in intensive treatment phase (Early
defaulters)
Sixty patients defaulted during the intensive treatment
phase. They were somewhat older (35.5 vs. 30.0 years median
age) than compliant patients and contained 1.5 times more
males than females. Patients living outside Sialkot district
defaulted two times more than those living in the district did
(RR=2.3; CI: 1.5; 3.7). Illiterate patients had a higher risk of
defaulting (RR=l .8; CI: 1.1; 3.0) compared to literate patients.
Single patients had half the defaulter rate (6.1%) than married
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patients (12.6%) while those widowed, separated or divorced
had the highest rate (14.3%). No significant differences were
found for other socioeconomic indicators.

Almost all patients were aware they had TB. Only one in three
patients knew the correct duration of the treatment and only
one out of four how TB is transmitted.

Table 1 summarizes factors significantly affecting

Defaulters anticipated more obstacles to the treatment

Table 1: Cognitive and emotional factors affecting early defaulting (n=563).
Factor

Modalities

%defaulters (n)

RR (95%CI)

p-value

Confidence in finishing
treatment

- Low
- Medium
- High

28.6 6/21
14.3 18/126
8.7 36/416

3.3 1.6;7.0
1.7 1.0;2.8
1

0.0019*t

Acceptance for DOT
Hospitalization
Score
Perceived stigma of TB

- No
- Yes
Stratum
- Early defaulters
- Compliant pts.

25.8 16/62
8.8 44/501
Mean Score
25.7 (±6.1)
23.4 (±5.6)

2.9 1.8;5.0
1
-

0.0000++
0.0030**

* Mantel-Haenszel test for linear association
++ Peason chi-square
** T-test for equality of Means

early defaulting. At the start of treatment, three quarters of the
patients felt very confident they would finish the entire
treatment course. Those who expressed less confidence in
their ability to conform to the treatment requirements had a
higher risk of early defaulting. Low confidence was related to
a lower belief in the curability of TB (P=0.024).
Early defaulter rates were three times higher in patients
who rejected hospitalization. They perceived more constraints
(mean score 15.5 ±5.0 vs 13.5 ±4.1; p=0.002) and had a more
negative image of TB (stigmatization score 25.2 ±6.6 vs 23.4
±5.5; p=0.02). Many patients perceived TB to be a
stigmatizing disease. The majority agreed that "one should
avoid talking to others about one's disease". They clearly felt
that their friends and relatives should not know they had TB.
Half of them believed "TB has life long consequences" and a
quarter felt "it is difficult to earn a living after recovering from
TB". Early defaulters felt stronger about the stigma. This was
mainly because considerably more defaulters felt "TB in the
family to be a disgrace" and "friends desert you when you
have TB". Initial knowledge of TB and TB treatment did not
differ significantly between defaulters and non-defaulters.

than compliant patients did (Table 2). The regular visits to the
doctor, long treatment and cost of the treatment were the most
important constraints. A significantly negative correlation was
observed between the motivation for the treatment and
perceived barriers (rp=0.29; p<0.0001) iii.

Second month defaulters
Thirty early defaulters were interviewed at T1 three
inter-views were missed. Six interviews of compliant patients
were also missed. After one month of treatment, almost all
patients felt their health had improved. The few, who did not,
had a seven times higher risk of defaulting in the following
month (RR=7.2; 95% CI: 3.0; 17.2). Low confidence in
finishing the treatment quadrupled that risk (RR=4.0; 95%
CIS: 2.0; 8.0). In addition, patients who were not convinced of
the harmful effects of discontinuing treatment had twice the
risk of defaulting in the following month.
The importance of social support became evident
during the second interview (Table 3). Less encouragement
from the family for the daily drug intake or for the
continuation of treatment, resulted in a higher risk for

Table 2: Early defaulting in function of perceived constraints at onset of treatment (n=563).
Constraints for treatment

Long treatment is frightening
Regular visits to the doctor difficult
Daily intake medicine difficult
Daily life strongly affected
Cost of treatment insuperable

Strongly agrees

% of early defaulters in stratum (n)
± agrees

Does not agree

p-value

25.0%(7/28)
34.0% (17/50)
18.8% (24/128)
15.5% (29/187)
23.4% (15/64)

13.6% (9/66)
11.7% (11/94)
9.8% (16/164)
7.7% (16/208)
10.9% (19/175)

9.4% (44/469)
7.6% (32/419)
7.4% (20/271)
8.90% (15/168)
8.0% (26/324)

0.0086*
0.0000*
0.0011*
0.0321**
0.0010*

*Mantel-Haenszel test for linear association
**Pearson chi-square
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Table 3: The role of family support in second month of treatment (n=527).
Family support

Modalities

%defaulters (n)

RR (95% CI)

Encouragement for treatment
compliance

- Low
- Medium
- High
- Seldom
- Regular
- Always
- Few
- Most/All

33.3 (4/12)
7.1 (12/168)
4.0 (14/347)
17.6 (6/34)
10.5 (2/19)
5.5 (3/55)
17.1 (7/41)
6.0 (4/67)

8.3 (3.2; 21.4)
1.8(0.8; 3.7)
1
3.7 (1.0; 13.7)
2.0 (0.4; 11.2)
1
2.9 (0.9; 9.2)

Participation in family life OPD
patients (n=108)
Social network is informed
patient has TB (OPD; n=108)

p-value

0.0012*

0.0667*
0.0641**

**Mantel-Haenszel test for linear association
**Pearson chi-square

defaulting. For OPD patients, a link was observed between the
degree of social isolation and defaulter rates. Not surprising,
those who seldom participated in family life or whose friends
ignored them, reported a higher stigma score (25.7±4.6 vs
23.4±5.6). Equally, OPD patients who concealed their disease
from their environment had three times the risk of defaulting
compared to those who did not. Again, concealing the disease
was linked to a significant stronger perception of
stigmatization (mean score 26.0±5.5 vs 22.7±5.4).

Defaulting during the continuation phase (Late
defaulters)

became important in the continuation phase and patients who
had no financial support had thrice the risk for defaulting
(Table 5). Material assistance from the social network such as
regular visits from family and friends, assistance with the care
of children, in the home, with the job or studies, contributed to
compliance. After two months of treatment, basic knowledge
of TB improved substantially. The number of patients that
correctly stated tile transmission mode of TB or the correct
length of TB treatment doubled from 21% to 44% and from
35% to 74% respectively. The effect of knowledge on
treatment adherence was rather negligible.

More late defaulters had no or only primary schooling;
lived outside the coverage area and had a longer history of
illness (Table 4). The relation between schooling and
defaulting was stronger in women than in men:

The perception on stigma related to TB had not
drastically changed. Ninety percent of the TB patients still
agreed that "you should not talk to others about your disease",
51% believed "TB to be a disgrace to the family". Late
defaulters scored significantly higher on four statements. They
feared that "even best friends might desert them because they
had TB". More agreed that TB patients should hide their
disease for their family or for friends and believed that "TB
patients wilt experience the consequences of the disease for
the rest of their life".

Illiterate women had a 3-1/2 times greater risk of
defaulting than literate women (RR=3.4; CI=1.6; 9.5); for men
this was only 1-1/2 times (RR=I.6; CI: 0.9; 2.7). Remarkably,
none of the higher educated females defaulted.
At this stage of the treatment, 99% of the patients were
receiving strong encouragement from their family to comply
with the full course. The financial support of the family

Correct drug intake and regularity of treatment
strongly related to a better treatment adherence (Table 6). If
during the first two months of treatment OPD patients forgot
to take their medicine, they had twice the risk for defaulting.
Those who were late for the scheduled appointment, even
once, had 3-1/2 higher defaulter rates as those who attended
regularly. The relationship became even stronger if

Of the 503 patients who complied with the intensive
treatment phase, 493 could be interviewed (T2). Seventy
patients defaulted in the continuation phase, 63 of these were
interviewed (90%). Only three interviews (0.7%) were missed
out of the 433 compliant patients.

Table 4: Socio-economic factors related to defaulting in the continuation phase (n=503).
Factor
Schooling

Coverage area
Duration of illness before
consulting BH

Modalities

%defaulters (n)

RR (95% CI)

p-value

- No Schooling
- Primary
- Higher
- No
- Yes
- > 3 months
- < 3 months

17.8 (44/247)
14.4 (18/125)
6.1 (8/123)
19.8 (25/126)
11.9 (45/377)
19.9 (40/201)
9.9 (30/302)

2.7 (1.4; 5.6)
2.2 (1.0; 4.9)

0.0022*

1.7 (1.1; 2.6)

0.0266**

2.0(1.3; 3.1)

0.0002**

*Mantel-Haenszel test for linear association
**Pearson chi-square
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Table 5: Risk factors of defaulting in the continuation phase, assessed at T2 (n=493).
Family support

Modalities

% Defaulters (n)

RR (95% CI)

p-value

Financial support from family

- No
- Yes
- None
- Low
- High
Modality
- No
- Yes
- No
- Yes
Modality
- Defaulters
- Compliant

32.1 (9/28)
11.6 (54/465)
16.7 (11/66)
14.7 (40/273)
7.8 (12/154)
% Defaulters (n)
15.2 (42/277)
9.7 (21/216)
11.1 (13/117)
13.3 (50/376)
Mean Score (SD)
15.1 (±3.9)
13.9 (±3.6)

2.8 (1.5; 4.9)

0.0016*

Material assistance from social net work

Cognitive factors
Correct knowledge of the cause of TB
Correct knowledge of treatment duration
Emotional Factors
Perceived stigma
(partial score)

2.1 (1.0; 4.6)
1.9 (1.0; 3.5)
1
RR (95% CI)
1.6 (1.0; 2.6)

0.0329*
p-value
0.07**

0.8 (0.5:15)

0.53**

-

p-value
0.012#

*Mantel-Haenszel test for linear association
**Pearson chi-square
#T-test for equality of Means

Table 6: Appointment keeping regular drug intake and late defaulting (n=493).
Treatment regularity
Forgot to take medicine
(OPD, intensive phase)
Appointments missed
(OPD, intensive phase)
Irregular appointment
Keeping (whole treatment)

Modalities

% Defaulters (n)

RR (95% CI)

p-value

- Yes
- No
- Yes
- No
- Yes
- No

25.0 (6/24)
11.6 (27/232)
31.0 (9/29)
10.6 (24/227)
24.4 (58/238)
2.0 (5/255)

2.2 (1.0; 4.7)

0.06*

2.9 (1.5; 5.7)

0.0019**

12.4 (5.1; 30.5)

0.0000**

*Mantel-Haenszel test for linear association
**Pearson chi-square

appointment keeping during the whole treatment course is
considered. In such cases, a patient who missed a single
appointment had more than twelve times the risk of defaulting
compared to patients who kept the scheduled dates.

Discussion
Different mechanisms influence treatment adherence
behaviour over time. Motivation at the start of treatment is an
important predictor for early defaulting. Lack of confidence in
the capability to finish the full treatment course increases the
likelihood for defaulting in the early weeks of treatment.
Motivation is easy to assess at the start of the treatment
through a simple question like "How confident are you that
you will be able to finish the treatment course?" However,
motivation has to be understood in the context of the
constraints patients' face in their ever day life. The greater the
anticipated barriers at the start of treatment, the higher the risk
for early defaulting. Early defaulters are also more reluctant to
accept the supervised treatment in hospital.17
The findings show that the family's encouragement for
the treatment is an essential element in the intensive phase. As
treatment advances, financial support from the family
becomes increasingly important. The financial burden of the
TB treatment is difficult to overcome by the patient and
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his/her nuclear family alone. To be able to fulfill the treatment
requirements patients often need practical assistance, such as
help with the children, household, job or studies. Kinship
institutions such as biraderi are central to the social life in
Pakistan. They provide, through a network of kinship, a
support mechanism. In case of illness, a person can count on
the biraderi for moral, financial and practical support.18 As
found elsewhere,19-21 for TB patients this support is extremely
important and positively associated with an improved
treatment adherence. Clearly, late defaulters receive less
support from their social network. They also feel more
stigmatized.
Stigmatization is reflected in the negative perceptions
patients have about the disease.13,22 Even after two months of
treatment, the majority of patients still conceal their health
problem from their environment. Neither the interaction with
the health care providers nor improvements in the patients
condition could after the preconceived ideas of the social
stigma.
Knowledge about transmission of TB and regimen
duration is low at the start of treatment but improves over
time. The study confirms that better knowledge does not
influence treatment adherence.23 However, a careless attitude
towards prematurely stopping the treatment dose. Apparently
J Pak Med Assoc (Suppl. 1)

imparting knowledge or an advice-giving approach is
insufficient to motivate TB patients to adhere to the treatment.
Efforts should rather focus on providing support and enabling
patients to overcome treatment barriers.
One of the best predictors of adherence to the full
treatment course is early compliance. Patients who forget to
take their drugs or who are late for their appointments, even
once, have a high risk of becoming defaulters. This
corroborates the findings of a study carried out in Rawalpindi
in which irregular appointment keeping was the strongest
predictor for subsequent defaulting.9 This factor is easy to
assess and has a powerful operational value: patients who are
from the start erratic in drug intake and appointment keeping
will need extra support and guidance.
Socio-economic status is often mentioned as an
important predictor for treatment adherence. We only found a
slightly higher "early defaulter" rate in vulnerable groups such
as widowed/separated patients. The predictive value of
geographical accessibility is apparent. Regular treatment
follow-up beyond a certain distance from the treatment centre
seems to be very difficult. This problem can only be solved
once a network of conveniently located TB treatment centers
becomes available.
The relationship between education and treatment
adherence has been established before.2,24 For Pakistan, a
country with a low female literacy rate,25 it is important to
report that in particular, female education has a strong positive
impact on treatment adherence.
Classical economic factors such as occupation,
dependency ratio or being the sole breadwinner are not related
to treatment outcome. In the cultural context of the Pakistani
"biraderi" support system, financial and material support from
the network is probably a more meaningful socio-economic
indicator.
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Abstract
An audit of 690 cases of tuberculosis out of 46,276
patients seen during the last 25 years in a busy general
practice is reported. Of the 690 cases, 67% were
pulmonary, 33% extra-pulmonary TB. Modes of both
types of tuberculosis are described and the reason for
increased incidence of extra-pulmonary tuberculosis are
discussed (JPMA 48:183, 1998).

Introduction
Tuberculosis is a common disease in Pakistan and
World Health Organization in 1987-88, reported a sputum
positive prevalence of 0. 17 per 1000 million.1 Tuberculosis
is more prevalent in urban low socio-economic conditions,
chiefly due to malnutrition, over crowding and unhygienic
conditions. With increased resistance to anti-tuberculosis
drugs that is being reported from all parts of the world, the
problem has become acute with AIDS compounding its
incidence in developing countries, specially in Africa and
South East Asia. Treatment with three or four drugs is being
advocated, which makes it much more expensive; this
further reduces the compliance, as not many patients can
afford expensive drugs over a period of six to nine months.
An audit of all the cases of tuberculosis seen in a busy
general practice, in a middle to lower middle class populace
during the past 25 years was conducted by adopting simple
organizational measures of health care to see the pattern of

management, treatment and follow- up.2 In this
retrospective analysis, case records of 813 suspected cases
of tuberculosis seen during the study period were reviewed.
In each case the patient had X-ray's, complete blood picture
with ESR, Mantoux test and sputum for A.F.B. Other
investigations i.e. FNAB, histopathology and specialized Xray's i.e. small bowel enema, lumbar puncture, ultra sound
guided aspiration of psoas abscess and thoracocentesis were
also obtained when required. Based on the site of lesion,
cases were divided into pulmonary and extra pulmonary
cases.

Results
Of 813 suspected cases of tuberculosis, 123 were
non-tubercular and hence excluded. Of the 690 remaining
cases, 335(485%) were male and 355(51.4%) females.3
Ages of the patients ranged from 2 to 60 years, 70% were
between 10-39 years; of the total, 466 (68%) were
pulmonary tuberculosis, 27 (4%) had both pulmonary and
extra pulmonary tuberculosis and 224 (32.4%) were only
extra pulmonary. The chief presenting symptoms among the
pulmonary cases were cough with expectoration, fever,
weight loss, malaise. Haemoptysis was present in 127
(18%) cases and night sweat in 10 cases, Infiltration was
observed in 218 (47%) cases, of which 110 (59%) were bilateral. Infiltration plus cavitations was seen in 91(20%) and
27(6%) were pneumonic (Table I).

Table I: Pattern of Lung lesions (n=466).
Total

Infiltration
Infiltration with cavities
Pleurisy
Pneumothorax
Pneumonic
Fibrotic

Nos.

%

Nos.

Left
%

Nos.

%

Both
Nos.
%

235
91
29
28
27
56

50
20
6
6
6
12

56
37
14
9
9
18

12
6
3
2
2
4

75
52
15
15
15
24

16
11
3
3
3
5

104
2
0
4
3
14

diseases encountered and evaluate the final out come.

Patients and Methods
In the general practice, records of all patients seen
over 20 years were maintained. Special sheets and reference
registers with complete details of the patients were filled in.
Reference cards had individual numbers for each patient
which were used for all the future ailments, that helped in
establishing a system for supervision and for operational
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Right

22
2
0
1
1
3

Among extra pulmonary tuberculosis the chief
presentation was swellings of glands. Very few complained
of constitutional symptoms, except those with pleural and
pericardial involvement and those suffering from
abdominal, bone and joint disease. The pattern of extrapulmonary lesion is presented in Table II. In this series,
except one case of axillary and one of suprca cavicular
lymph adenopathy, none required surgical intervention.
J Pak Med Assoc (Suppl. 1)

Table II: Pattern of extra pulmonary lesions (n=224).
Lesion
Hilar lymph adenitis
Peripheral lymph adenitis
Pleural effusion
Primary abdominal tuberculosis
Spines
Bones and joints
Meningitis
Pericardial effusion
Paratrachial lymph adenitis
Others (Larynx, BCG vaccination etc.)

Nos.

%

80
51
34
23
15
8
4
3
2
4

36
23
15
10
7
4
2
1
0.9
2

Discussion
The frequency of extra pulmonary tuberculosis is
consistent with UK experience,1 where 34% of the Asians
compared to 18% of whites were seen with this lesion. In USA
there has been a gradual increase of extra pulmonary disease
over the years. It has always been suggested that in areas
where bovine tuberculosis is common, lymphatic and
abdominal tuberculosis is more frequent. In a study from
Lahore no bovine bacilli were discovered in 100 cervical
gland specimens4 some a typical mycobacteria, mainly
Scotochromnogenic were isolated. Similarly in Saudi Arabia,
atypical Mycobacterium mainly Mycobacterium Fortuitum
and Mycobacterium Chlonie were isolated. Asian and African

variants were isolated from both Saudi and non Saudi
patients.5 The incidence was highest among young adults, and
in females. In Karachi there is a gradual increase in extra
pulmonary tuberculosis. It seems that altered immune status
may be responsible for this change. Tubercular meningitis, a
disease of childhood is now being reported amongst adults.
Recently fifty consecutive cases of meningeal tuberculosis
amongst adults aged 15-70 years were reported from tertiary
treatment centers.6 Diagnosis of extra pulmonary tuberculosis
presents a problem specially in abdominal tuberculosis, which
comprised 10% in these series. Fourteen (61%) of these had
ileocaecal tuberculosis and 6 (26%) had peritonitis. In
majority of cases modern technique of imaging i.e. small
bowel enema, ultra sound, fine needle aspiration biopsy are of
great help for diagnosis, subject to proper clinical assessment.
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Recent Trend in the Radiological Presentation of Pulmonary
Tuberculosis in Pakistani Adults
N.A. Rao, M. A. Sadiq
Ojha Institute of Chest Diseases, Karachi.

Abstract

(pattern other than typical one).

Objective: To determine the radiological presentation of
pulmonary tuberculosis in adults and to compare it with that
of other national and international studies.

Conclusion: Typical pattern of pulmonary tuberculosis is still
the common mode of presentation in adults but there is a trend
toward increase in atypical pattern.

Method: This descriptive study was done on 150 newly
diagnosed smear positive pulmonary tuberculosis patients.
Two chest physicians reviewed the chest radiographs. Those
x-rays were selected in which there were no difference of
opinion.

Introduction

Results: There were 77 male and 73 females. The average age
was 34.52 years with range of 17 to 80 years. Out of 150 films,
eighty-seven (58%) showed the typical pattern (infiltration
and / or nodules with or without cavitations, involving upper
zone). While sixty three (42%) showed the atypical pattern
Vol. 59, No. 4 (Suppl. 1), April 2009

Pulmonary tuberculosis is generally classified into
primary and post primary tuberculosis, both have distinct
characteristic on radiology. Post primary tuberculosis is the
commonest form in adults, in which the patients usually
present with infiltration with or without cavitations involving
the apical and posterior segment of upper lobe.1-3 In some
cases the apical basal segment of the lower lobe is the first to
be involved. The other lobes may be involved but classically
follow involvement of the upper lobe. Based on these
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characteristics, pulmonary tuberculosis is divided into typical
or usual pattern and atypical or unusual pattern.
In the typical pattern, there is upper zone involvement
in the form of infiltration or nodules with or without
cavitations. In the atypical pattern all other forms are included
e.g. lower lung field tuberculosis, hilar lymphadenopathy.
miliary tuberculosis, diffuse pulmonary tuberculosis,
tuberculoma, atelectasis, pleural effusion, pnemothorax etc.
The object of the study was to determine the current
radiological presentation of pulmonary tuberculosis and to
compare it with that of other national and international studies.

Material and Method
This prospective study was done between August 2000
and November 2000, in patients attending Nazimabad and
Malir Chest clinics of Ojha Institute of Chest Diseases,
Karachi. We included those cases that were diagnosed as
smear positive pulmonary tuberculosis and the fresh chest Xrays were available These Chest radiographs were reviewed
by two chest physicians. Only those X-rays were selected in
which there were no difference of opinion.

Results
A total of 150 patients were included in the study,
seventy-five from each clinic. There were 77 male and 73
females. The average age was 34.52 years with range of 17 to
80 years.
Out of 150 films, eighty-seven (58%) showed the
typical pattern and sixty three (42%) showed the atypical
pattern. Among the typical, 65 films (74.71%) had unilateral
and 22 films (25.28%) had bilateral disease. Table 1 shows the
distribution of atypical radiological pattern.
Table 1: Atypical radiological presentation.
Diffuse pulmonary TB
Lower long field TB
Middle zone infiltration only
Hilar lymphadenopathy
a)
Unilateral 5
Bilateral 1
b)
Military TB
Atelectasis

32
14
7
6

21.33
9.33
4.66
4

3
1

2
0.66S

Discussion
Although the gold standard for the diagnosis of
pulmonary tuberculosis is isolation of mycobacterium
tuberculosis from respiratory secretions but chest X-ray is
equally important in the diagnosis. There are a number of
cases in which there is no expectoration or in which the
disease is minimal or who cannot just bring their sputum up.
In such cases we rely on clinical and radiological features.
It is well known that tuberculosis can be included in
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the differential diagnosis of almost any pulmonary case, so
knowledge of radiological presentation of pulmonary
tuberculosis is beneficial for the practicing physicians.
In this study 58% of the patients presented with typical
radiological pattern, which mean still the majority of the
patients present with typical pattern.
In 1993, Javaid K. et a14 reported the typical pattern in
76% of culture positive pulmonary tuberculosis cases. In
1997, Saulatullah et al5 reported the typical pattern in 60% of
Diabetic and 70.7% of non-diabetic patients. In our series only
10 patients were diabetic, out of which 3 (30%) presented with
typical pattern and 7 (70%) with atypical pattern. Table 2
Table 2: Typical pattern - Comparison with national studies.
Rao, Sadiq Javaid et al

Unilateral disease
Bilateral disease
Infiltration / Nodule
Cavitation

74.70%
25.30%
78.00%
25.30%

35.00%
65.00%
87.70%
49.10%

Saulatullah K et al
Non-Diabetic
Diabetic
37.8%
62.2%
60.4%
39.6%

33.4%
66.4%
35.6%
64.4%

compare the pattern of lung involvement in patients presenting
with typical chest X-ray. In this study unilateral disease was
more common than other two locally reported studies.
Table 3 compares the atypical pattern. The higher
Table 3: Atypical pattern — Comparison with national studies.

Lower lung field T.B.
Diffuse T.B.
Hilar lymphadenopathy
Miliary T.B.
Pleural effusion
Middle zone
infiltration only
Pneumothorax
Atelecatasis

Rao NA
et al

Javaid K.
et al

Saulatullah K et al
Non-Diabetic Diabetic

9.33%
21.33%
4.00%
2.00%
-

9.33%
0.66%
3.33%
2.00%
8.66%

8.00%
6.70%
5.30%
6.50%

14.7%
13.3%
6.7%
4.0%

4.66%
0.66%

-

2.70%
-

2.7%
-

presentation of diffuse pulmonary tuberculosis in this study
i.e., 21.33%- is noteworthy, while Javaid K reported just
0.66%4 The inclusion criteria of the patients reported by
Javaid K was culture positive pulmonary tuberculosis, and
their patients usually belong to higher socioeconomic group
and they consult medical services earlier. Our patients belong
to the poor community and for them daily earning is top
priority than their health. So they seek medical advice late.
Pleural effusion has not been reported in any case in
this study because our cases were smear positive for
pulmonary tuberculosis. Middle zone infiltration only was
J Pak Med Assoc (Suppl. 1)

noted in 4.66% cases, which most probably represents apical
basal segment. Which is also the common site of post primary
pulmonary tuberculosis.
One of the patients presented with atelectasis and was
smear positive, which indicate endobronchial tuberculosis
with or without lymph node enlargement. While comparing
this study with international ones the typical pattern is
reported from 68% to 86%6-8 Among the atypical pattern,
lower lung field pulmonary tuberculosis was from 5.31% to
7%,6-8 hilar lymphadenopathy from 7.44% to 9.7%7,9 and
miliary tuberculosis 4.5%.6
In 1998, Vanden BP et al reported an increase in
unusual presentation of tuberculosis from 24% in 1981-85
to 35% in I986-9010 but this study was from Belgium
where tuberculosis is well under control. We are observing
the same phenomenon of increase in unusual presentation
in this part of the world where tuberculosis is highly
prevalent. In this regard it is suggested that radiological
presentation of pulmonary tuberculosis must be stressed
during undergraduate training. This is important because
in post sanatorium era, emphasis on tuberculosis teaching
has been declining. A study was carried out to determine
the fact. In that study11 44% of the patients was
undiagnosed on admission despite of the fact that majority
of them had characteristic chest X-ray findings. This
likelihood is greater when the patient present with atypical
radiological pattern.

Conclusion
Typical pattern of pulmonary tuberculosis is still the
common presentation in adults but there is a trend toward
increase in atypical pattern. It is suggested that medical
students and practicing physicians must also be aware of
atypical presentation.
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Tuberculosis Control in Pakistan: Critical Analysis of its Implementation
A De Muynck, S. Siddiqi, A Ghaffar,1 H. Sadiq2
GTZ/HSA, Islamabad, Health Services Academy,1 Islamabad, DOTS Project, TB Centre,2 Rawalpindi.

Introduction
Tuberculosis (TB) constitutes a major public health
challenge. Due to the emergence of HIV, increased migration
and the deterioration of the health services in many countries,
the incidence has risen so drastically in recent years, that TB
was declared a global emergency by WHO in 1993.1 Without
increased investment in intervention strategies, the global
tuberculosis situation is expected to worsen in the near future.2

Epidemiology of TB in Pakistan
There is little reliable epidemiological data available
for Pakistan, although TB is considered to be a major cause of
ill health.3 The annual incidence rate of infectious TB cases is
estimated to be between 85-100/100,000 persons. Annually
around 120,000 new TB cases are being added to the existing
Vol. 59, No. 4 (Suppl. 1), April 2009

number of infectious individuals. Some areas in the country
have much higher figures, such as Northern Pakistan where a
prevalence figure of 554/100,000 cases was observed.4
As in other developing countries, young age groups
are affected the most. Male patients outnumber females in
most age groups, except in the adolescents. Based on Burden
of Disease estimates, TB represents 5% of the total DALYs
(disability adjusted life years); which indicates that the burden
of tuberculosis in Pakistan, is substantially higher than the
world average of 3%.5

Historical Review of TB control activities in
Pakistan
The first survey was carried out in 1962. The results
triggered a collaborative effort between MoH, WHO and
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UNICEF for a twenty year TB control programme, that
focused on establishing specialized TB centres and special TB
wards at the DHQ Hospitals. In 1985 UNICEF withdrew its
financial support. WHO declared TB a global emergency in
1993 and the GoP endorsed the DOTS strategy. In 1994 the
MoH, in collaboration with WHO, revised the TB control
policy. National policy and technical guidelines were drafted;
however, to date there is no draft yet for operational
guidelines. In 1995 the MoH decided on the location of 5
DOTS pilot sites, but only 1 site became operational. A highly
centralized and vertical five-year development plan was
prepared by the Federal NTP. Since the Provinces expressed
certain reservations with regard to the plan, it was not
approved. In 1996 the Directorate for TB Control of Pakistan
was abolished and the MS of the TB Centre in Rawalpindi
made responsible for National TB Control programme, but
without any additional support. In 1998 Pakistan was declared
1 of the 16 countries without an appropriate NTP. Recently it
was decided that each Province would be responsible to plan
and manage its own NTP under Federal NTP guidelines.
Funding for the plans will be provided through SAPP II.

achieve, its ambitious objectives. TB control activities in
Pakistan have suffered during the last five years because of
the dilemma of either managing the programme from the
federal level or handing it over to the provinces. A decision in
favour of the latter option was taken as late as mid-1998.
Under this arrangement the roles of the provinces and the
fedral government have been well defined. The provinces
have been given the responsibility of independently
developing and implementing their own TB control
programmes. TB control activities suffered in the past as
there were no funds earmarked for TB control in the
provinces. District managers were expected to support TB
control activities from their already insufficient regular
budgets. For the fiscal year 1999-2000 the federal
government has indicated support and earmarked funds for
all the provinces as well as for the federal component. Health
sector reform is a major driving force for improving the
health systems throughout the world.6 Proponents of this
reform believe services to be more cost-effective and
sustainable if they are integrated into and delivered through a
comprehensive district health care system.

Critical Analysis of the NTP

Programmatic reforms in the health sector of Pakistan
have over the years improved public health services through
better targeting of populations, funds and services. The TB
Control Programme is one example. Recently there has been
an effort on the part of the provincial health departments to
introduce structural and management reforms in the health
sector in order to improve the efficiency of services delivery
and resources development.

Given the magnitude of the TB problem in Pakistan as
well as the size of the country, a vertical TB control
programme is financially prohibitive and difficult to sustain.
Integration of the TB control programme in PHC has recently
been opted for, as a solution to its technical and managerial
deficiencies. Hereto, a network of laboratories needs to be
created as well as a system for ensuring quality of sputum
smear microscopy put in place.

The Objectives of the NTP Policy
The two major objectives are:
a) To increase the cure rate of sputum smear positive
cases to at least 85%;
b) To increase the detection of new cases to 70%, once
the first objective is reached.

Federal role in the NTP
Provision of a policy framework, technical
assistance, supervision, surveillance, co-ordination, research
and development and advocacy.

Provincial role in the NTP

Interest in the control of tuberculosis has been further
renewed through a recent policy initiative to strengthen PHC
services through an integrated approach. The Social Action
Programme, with multi-donors' support, has also pushed TB
high on the agenda, and the programme priorities of Provincial
Health Departments have been redefined.

Screening and Diagnosis Policy
According to the NTP guidelines, detection of
pulmonary TB should be based on sputum examination.7
From TB suspects at least 3 specimens should be collected and
examined.
Criteria for "AFB + caseness" consist of 2 positive
smears OR one AFB+ sputum as well as radiographic
abnormalities consistent with active pulmonary tuberculosis,
OR if determined by a competent medical officer.

Planning, accessing funds, management of
programme, implementation of DOTS through integration
with the PHC.

The diagnosis of a "Smear-Negative" TB case is made
if the following 3 criteria are met:

Practice

u

The NTP has been unable to come close to, let alone
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u

At least 3 specimen AFB sputum by microscopy.

Radiographic abnormalities consistent with active
tuberculosis.
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u

Clicical evidence substantiated by a competent medical
officer.

Practice
In Pakistan TB detection and diagnosis is generally
based on X-ray, clinical impression and blood examination
rather than on sputum examination. Some clinicians rely on
Mantoux results, although tuberculin is rarely available.
The network of laboratories able to correctly carry out
sputum examinations is inadequately developed with virtually
non-existent supervision. Consequently many laboratory
results are not reliable. These unreliable test outcomes weaken
the trust of the clinicians in the laboratory results and
strengthen their belief in clinical impression, ESR and/or Xray as diagnostic tools.
Many centres start TB treatment even when no sputum is
available: in the Rawalpindi study8 no sputum was available for
6.2% of the patients. In Delhi, India9 it was found that for only
12% of the TB suspects, a sputum examination was advised.
In practice the number of diagnostic AFB exams is
limited to two. A recent study has shown the sensitivity of 2
AFB exams to be 93% of that of 3 AFB exams.10 PCR
(Polymerase chain reaction), although more sensitive and
specific than smear microscopy, is prohibitively expensive,11
and is not routinely used in Pakistan. As a routine exam, the
ELISA test for detecting tubercular antigen in sputum has not
yet been implemented in the country.

Contact Tracing Policy
Bacteriological examination of all the contacts with a
smear positive index case. Especially children and young
adults should undergo 3 sputum examinations.

Practice
In Pakistan only some specialized centres routinely
perform contact tracing, although not appropriately. Since the
NTP guidelines do not detail the mechanisms of contact
tracing; this is an area that needs attention, especially for
operational guideline preparation.

Treatment Regimens Policy
The NTP proposes short course chemotherapy for all
sputum positive cases for 8 months duration. The guidelines
distinguish 3 main categories of patients:
u

Category I patients are new AFB smear positive cases;
Category II refers to smear positive re-treatment and failures
after a full short chemotherapy course;

u

u

Category III refers to sputum smear-negative and extra
pulmonary cases and to children who are unable to produce
sputum.
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The recommended treatment strategies for these three
categories are described in Table. NTP guidelines recommend
daily dosages according to weight.
Table: National TB treatment strategy.
Category of patients

Intensive
phase

Treatment Continuation
phase

I

2HRZE (or 2HRZS)

6HT (or 6HE)

II

2HRZES

1HRZE + 5HRT

III

2HRZ

6HT (or 6HE)

Practice
General practitioners and specialists have a poor
awareness of the WHO guidelines12,13 and do not adhere fully
to the national treatment guidelines. Almost all treatment
centres are using strengths and combinations of drugs that
differ from the accepted guidelines.
This situation is not unique to Pakistan. Unsatisfactory
practices of private care providers have also been observed in
India.14 In Delhi 102 different regimens were being reported,
51% of the patients were over-treated and only 20% of the
care providers did emphasis the importance of regular
treatment.

Follow-up of Patients Policy
Patients should be monitored at regular intervals
through:
u

Sputum smear examination

u

Regularity of drug intake, to be monitored by DOT

u

Prompt recovery of defaulters

Sputum has to be examined at 2, 5 and 8 months after
the start of treatment. For monitoring purposes, a single
sputum specimen smear examination is sufficient. If the
sputum results of a sputum smear positive patient are negative
at months 5 and 8, he/she should be discharged from treatment
after completion of the treatment course. If the sputum result
is positive at 5th or 8th month, then the treatment must be
changed to sputum smear positive re-treatment regimen.
No post-treatment follow-up is necessary for patients
who have successfully completed their treatment.
Given that Rifampicin is part of the intensive phase
treatment scheme, careful supervision is necessary and no
Rifampicin containing regimens should be given to patients
who are taking the drugs at home without supervision. When
outpatients fail to attend more than two consecutive follow-up
appointments during the intensive phase, they should be
traced within a week of missing their second appointment.
This means that a visit should be paid to the home of a TB
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patient who did not attend the scheduled appointment for drug
supply.

Practice
In Pakistan low treatment adherence prevails. In the
sixties Sloan and Sloan observed dropout rates of 66% in
Sindh,15 similar rates were found in the recent Rawalpindi
cohort study.8 A characteristic of case holding in Pakistan, is
the important very early defaulting. Several studies have
shown behavioral factors,16 including social stigma,17 to
contribute to non-adherence to treatment. Research has shown
irregularity of attendance during the initial phase to be a major
determinant for treatment adherence not only in the initial
phase, but also in the continuation phase.8 Incorporating DOT
in the initial phase can thus have an important impact on early,
as well as late defaulting. So far Pakistan has only launched a
few pilot DOTS projects in selected districts,18 but the DOT
strategy needs far greater support than it has received thus far.
Some centres hospitalize patients during the initial 2 months
of treatment, to guarantee very close DOT supervision.
No firm data is available on defaulter tracing
mechanism in Pakistan, but it is strongly suspected to be rather
deficient. The objective is to bring the patient back to regular
treatment in order to cure the disease, avoid development of
resistance, and avoid spreading the disease in the community.

Drug Resistance and Re-Treatment Policy
Drug resistance is one of the consequences of low
adherence to treatment. Sputum positive patients who have
previously taken anti-tuberculosis drugs for 1 month or more
must be suspected of discharging tubercle bacilli resistant to
INH and/or other drugs. Such patients must be started on retreatment regimen (2 SHRZE/1 HRZE/5 HRE).

Practice
In Karachi resistance rates to the four first line anti TB
drugs were found to be 27% to INH, 15% to Ethambutol, 11%
to Rifampicin and 13% to Streptomycin; MDR (multi drug
resistance) was 8%.19 The guidelines for re-treatment of
resistant TB cases are based on WHO recommendations rather
than on local studies.

Involvement of Private Practitioners Policy
There is no explicit policy for involvement of private
practitioners in the treatment and follow-up of TB patients.

Practice
Eighty percent of the TB patients consult a private
practitioner first;20 these findings have been confirmed in the
PMRC health seeking behavior study. Hassan has found an
even higher figure of 96%. Marsh has demonstrated poor
performance of some private practitioners in screening,
S-71

diagnosing, treating and monitoring their TB patients.20
Ekbal21 has discussed the main errors in drug prescribing
practices as:
Starting with a single drug, adding a single drug to a
failing regimen, inappropriate prescription, ignoring DOTS,
extensive prescription of combined anti-TB drugs and
insufficient instructions to illiterate patients.
The fact that most TB patients first contact a private
practitioner has been revealed by several surveys. In spite of
this, official policies are directed towards detection, treatment
and follow-up of TB patients at public sector health facilities
only. Public sector managers should be more innovative and
develop public - private collaboration. One way could be to
train GPs in opportune diagnosis, treatment and follow-up of
TB patients and encourage them to refer these patients to the
laboratories of THQ hospitals for sputum examination and
registration.

Integration of TB control into PHC services
Policy
The official policy is to integrate TB control services
into the PHC services. A network of laboratories will be
established. 1 in each RHC and THQ hospital. Sputum
collection and smear fixation will be done at BHU level, once
personnel have been adequately trained. Human and material
resources will be integrated into the PHC. NTP plans to ensure
a continuous drug supply by establishing a system for national
procurement, storage, and delivery and monitoring of anti-TB
drugs. Continuous supervision will enable prompt detection of
deficiencies in implementation motivation and skills of staff.

Practice
Pakistan has a relatively well-developed health care
infrastructure. The centres have, in theory, sufficient
manpower; a recent World Bank report6 even speaks of
overstaffing, mainly of general practitioners. But many rural
areas lack female doctors, which limits the access of female
patients to care. Contrary to NTP mandate, to date only
sporadic training sessions for staff of public services have
been held. There is limited involvement of the THQH in TB
control activities and no involvement of the BHUs in case
detection or follow-up.
Generally the laboratories at the RHC and THQH do
not function due to either failure of necessary reagents, or
insufficient training of laboratory technicians. Most of the
time, however, the reason for the poor functioning of the
laboratory is the lack of requests for sputum examination by
the medical practitioners.
Many RHC and THQH have no regular TB drug
supply, or the stock consists of a few selected drugs only. The
danger is that the patients do not buy the other drugs and
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consequently resistance develops. Visits to several first and
second line centres in Pakistan have shown that the drug
supply is very irregular, partial and insufficient.

recording, it is not standardized and generally not in
accordance with WHO recommendations.

NGO’s Policy

Regular supervision of the TB program activities is
one of the weakest elements of the system. The concept of
supervision as continuous education has not been introduced
yet. There is normally no back referral of diagnosed TB cases
by the specialized centres.

The NTP proposes to strengthen cooperation and
coordination with NGO's.23 The latter are expected to play a
crucial role in enhancing patient education and community
assistance.

Reporting System

Practice

The IUATLD (International Union Against
Tuberculosis and Lung Disease) recognizes a reliable
information system to be the key element for the success of
national TB control programmes.22 Experience from several
countries shows the data generated by the NTP to be more
reliable and complete than that generated by HMIS (Health
Management Information System) and more suitable for
programme management. Following IUATLD both
information systems should complement each other; therefore
NTP should collect the relevant TB data and communicate it
to the HMIS managers at all levels of the health system.

The majority of NGO's are working in isolation,
involved mainly in the treatment and drug provision. Some
NGO's have not yet adopted the NTP guidelines. Little effort
has been undertaken to streamline the NGO's efforts.

Policy
The NTP has planned to introduce a standard system
of registration and reporting, to monitor the results of
treatment and to assess progress of the programme by means
of ongoing quarterly analysis.

Role of Communities Policy
Four main roles for the communities are envisioned:
u To encourage the TB suspects to promptly visit a health
facility for assessment.
u

To support the diagnosed cases to complete treatment.

u

To improve general understanding of the disease and its
prevention.

u

To supervise treatment.

Practice

A series of standardized records have been created: TB
treatment card; TB appointment card; District TB register; TB
laboratory register; TB smear examination request/report
form; TB culture/sensitivity. Test request/report form; TB
referral/transfer form; Quarterly order form for TB treatment
supplies; Quarterly order form for TB laboratory supplies.
The case finding, smear conversions at follow-up, and
final results of treatment have to be reported to the NTP on a
quarterly basis. A cohort analysis has to be carried out. A
feedback mechanism will also be established.

The national policy makers perceive the community as
a natural partner for public sector development. However,
hardly any sustainable model has been designed and practiced
in the health sector and almost none for either reductin or
control of TB. In pilot projects going on in Balochistan and
NWFP provinces, LHWs are being used to implement the
DOTS, with encouraging outcomes. However, to fully realize
the additional benefits obtained from community
participation, the NTP may have to design some culturally
appropriate, socially acceptable and sustainable partnerships
between the people and the public health sector of this
country.

Practice

Political Commitment Policy

At present there is no uniform system of recording and
reporting in the public sector. The HMIS has a different format
from that suggested by NTP. In some areas where DOTS is
implemented a dual system exists. The method of recording
and collecting information differs from one centre to another
and is generally not in accordance with WHO guidelines. Case
definitions for pulmonary and extra pulmonary cases may
differ and cohort analyses are computed differently as well.
Data is as yet not being used for the planning and management
of TB services. No reliable national data is available
concerning TB case detection and TB case holding. The
quality of the HMIS data is interior to the recommended NTP

A strong political commitment is essential for the
success and sustainability of any TB control programme.
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Practice
The political commitment at the federal and provincial
levels is rather weak, although interesting pilot projects are at
present being undertaken in the provinces of Balochistan and
NWFP.

Future Strategies and Recommendations
The weaknesses and shortcomings at each level of
the NTP need prompt political, technical and/or
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managerial solutions.
At the political level: TB should be given much
greater importance, and commitment, as well as support and
resources. The Federal NTP unit should be made fully
operational.
At the technical level: All care providers working in
both the public and private sectors should be updated on the
NTP guidelines. District and Tehsil headquarter hospitals
should be equipped to carry out reliable sputum exams.
Laboratories should adhere to quality control principles.
DOTS will have to be applied throughout the country, and
lessons learned from patient counseling experiences should be
incorporated in patient management. The communities should
be involved in the DOTS scheme.
At the managerial level: The NTP has to be
strengthened, and specific tasks for all levels (federal,
provincial, district and community) have to be planned. The
activities have to be implemented, monitored and assessed
with clearly defined indicators. Following the lessons learned
from neighbouring countries, private practitioners should be
involved. The cooperation with NGO's has to be strengthened.
The public should be much better informed, and the message
that the disease is curable should be spread through all means
of communication. There is a need for continuous laboratory
supplies, as well as for a continuous drug supply system.
There is a need for a drug resistance surveillance system. The
personnel in charge of Tehsils and districts should be trained
in data management and analysis, so that programme
management will become more evidence based.
At the community level: Strategies to overcome the
stigma attached to TB have to be developed.
At the individual care level: The continuity of the
care has to be addressed in the context of the socio-economic
constraints of the households and communities. Specific
treatment should be given free of charge, and efficiency
improved by reducing the number of visits to the least
required, and by following up the patients as close to their
homes as possible.
At the research level: Operational research is needed
to find solutions for the constraints and to continuously
optimize the programme output.
Behavioural research is needed to create awareness of
the TB problem24 and to contribute to its destigmatisation; as
well as to develop a socially acceptable DOTS programme.
Socio-economic research is needed to quantify the burden of
disease, the cost of defaulting and the benefits of DOTS.
Epidemiological research is needed to determine the
magnitude and spread of the disease, and the drug resistance
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in order to analyse the risk-factors for the incidence of
infection and disease, and to determine the nosocomial risk.
Therapeutically research is needed to find more cost
effective ways of treatment.
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Cutaneous Tuberculosis: a three year prospective study
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Abstract
Objective: To study the pattern of clinical presentation of
cutaneous tuberculosis.
Methods: All patients with clinical suspicion of
cutaneous tuberculosis, visiting outpatient department of
Dermatology Unit, Jinnah Postgraduate Medical Centre,
Karachi were included in this study. Total number of the
patients enrolled were 74. The lesions were then
classified into four clinical types viz: lupus vulgaris,
scrofuloderma, tuberculids and tuberculosis verricosa
cutis.
Results: A total of 0.1% patients visiting out patient
department had cutaneous tuberculosis. Scrofuloderma was
the commonest form seen in 48 (64.9%) patients, followed
by lupus vulgaris in 16 (21.5%), tuberculosis verrucosa
cutis in 6 (8.1%) and tuberculids 4(5.6 %).The presence of
regional lymphadenopathy had correlation with the
disseminated disease.
Conclusion: There is an increasing trend of cutaneous
Tuberculosis over the years. Scrofuloderma was the most
common clinical presentation, followed by lupus vulgaris,
tuberculosis verrucsa cutis and tuberculids. Tuberculous
gumma was not seen in any patient.

Introduction
Tuberculosis (T.B) has plagued humans and animals
from ancient times. This human infections has been
documented in history as early as 8000 B.C. Hippocrates
(460 - 376 B.C.) gave T.B. the first intelligent description
"phthisis" (to waste away).1 The ancient Chinese literature
reports its presence in China before the great wall was built.
The history of systemic tuberculosis is well documented;
little has been said about a tuberculosis skin lesion in the
ancient medical scriptures.
However chronic draining sinuses of scrofuloderma
reported by Rene Laennec (1918) forms the earliest of
cutaneous tuberculosis lesion. In 1882 Robert Koch not
only discovered tubercle bacillus but also found it to be the
causative agent of lupus.2
Even after many centuries patients still suffer from
this potentially curable illness. The fact that it is now more
prevalent in developing countries suggests that low
socioeconomic status, malnutrition and overcrowding play a
role in its causation.
The lack of medical facilities because of poverty
or poor health infrastructure has led to long standing
Vol. 59, No. 4 (Suppl. 1), April 2009

and more extensive tuberculosis skin lesions. Another
reason for chronic cases is misdiagnosis and
subsequent wrong treatment by doctors or treatment by
quacks or hakims.

Patients and Methods
The study was carried out in O.P.D of dermatology
department, Jinnah Postgraduate Medical Center from 1
July 1999 till 30 June 2001 (3 years duration). A total of 83
patients with clinical suspicion of cutaneous tuberculosis
were enrolled. Both sexes and patients of all ages were
included. A detailed Performa stating age, sex, duration of
illness, examination of lesion, site and number of lesions etc
was filled in for each patient.
Investigation performed were ESR, Mantoux test
and X-ray chest in all patients. Biopsy of the lesion was
performed only in 28 patients. Nine patients were
excluded from the study because of incomplete data.
Finally the data of 74 patients was analyzed. The lesions
were classified into four clinical types viz: lupus vulgaris,
scrofuloderma, tuberculids and tuberculosis verricosa
cutis (TVC).

Results
The patients mainly belonged to the city of Karachi
or its outskirts. However some patients came from rural
areas of Sindh and Balochistan. Four patients were Afghan
refugees settled in Karachi. Females were 45 (60.8%) and
males 29 (39.2%).
The age ranged from 1-80 years. Of these 10% were
between 1-10 years, 37.8% between 11-20 years, 18.9% in
range of 21-30 years, 16.2% in 31-40 years while 16%
above 40 years.
Positive family history was present in 43.5%
cases. Duration of illness of less than 6 months and 6
months - 1 year was 17.3% each, while 34.9% had
lesion for 4-8 years before presenting to the clinic.
Primarily the lesions involved the lower limbs (43.4%)
of which thigh had 26% of lesions while those on the
feet were present in 17.3%. Face, neck and trunk
involvements was 17.3% each while genitalia were
involved in 8.6%.
Most of the patients had more than one lesion
(56.6%), solitary lesions were seen in 43.4%. (Figure 1)
Scars and plaques were the main presenting feature
(56.5% and 47.8% respectively) whereas nodules (39%),
chronically discharging sinuses (39%) and ulcers (30.4%)
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consistent with clinical diagnosis.

Discussion

Figure - 1

Figure - 2

Figure - 3

were also seen (Figure 2). Some patients had a
combination of different types of lesions. Scrofulderma
was diagnosed in 65% followed by lupus vulgaris in 21%,
TVC in 8.2% and tuberculids 5.6% (Figure 3) Mantoux
test was done in 60 % patients and was positive in 26%, Xray chest had hilar lymphadenopathy positive in two
patients. Biopsy was done in 40% of patients and was
S-75

Cutaneous T.B is a relatively rare clinical entity in
western countries but is still prevalent in the developing
world such as in Far East it accounts for 0.4% of patients
with skin disease.3 The results of this study clearly show
that cutaneous tuberculosis is still far from extinct. In fact it
is still present in cities like Karachi. A rising trend over the
years (from 1998 through 2002) has been observed. The
exact reason for this increase in incidence could not be
identified as this was not the aim of study. However, it may
reflect the true rise of cutaneous T.B. (Such as systemic
T.B.), or simply a better referral from regional centers. The
fact that it forms 0.1% of outpatient visit is also important
(total O.P.D. visits in three years were 73510). This is
comparable to reports from northern India which reported
0.1% incidence in the population between 1975-95.
Cutaneous T.B. was a common chronic skin infection in
Hong Kong as reported to be 0.35% in a study in 1968.
However it has dropped considerably in recent decades,
reflected in another survey, where it accounted for only
0.067% of total skin cases.4 Reported incidence from
Europe (Madrid) is 0.14%. In USA skin involvement with
tuberculosis is less then 1.5% of total skin attendances
where HIV patients were more infected then immunocompetent patients. But in this study none of the patients
had any immuno-suppressive condition like acquired
immune deficiency syndrome (AIDS), Hepatitis B and C.
Although age is no bar to cutaneous tuberculosis, unlike
systemic tuberculosis which is more common at both
extremes of age. The youngest child with tuberculosis skin
lesion was 3 years old and oldest 75 years. However a case
report from Vietnam has reported a 5 month old infant
presenting with several erythematous nodules and localized
adenopathy.5 In the younger children scrofulderma was
commonly encountered where as in older children and
adolescent lupus vulgaris was more common.
A slight sexual predilection was observed in our
study in all types cutaneous tuberculos lesions. Lesions
were more commonly seen in females and primarily on
limbs or face. There was a gross delay in seeking specialist
advice for skin lesions especially in chronic ones like
tuberculosis. This delay was partly attributed to personal
indifference and partly to health care facility in the vicinity
of residence. Cutaneous tuberculosis being a notoriously
chronic lesion has been neglected for months to years before
coming to a dermatological clinic by patient or care givers.
One patient had a plaque for 8 years on the chest, in another
case lesions in groin were present for 7 years. Both were
treated by hakims or quacks for years.
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The type of cutaneous tuberculosis differs from
country to country and is closely related to social and health
system development.6 In our experience scrofuloderma was
the commonest type involving skin overlying the
tuberculous focus which is usually a tuberculous lymph
node in the neck. However underlying tuberculosis of bone
may also be found in some cases.
Groin involvement in scrofuloderma was also very
common and the lesions were usually multiple. Lupus
vulgaris was the next common type of lesion encountered;
occurring on face or upper limbs. The lupus lesions were
solitary with typical clinical appearance; central scarring with
active margins. Tuberculosis verrecusa cutis (TVC) or warty
tuberculosis was seen in 8% of patients mostly on limbs
exposed forearms. A somewhat similar experience has been
reported from other countries (Hong Kong 5%. India 14%).7
The common type of cutaneous tuberculosis in developing
countries, is in contrast to result from developed countries
where tuberculosis was the commonest variety (85%).8,9
In conclusion it can be stated that a rising trend of
cutaneous. T.B. has been observed which may be linked to
global resurgence of T.B Cutaneous form of T.B mostly

affects young or middle aged people with slightly higher
female preponderance. Scrofuloderma is the most common
type followed by lupus vulgaris. Delayed referrals leading
to long standing extensive lesions are still common
necessitating more awareness in general practitioners and
mass education of general public.
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Assessment of Resistance in Multi Drug Resistant Tuberculosis Patients
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Abstract

cases within the community.

Objective: To study MDR-TB isolates and to identify
primary and secondary resistance at microbiology
laboratory Aga Khan University, Karachi, Pakistan.

Introduction

Methods: All samples positive for Mycobacterium
tuberculosis (MTB) received during January - September
2004 were reviewed for drug resistance pattern as well as
for history of previous antituberculous drugs exposure.
Results: Out of 216 Mycobacterium tuberculosis cultures,
138 (64%) showed resistance to one or more agents. Multi
drug resistance (MDR) was observed in 102 (47%) isolates.
Of 138 drug resistant isolates; primary resistance to any one
or more agent was noted in 31(39%) and secondary
(acquired) resistance in 107 (79%) isolates. On analysis of
the 102 MDR-TB strains 8 (10%) showed primary
resistance while 94 (69%) showed secondary resistance.
Conclusion: In this group MDR-TB was mainly associated
with previous anti-tuberculous treatment. However, primary
MDR was also observed and reflects dissemination of MDR
Vol. 59, No. 4 (Suppl. 1), April 2009

Drug resistant tuberculosis is becoming a major
concern in the control of tuberculosis (TB)1. A survey
conducted by the World Health Organization and the
International Union against Tuberculosis and Lung Disease
in 35 geographic sites, revealed that drug resistant
tuberculosis is ubiquitous and prevalence of primary
resistance to at least one drug is around 10.7 percent.2
Multi drug resistant tuberculosis (MDR TB), defined
as resistance of Mycobacterium tuberculosis to at least
Isoniazid and Rifampicin3 is a major threat to the
tuberculosis control program. The mortality from multidrug resistant tuberculosis is 40-60%4 which is equivalent
to the outcome of untreated tuberculosis. Therefore, the
spread of resistant strains in poor countries would mean a
return to pre-chemotherapy patterns of mortality.
Acquired drug resistance was defined as the acquisition
of resistance to anti-tuberculosis drugs by the multiplication of
S-76

the resistant mutant strain of bacteria as a result of inadequate
chemotherapy. Primary drug resistance, on the other hand,
develops in patients who become infected with a resistant
strain without ever having been treated with anti-tuberculosis
drugs.5 While resistance in previously treated patients is likely
to reflect past incorrect or irregular treatment, resistance in
new, untreated patients is evidence of transmission of resistant
strains. Globally, the prevalence of MDR-TB is reported at
1.4% in primary cases and 13% in previously treated patients.6
Early detection and treatment of MDR strains is important in
disease control. In addition, knowledge of drugs susceptibility
pattern in MDR clinical isolates is necessary in order to design
appropriate treatment regimen.

All samples (except those from the sterile sites) were
decontaminated with N-acetyl-L-cysteine (NALC) sodium
hydroxide. Sterile body fluids were processed without
decontamination procedure. The sediments were used for
AFB microscopy and cultured on BACTEC (12Bvial
Becton Dickenson) and LJ slant (Oxoid).
Smears for microscopy were checked using
Auramine staining, positive slides were further confirmed
by staining with Kinyoun modification of Z-N stain.
Cultures were performed using LJ slants and
BACTEC 460. For LJ slant 0.1 ml of concentrated specimen
was inoculated and incubated for 8 weeks.
Similarly BACTEC vials were inoculated with 0.5 ml
of specimen and incubated at 37oC after supplementation of
medium with PANTA; containing Polymyxin B,
AmphotericinB, Nalidixic acid,Trimethoprim and Azlocilin.
Growth index of inoculated vial were checked for four
weeks. Growth from the positive vials and LJ slant tube were
first stained with Kinyoun and confirmed using NAP test.

In Pakistan, where incidence of tuberculosis is
estimated at 181 per 100,000 populations, rising drug
resistance is alarming.7 Recent report8 showed 28% of
MDR TB strains from northern Pakistan, a marked
difference from previously reported9 rate of 16% MDR in
2001 (Table-1). Continuous monitoring of drug

Table 1: Reported antituberculous resistance from Pakistan.
Reference

Overall Resistance (%)

Resistance (%)

MDR (%)

Sample
size

Total

10

20

INH

RIF

PYR

ETH

STREP

Total

10

20

Karachi 1993 (14)

145

-

17

36

-

-

-

-

-

-

-

-

Karachi 1996 (15)

156

45

-

-

27

11

-

14.5

13

8

-

-

Rawalpindi 1999 (16)

300

53

-

-

26

24

-

23

28

14

-

-

Lahore 2001 (9)

228

52

-

-

25

25

24

10

21

16

7.3

26

Sind 2002 (17)

50

73

-

-

60

24.4

-

22

38

25

-

-

Lahore 2002 (18)

100

36

-

-

25

15

-

12

19

11

-

-

Lahore 2003 (19)

678

53

-

-

26

28

29

15

24

16

-

-

Rawalpindi 2004 (8)

325

49

-

-

37

32

-

17

19

28

-

-

1o= Primary resistance, 2o= Secondary resistance, Overall resistance= Resistance to any antituberculous agent.
MDR= Multi drug resistance , INH=Isoniazid; RIF=Rifampicin; PYZ=Pyrazinamide; ETH=Ethambutol; STREP=Streptomycin
% Resistance= Resistant organisms as% of total isolates.

resistance pattern especially of MDR isolates to
determine the extent of primary (1o) and acquired (2o)
resistance is a crucial need for future TB control in
Pakistan. In this study we assessed the primary and
secondary MDR isolates.

Material and Methods
This study was conducted in the Clinical
Microbiology Laboratory of The Aga Khan University
between January-September 2004. Detailed history of
antituberculous therapy was obtained and reviewed in all
patients with positive cultures for Mycobacterium
tuberculosis (MTB).
S-77

Indirect antimicrobial susceptibility test
Antimicrobial susceptibility for four primary drugs
including Isoniazid (INH) 1.0 µg/ml, Rifampicin (RIF) 1.0
µg/ml, Ethambutol (E) 10.0 µg/ml and Streptomycin(S)
10.0 µg/ml was tested using modified agar proportion
method. Disc elusion sensitivity plates were prepared using
paper sensitivity disc (BBL).
McFarland No.1 standard suspension of isolate
was made from growth on LJ slant and diluted to 10-2
and 10-4 dilutions. The inoculated plates were
incubated at 35°C and examined for growth each week
for 8 weeks. M.tuberculosis was considered resistant to
J Pak Med Assoc (Suppl. 1)

60.0

0.0

1 Drug

2 drugs

3 Drugs

4Drugs

n=36

n=25

5.0

n=25

10.0

n=20

15.0

5 Drugs

INH

RIF

PYZ

ETH

STREP

Anti tuberculous drugs
INH=Isoniazid; RIF=Rifampicin; PYZ=Pyrazinamide; ETH=Ethambutol;
STREP=Streptomycin

Figure 1: Individual Drug Resistance in M.tuberculosis isolate (n=216).

Resistance to a single agent was noted in 20 (15 %)
of the 138 resistant isolates Figure 2, majority of which was
against Isoniazid (n=13). Among the strains showing
resistance to two drugs resistance to a combination of
Isoniazid plus Rifampicin was highest (n=14), followed by
resistance to Isoniazid plus Pyrazinamide (n=5) and
Isoniazid and Streptomycin (n= 4). Thirty two strains
showed resistance to three drugs. The largest amongst these
were resistant to Isoniazid plus Rifampicin plus
Pyrazinamide (n=28). Finally 25 (18%) isolates showed
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Figure 2: Analysis of drug resistant isolates in term of resistance pattern (n=138).

resistance to four drugs with combination of Isoniazid
Rifampicin Pyrazinamide and Ethambutol in 21/25.
Multi drug resistance (MDR) was observed in 102
(47%) isolates studied.
Analysis of 102 patients with MDR-TB showed that
8 (10%) had primary resistance while 94 (69%) had a
history of previous exposure to anti-TB drugs (acquired
resistance)
No cross-resistance to other antituberculous drugs
was noted in 14 (10.5%) MDR strains, while 28 (27%)
showed cross-resistance to one other drug and 24 (23.5%) to
two drugs and 36 (35.2%) of MDR isolates were resistant to
all five first line antituberculous agents.

Discussion
n=52

10.0

n=63

n=97

20.0

n=104

40.0
n=130

% Resistance

50.0

0.0

20.0

Anti tuberculous drugs

We reviewed 216 cases for history and drug
susceptibility pattern, 80 (37%) cases had no history of prior
antituberculous treatment, while 136 (63%) cases had
previous exposure to anti tuberculous therapy. Almost one
third 78 (36%) cases were fully sensitive to all five first line
drugs (Isoniazid, Rifampicin, Pyrazinamide Ethambutol and
Streptomycin) while 138 (64%) showed resistance to one or
more agents. Amongst these, primary resistance was seen in
39% and secondary resistance in 107 (79%) of our samples,
whereas 60% of isolates were resistant to Isoniazid Figure 1.

30.0

25.0

n=32

Results

30.0

% Resistance

a given drug when growth >1% above the antibiotic free
control was observed in drug containing area. MTB
H37Rv was used as control with each batch of
susceptibility testing.
Sensitivity of Pyrazinamide (PZA) was performed
using BACTEC 7H12 medium pH 6.0 (BACTEC TM PZA
test medium). Lyophilized PZA was reconstituted and
aseptically 0.1ml of PZA solution was added to PZA
medium vial. 0.1ml of freshly sub cultured organism was
added to PZA and incubated at 37oC with daily check of test
and controlled vial in BACTEC 460.

Globally, prevalence of multi-drug resistance
tuberculosis (MDR-TB) has increased over the past few
years. World Health Organization (WHO) estimates
suggest that over 50 million people worldwide are
infected with drug-resistant tuberculosis.10 A number of
global hot spots with >3 % primary MDR-TB have been
identified including Estonia, China, Russia, India and
Iran.11 WHO concerns have been raised indicating that
levels of MDR-TB will reach an alarming state in South
East Asia unless urgent steps are taken to control the
increasing level of resistance.12
Pakistan ranks sixth among the list of 22 high TB
burden countries with a TB related death rate of 43/100,000
population annually.13 Resistance to TB drugs has been
widely reported from various parts of the country8-9,14-19,
however, pertinent community based data that represents a
national profile is lacking. In the absence of community
data, hospital based studies provide indication of the levels
of drug resistance and particularly of resistance trends over
the years. Our study showing an overall resistance rate of
S-78

worldwide situation the WHO/IUATLD Global Surveillance project.
International Union Against Tuberculosis and Lung Disease. Clin Inf Dis
1997; 24Suppl 1:S121-30.

64% to the antituberculous drugs confirms 36-73%
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Thirty nine percent primary drug resistance to at
least one drug however represents a marked increase from
17% resistance reported in 1993 by Khan et al.16 We report
an overall 79% acquired resistance, which indicates
magnitude of non-compliance as well as partial treatment in
TB patients.
Sixty percent of the isolates in this study were
resistant to Isoniazid of which 80% (102/130) were
MDR. More alarming is a fact that 67%( 93/138) of total
drug resistant isolates showed resistance to three or
more agents. This finding is again consistent with the
rising Isoniazid and Rifampicin resistance reported
earlier from this country.8
The reported single drug resistance worldwide is
10%. Analysis of 138 resistant isolates in our study revealed
15 % (n=20) resistance to single agent with the majority
being resistant to Isoniazid (a risk factor for future MDR)
with 39% being primary resistance. It has earlier been
reported that 70.8% of tuberculosis patients with either
Isoniazid or Rifampicin resistant strains acquire MDR-TB
following treatment failure.20
We observed very high level of MDR-TB strains
(47%) in our isolates. This finding support the rising
MDR trends reported in earlier hospital based studies
from the country and is consistent with a recent hospital
based study from Mumbai (India) indicating 51% MDR
rate in their isolates.21 The high MDR rate noted in this
study and reported elsewhere in the country and region
is a matter of great concern. We report 10% primary
MDR cases which again supports the hypothesis of
rising trend of primary and secondary resistance when
compared with 7% primary MDR reported by a hospital
based study in 2001.9
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BCG Scar Survey in Karachi Schools
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Introduction
Scar surveys at regular intervals are a measure of
BCG coverage in a population. BCG has been the main stay
of tuberculosis control in Pakistan since 1952. In 1977
mobile teams were disbanded and responsibility for BCG
was given to rural health centres and tehsil hospitals.
Recently BCG vaccination has been integrated with
extended program of immunization (EPI).1 According to
1974-78 survey BCG scar was seen in only 9.4%2 of
children between the ages of 0-14, while in Sindh it was
only 4.9%. This was a poor result, confirming very low
BCG coverage.
The present study was planned to see the beneficial
effect, if any, of BCG in making it a part of EPI programme
by conducting a scar survey in Karachi school population.

Subjects, Methods and Results
A cross section of primary and secondary schools of
Karachi both in upper and lower socio-economic areas were
selected and all students of the selected schools were
examined for BCG scars.
A total of 6214 students (2016 males and 4198
females) were examined. Male to female ratio was 1:2 and the
average age was 10 years with a range of 5-19 years. Scars
were seen in 2025 (33%) while 4189 (67%) had no scars.
Amongst 2025 patients with scar, 769 (38%) were males and
1256 (62%) females (Table I). The percentage coverage was
Table I: Scars survey in Karachi school.

Male
Female

fairly constant in different age groups (Table II) which ranged
from 32% amongst 10-19 years to 37% amongst 5-9 years.
Table II: Age distribution in scars positive and negative.
Age group

Positive
(n = 2025)

Negative
(n = 4189)

Total
(n = 6214)

9-May
14-Oct
15-19

368 (37%)
1294 (32%)
363 (32%)

621 (63%)
2812 (68%)
756 (68%)

989 (16%)
4106 (66%)
1119 (18%)

Comments
The 1974-78 national tuberculosis prevalence survey
showed BCG scar in 9.7% of the Pakistani population and
for Sindh province the figures were half that of national
figures, being only 4.9%.1 Though break-up for urban and
rural population is not available, one would presume that
percentage for urban areas would be higher.
Situation seems to have improved some what but
coverage still remains very low. Karachi being the most
developed city of the province with better medical facilities
showed that only 33% had scar; the figure would be even
lower for the rural areas. The percentage of those who
actually develop immunity would be even lower when other
factors like break-down in the cold chain and faulty
technique are taken into consideration.
For BCG to have any epidemiological effect the
coverage of BCG will have to be at least 80% or more.
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Abstract
Objective: To explore the factors influencing decisionmaking process at household level vis-à-vis decision to seek
health care, decision regarding the type of care and the
decision to continue treatment.
Design: Cross-sectional study.
Place and Duration of Study: Government TB Center,
Rawalpindi, from 16th January 2002 to 28th February 2002.
Subjects and Methods: In total, 100 smear positive patients
were included in the study. First questionnaire was
administered to first 50 randomly selected patients. The
ethnographic decision models (EDM) were developed from
the responses. The second questionnaire, derived from these
models, was administered to the second group of randomly
selected 50 patients to test the predictive ability of the EDM.
Results: Decision-making regarding treatment of
tuberculosis was influenced by patients' knowledge about the
disease itself as well as its severity, infectivity and curability.
Close relatives were found to play a critical role at all the
decision-making levels. The EDM developed on these results
had 80-90% ability to predict the decision-making in
tuberculosis patients.
Conclusion: Effective health education, easy accessibility to
treatment centres and trained and motivated health care
providers can go a long way in making national TB control
program a success.

Introduction
Health and well-being is the net result of multiple,
inter-linked biological and socioeconomic factors.
Management and control of any known disease depend on
knowledge, social acceptance, norms and attitudes not only
towards the disease but also towards persons suffering from
that disease. Communities asually perceive tuberculosis (TB)
as a dangerous, contagious and untreatable disease.1 This
understanding has many social implications particularly
stigmatization2 and social isolation of TB patients and even
their families. Due to the social connotations, patients are
often reluctant to accept or reject the diagnosis and
treatment.3 The success of any tuberculosis control program
depends upon early diagnosis, treatment initiation and
treatment adherence for a prescribed period of time.2 In this
context the socioeconomic factors that influence the
decisions made at the household level are very important as
these directly affect the above variables.
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Pakistan is included in the sixteen countries where
lack of progress in fighting tuberculosis is threatening global
TB control efforts.4 Case detection (25%) and case holding
(50%) is very poor.5 Household decision-making has a role in
utilizing public sector health facilities for tuberculosis
control.
Medical decision-making process is three tiered
comprising of decision to seek care in case of illness, type of
health care and continuation of treatment for the prescribed
period of time. These levels are influenced by various factors
related to the patients, the health care system and treatment
outcomes.6 Perceived susceptibility to and severity of the
disease are of paramount importance in decision-making.7
Ethnographic decision models (EDM) are qualitative
causal analyses that predict the choices people make in
certain illness conditions.8,9 They have been used to study
how people decide and select the type of treatment for an
illness and chose among various available alternatives. In the
first instance, the patients are asked relevant questions
without directly addressing the dependent variable or the
actual decision. Their answers are used to develop an
ethnographic model that can predict responses in similar
patients. Later a second set of patients is directly asked about
the variable of interest. A good model should have the ability
to predict 80-90% of the decision. Prediction of dependent
variable (like decision to seek health care, decision to
continue the treatment) on the basis of some independent
variable like family involvement, education of the patient and
socioeconomic status is the objective of analysis.
The objective of this study was to explore the factors
influencing decision-making process at household level visà-vis decision to seek health care, decision regarding the type
of care and decision to continue care .

Methodology
This cross-sectional study was based on ethnographic
decision modeling (EDM). The study was completed in two
phases. In the first phase, the factors influencing the decisionmaking were identified and used in developing three separate
EDM trees, corresponding to the three levels of decisionmaking. These models were then tested during the second
phase to determine their ability to predict the decision of a
different group of patients.
All the sputum-smear positive patients registered at
TB Center, Rawalpindi and being treated at this center, during
J Pak Med Assoc (Suppl. 1)

January-February 2002, were included in the study. Every 5th
patient was administered exit questionnaire, a total of 50
patients in each group. Sputum-smear negative patients,
extra-pulmonary tuberculosis patients and patients under 15
years of age were excluded from the study.

knowledge about the curability of tuberculosis. The EDM
tree regarding decision to seek medical care is shown in
Figure 1.

A structured questionnaire, used for the first phase of
study, was developed which sought information about factors
influencing their decision to seek care, choosing type of
health facility and treatment continuity. EDM for three levels
of decisionmaking process were built upon the responses of
the interviews. A second structured closed-ended
questionnaire was derived from these models which had four
sections, first section required general information while the
rest three sections dealt with the factors determining the three
decisions. The questions were constructed in such a way to
get Yes/No response. At the end of each section there was one
open-ended question to seek any new information which was
missed in the first round of interviews. It was administered to
the second group of 50 patients to test the predictive ability of
the EDM. The two types of questionnaires were translated
into Urdu and pre-tested. After minor additions and
modifications these were administered to the selected
respondents. All the information gathered was pre-coded and
entered in Statistical Package for Social Sciences, version 7.5
(SPSS 7.5). Both the data sets were analyzed separately.

Results
In the first phase, data was collected from a total of 50
patients. This group comprised of 60% males and 40%
females. The mean age of the respondents was 34.2 years (±
16.03), with an overwhelming majority (90%, n=45) in the
economically productive age group (15-59 years). Most of
the respondents (60%) were illiterate and living in 1-2 rooms
house. Threefourth of the respondents reported an average of
8 family members in their households.
The factors influencing the three tiers of decisionmaking process, namely seeking health care, choosing a
specific health care facility and continuing the prescribed
treatment, were explored in detail through individual
interviews with the respondents.
Symptoms suggestive of TB, like cough, fever, chest
pain and general ill- health, were cited as the reason to seek
medical care by all (100%) respondents. Although all the
respondents were aware of the seriousness of the disease, it
was the severity of symptoms that prompted 62% of the
patients to seek medical care. Family advice influenced this
decision in most (68%) of the respondents, while 32%
decided on their own. Family support was a very important
factor for a vast majority (94%). The other contributory
factors were inability to work, fear of harming one-self and
other family members due to the disease and the patient's
Vol. 59, No. 4 (Suppl. 1), April 2009

Figure 1: EDM tree for decision to seek care.

Family and relatives played important role regarding
the selection of a particular type of health care and 68% of
respondents decided after taking advice from them. The other
factors that influenced their decision in this context were
favorable distance from their place of residence, waiting time
and the cost of treatment. The EDM tree for this decision
follows in Figure 2.
An important factor for continuation of care decision
was the continuing family support and encouragement.
However, 70% of patients acknowledged the positive attitude
of the health care provider. The availability of free medicines
at the health care facility and improved ability to work due to
treatment adherence also contributed towards continuity.
Other factors found to be important were fear of social
isolation, developing complications and infecting close
family members. Knowing about someone who had been
cured of TB, due to successful treatment, was also given as a
positive influence on the decision to continue treatment.
The three decision models based on the responses of
the first group of patients were then tested on a second group,
in order to find out their ability to predict the most likely
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patients in any society, which can either facilitate or delay
appropriate remedy for any disease.10
In this study the mean age of the respondents was 34.2
years (± 16.03), and most of the patients (91%) were in the
economically productive age group of 15-59 years. This
finding is comparable and consistent with those reported for
tuberculosis cases in developing countries.11,12 The low rate
of diagnosis, in-effective treatment, insufficient health
services and patients' non-adherence are the cause of high
prevalence of tuberculosis in Pakistan.3
The gender distribution of the study population shows
the predominance of males (56%) over females. This trend, as
also reported from other areas of Pakistan,13 may be due to the
fact that males have less social constraint in seeking medical
care as compared to females in Pakistani society. Most of the
respondents (60%) were illiterate and belonged to the low
socioeconomic strata. With as many as eight family members
living together, congestion is taken as an indicator of poverty.
Similar findings in other studies support that tuberculosis is
basically a disease of the poor, not only in a developing
country like Pakistan, but also in the developed world.14
Figure 2: EDM tree for decision regarding type of medical care.

option in decision-making. The second group had 26 (52%)
males and 24 (48%) females. These EDMs were able to
predict the decision to seek care in 88% respondents, decision
regarding the type of care in 83% of the patients and the
decision for the continuity of care was predicted in 89% of
respondents. Figure 3 illustrates these results.

Figure 3: Results of EDM testing in 2nd phase.

Discussion
It is important to identify the factors influencing
decisionmaking process at household level in tuberculosis
S-83

A majority of respondents 85% (n=85), suffering from
symptoms suggestive of tuberculosis, decided to seek
medical care after getting advice from close family members
usually living under the same roof (75 %, n=75). The
facilitative role of close family members in deciding to seek
care was also observed in a study done in India.15
The majority (>80%) decided to seek care because the
symptoms were severe and they also realized the seriousness
of disease. Patient's understanding about the disease was an
important factor, which influenced their decision to seek care.
Here, 85% of respondents thought it was a harmful disease if
not treated, and 75% perceived it to be dangerous to other
family members.
The choice regarding type of medical care was
influenced by recommendation from family and relatives
(68%). This factor influencing choice of a particular
healthcare provider was also noted in a Karachi-based
study.14 More than 80% of the patients had decided on
privately practicing doctors for treatment, giving reasons
such as perceived competence of the health care provider to
treat a serious disease like TB, less distance and less waiting
time at the health care facility. Reduced cost was also an
important factor in those respondents who opted to utilize a
public health care facility. Comparable findings were also
reported in an Indian study.16 Unfortunately their first contact
health provider diagnosed only 36% of the respondents,
although this is higher than what is reported elsewhere.5,16
This difference may be due to the fact that many urban
respondents were also consulting government doctors in
other hospitals at Rawalpindi. Family members of the
J Pak Med Assoc (Suppl. 1)

respondents played an important role in choosing the type of
health facility. This is similar to other studies found in
literature.3,9
Lack of treatment completion is an important problem
in tuberculosis control program in Pakistan. It is estimated
that over half of the patients taking anti-tuberculosis drugs do
not complete their treatment.3 In this study, the factors that
contribute to completion of TB treatment vary from
individual and family, to provider. Majority of respondents
(90%) said that the support and encouragement extended by
their family enabled them to complete TB treatment. Health
education and counseling to the patients and their families by
the staff of TB center was mentioned by 85% of respondents
as a positive influence in this regard. Comparable
observations were made in other studies.10,13 All of the
respondents mentioned general improvement in health as an
important reason for their decision to continue treatment,
while improved ability to work was found to be an influential
factor for 54% of respondents, particularly married women
and breadwinner of the family.
The patients' perception about seriousness and
infectivity of tuberculosis and their belief in its curability
were major contributory factors in the decision to complete
the treatment period. Fear of infecting others and developing
complications were also stated as reasons for compliance
with treatment. Knowing someone who had been cured of the
disease was also an important factor to continue the
treatment. Free treatment, including tests and regular
provision of anti-TB drugs, was also found to be a reason for
continuation of treatment in a study conducted at Services
Hospital, Lahore.18

2. Public-private collaboration is very important as
nearly 80% of the population go to private sector but can only
be effective after strengthening the public sector first. Very
few of TB patients are correctly diagnosed and properly
treated.5 Providing organized educational inputs and
guidance to the private sector health care providers, in line
with the standard TB control guidelines, can rectify this
problem.
3. The program should be more patient-friendly.
Diagnosis of TB, its treatment, and follow-up of patients till
they are cured are all, simple enough to be effectively carried
out at the level of primary health care.
4. Field-based research at community level is
recommended to explore the problems and their solutions in
order to improve program utilization.
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Conclusion
In this study the factors affecting decision-making
process were explored at three levels, vis-à-vis decision to
seek medical care, decision regarding type of health care and
decision to comply with the treatment regimen.
Family support, free and uninterrupted supply of
drugs, motivation by the health care providers and the
knowledge about tuberculosis are the factors operative at all
three levels of decision- making.

Recommendations
To strengthen the TB control, the study recommends
some interventions, both immediate, for shortterm
improvement, and long-term, for a sustainable change.
1. Correct knowledge and increased awareness about
TB among the common people can remove their
misconceptions and influence their health-seeking behavior
favorably.
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Abstract
Objective: To determine the frequency of dual infection of
Tuberculosis and Human Immunodeficiency Virus (HIV)
and document the sexual practices of infected patients.
Design: Cross-sectional study.
Place and Duration of Study: Medical Unit-IV of Civil
Hospital, Karachi, Pakistan, in collaboration with Sindh
AIDS Control Program at Services Hospital, Karachi, from
January 2003 to December 2004.
Patients and Methods: Patients were recruited in the study
at both centers and tested for both HIV and TB if any one
disease was identified. Diagnosis of TB was based on
positive sputum AFB smear / caseous granulomatous lesion
on histopathology. Diagnosis of HIV was based on positive
anti-HIV serology by LISA technique. A questionnaire was
also administered to all the study participants regarding
demographics, sexual practices, blood transfusion and
intravenous drug abuse.
Results: A total of 196 patients of HIV and TB were
screened for the presence of dual infection (TB/HIV). Dual
infection was present in 38 (19.39%) of patients. Out of 126
patients of HIV, evidence of TB was detected in 38
(30.16%). During the same duration, 70 patients of
tuberculosis were screened for HIV and none was tested
positive for HIV. History of illicit sexual relationship was
found in 121 (96.03%) patients and 5 of these were
homosexuals.
Conclusion: Dual infection was present in patients of HIV
with TB but vice versa was not documented in this study.

Introduction
Globally, tuberculosis (TB) is becoming a leading
cause of HIV-related morbidity and mortality. In developing
countries, HIV-infected people run 10% annual risk of
developing TB.1 At least one in three people with HIV are
likely to develop TB.2 HIV fuels the TB epidemic, since it
promotes progression to active TB in people with
mycobacterium tuberculosis infections, either acquired
recently or in the past.1 Increased risk of TB is present
across the entire spectrum of immunodeficiency. The
implication for TB control in high HIV prevalence
populations is that prevention of HIV is crucial to control
TB.3 HIV- related TB can occur at any stage.1 The risk of
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death in HIV infected patients with TB has been reported to
be twice that in HIV infected patients without TB
independent of the CD4 cell count.5
Pakistan has been ranked sixth by WHO in terms of
the estimated number of TB cases. The South East Asian
statistics for TB per 100,000 population reported the
incidence at 182, smear positive cases at 81, prevalence at
304 and mortality at 33.6 HIV is now increasingly being
documented in patients suffering from TB in various parts of
the world including neighboring India.7-10 Pakistan has a very
strong private health sector, particularly in the major cities,
and it is estimated that approximately 80% of TB patients,
seeking treatment, initially report to private medical
practitioners for their diagnosis and treatment.11 HIV in
Pakistan is on the rise. According to the UNAIDS report on
Global AIDS Epidemic 2006, there are 85,000 cases of
HIV/AIDS in Pakistan. Among them 84,000 are more than 15
years of age and 14,000 are adult females. The report also
states that there were 3000 deaths related to HIV/AIDS in the
year 2005.12 The prevalence of dual infection of TB/HIV is
not reported from Pakistan. The purpose of this study was to
document the frequency of dual infection of TB/HIV and
sexual behavior in infected persons.

Patients and Methods
This cross-sectional study was conducted at Medical
Unit IV, Civil Hospital, a tertiary care teaching hospital in
Karachi, Pakistan, in collaboration with Sindh AIDS Control
Program from January 2003 to December 2004. Patients were
recruited in the study at both centers. Patients presenting with
tuberculosis were enrolled at medical unit of tertiary care
teaching hospital (CHK) and allocated to group A; while
patients with HIV were enrolled at the Sindh AIDS Control
Program at Services Hospital, Karachi and allocated to groupB. Informed consent was obtained from the study participants
and counseling for HIV and TB was done before subjecting the
patients for further testing. Exclusion criteria included those
unwilling to participate and patients less than 16 years of age.
Investigations carried out in all patients included complete
blood counts (CBC), ESR, sputum for AFB smear, anti HIV-I,
anti HIV-II, chest X-ray and in selected cases ultrasound, CT
scan, MRI and biopsy with tissue histopathology, if indicated.
CBC was done on Sysmex auto-analyzer, AFB smear was
reported after Ziehl-Neelsen staining by microbiologist, tissue
histopathology by histopathologist and chest X-rays were
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reported by radiologist. HIV-antibody tests were carried out
according to WHO and national HIV testing guidelines at
referral laboratory of Sindh Aids Control Program. All samples
were initially tested for HIV-I and II on Dade Behring (EIA) kit
(WHO listed) on multiscan MS system. All reactive samples
were further tested on Organon EIA plus Abbotdetermine (ICT
method) kit as a part of protocol based on WHO guidelines. All
reactive samples were further tested on western blot assay (Gen
lab kit), which confirms HIV-I infection. All HIV positive
patients were subjected to chest Xrays and sputum for AFB
smear testing. Three morning fasting sputum specimen were
collected. Those who were not producing sputum were
nebulized with saline to get the required sample. Patients
having lymphadenopathy were subjected to fine needle
aspiration cytology/excision biopsy.

Figure 1: Frequency of TB and HIV.

A questionnaire was also administered to all the study
participants. It collected information regarding demographics,
sexual behavioral characteristics, blood transfusion and
intravenous (IV) drug abuse.
Frequency of patients positive to both TB and HIV was
estimated from the total number of patients enrolled.
Percentages were calculated for ethnic, sexual practices and
drugs. Mean ± standard deviation were calculated for age. As
no comparative analysis was done, p-values were not
calculated.

Results
A total of 196 patients of HIV and TB were screened
for the presence of dual infection of TB/HIV during the study
period. Dual infection was present in 38 (19.39%) of patients
(Figure 1).
During the study period, 126 patients of HIV were
detected at Sindh AIDS Control Program and all of them were
screened for tuberculosis. Mean age of these patients was 36.8
± 6.4 years. Ethnic distribution of these patients was Balochi 50
(39.68%), Sindhi 20 (15.87%), Urdu-speaking 25 (19.84%),
Punjabi 15 (11.90%) and Pathan 16 (17.70%, Figure 2).
Evidence of TB was detected in 38 (30.16%) patients. Eighty
seven (69.04%) patients were married.
All patients were not aware about the mode of
transmission of HIV before acquiring the disease. History of
needle sharing for drug was present in 5 (3.97%) patients.
One hundred and twenty (95.24%) had acquired the
infection out of Pakistan and all of them were working in
Gulf countries. They were deported when their HIV status
was checked at the time of renewal of visa. None of these
patients gave history of blood transfusion.
For the same duration, 70 patients of tuberculosis
presented at medical unit and were screened for HIV. None
of the patients tested positive for HIV. The mean age of
these patients was 30.6 ±11.3 years. These included 58
Vol. 59, No. 4 (Suppl. 1), April 2009

Figure 2: Ethnic distribution of HIV and TB patients.

(82.86%) males and 12 (17.14%) females. Among this
group, 56 (80%) patients were married. Ethnic segregation
in this group was 21 (30%) Urduspeaking, 17 (24.29%)
Balochi, 17 (24.29%) Sindhi, 11 (15.71%) Pathan and 4
(5.71%) Punjabi (Figure 2). Thirty nine (55.71%) were
uneducated and belonged to labor class whereas remaining
had studied from 10-12 classes.
These patients were also questioned for the risky
behaviors which were negligible. Only 3 married patients
gave history of ever having sex out of wedlock that too not
with any high risk group. There was no IV drug user in this
group of patients. Only 2 patients had history of blood
transfusion.

Discussion
While TB is highly prevalent in South East Asia
including Pakistan, it is common among HIV infected
patients also.9,13 It is responsible for one-third of all the
AIDS-related deaths in developing countries.13 The present
study showed about 30% of HIV patients found were
suffering from TB on screening. This was in comparison to
25% by Indian author and 24% in Cambodia. These studies
all support the WHO recommendations of screening HIV
patients for tuberculosis before initiation of Highly Active
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Anti-Retroviral Therapy (HART).16
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Abstract
Tuberculosis (TB) continues to be the bane of
mankind. Early diagnosis is the cornerstone of
tuberculosis control strategies. Recent years have seen
major advances in the fields of biotechnology and
molecular biology with introduction of several new
diagnostic techniques for tuberculosis and improvement
in the existing ones. The new automated culture
techniques have appreciably reduced the time required
for detection and antimicrobial susceptibility testing.
The molecular amplification techniques like the
Polymerase Chain Reaction (PCR) have made the sameday diagnosis a reality. Improvements in serology and
introduction of novel new techniques like the
bacteriophage assays have also shown a lot of promise.
However, most of these new techniques are too expensive
and sophisticated to be of any practical benefit to the
vast majority of TB patients living in underdeveloped
countries like Pakistan for whom an early and
inexpensive diagnosis remains as elusive as ever. In this
article various existing modalities as well as the new
advances in TB diagnostics are reviewed.

Introduction
Tuberculosis (TB) describes a broad range of clinical
illnesses caused by Mycobacterium tuberculosis complex.
Characteristic features include a generally prolonged
latency period between initial infection and overt disease,
predominantly pulmonary disease (80% of all cases) and a
granulomatous response with intense tissue inflammation
and necrosis.1
Man's association with tuberculosis goes back to
antiquity. Recent DNA fingerprinting of Mycobacterium
tuberculosis complex using the Restriction Fragment
Length Polymorphism (RFLP) analysis has suggested that
the common progenitor of the tubercle bacilli had evolved
around 15-20,000 years ago and was already a human
pathogen.2
Mycobacterium tuberculosis is probably the most
important human pathogen today and TB one of the
deadliest diseases known to man. According to World
Health Organization (WHO) estimates, one-third of the
world's population is infected with Mycobacterium
tuberculosis. Each year more than 8 million new cases occur
worldwide and 3 million people die from the disease.
Tuberculosis is the leading cause of death worldwide due to
any single infectious agent. Ninety-five percent of these
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cases occur in the underdeveloped world where diagnostic
and treatment facilities are rudimentary or nonexistent.3,4 In
Pakistan, its incidence is estimated to be 175 per 100,000 of
population.5
Robert Koch's famous discovery of the tubercle
bacillus in 1884 was the first step in man's fight against
tuberculosis. Soon new diagnostic techniques were being
developed and with the discovery of streptomycin in 1944
and introduction of other anti-tuberculosis drugs, it was
thought that TB would soon be conquered.6,7 However, the
emergence of multi-drug resistance and association of
tuberculosis with the Human Immune Deficiency Virus
(HIV) has led to the return of TB with a vengeance.7 By
1993, the situation had become so alarming that WHO
declared TB, a global emergency.1,3
Rapid and accurate diagnosis of symptomatic
patients is a cornerstone of global tuberculosis control
strategies. Diagnostic mycobacteriology is a complex and
technically demanding branch of clinical microbiology. The
TB clinical laboratory plays a critical role not only in the
diagnosis and management of the disease, but also in
control and elimination strategies.8 Early diagnosis, proper
treatment and effective prevention strategies are essential
for tuberculosis control.9,10 The last two decades have seen
rapid technological advances in the field of biotechnology
with the introduction of new and better techniques for the
diagnosis of various infectious diseases including TB. This
article reviews both traditional and modern methods of
diagnosing tuberculosis with a special emphasis of their
implications for our population.

Clinical Diagnosis of Tuberculosis
Traditionally, diagnosis of tuberculosis, especially in
the underdeveloped countries, has been based upon clinical
presentation and radiological findings on chest x-rays.
Clinical signs and symptoms, however, are variable and
non-specific, often being absent in early disease, and
physical findings in tuberculosis are generally not very
helpful in establishing the diagnosis.1,11
Chest x-rays have been the cornerstone of TB
diagnosis for almost a century and would continue to play
an important role in future. Although pulmonary
tuberculosis almost always shows abnormalities on the
chest x-ray,11 radiological diagnosis alone can only be
presumptive since the diagnostic criteria are non-specific.1
As clinical picture and chest x-ray pattern cannot always be
used to distinguish between TB and other pulmonary
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pathologies,12 the diagnosis can be misleading.13
Association of HIV with TB has further complicated the
issue. Both the clinical as well as radiological presentation
in such cases can be atypical or even non-existent.1,7,11
Furthermore, almost one-fourth of all TB cases are
extrapulmonary14-16 and in such cases x-rays are of limited
use while clinical presentations are protean.

Conventional Laboratory Diagnosis
Laboratory plays the definitive role in diagnosis of
TB. Conventionally, laboratory diagnosis of tuberculosis
has been based upon smear microscopy, tuberculin skin test
and culture. However, many other different diagnostic
techniques have become available in recent years. A brief
discussion of these is given below.
Microscopy: Identification of acid-fast bacilli (AFB)
on microscopy of specimen smears is the primary
laboratory tool for the diagnosis of TB. In underdeveloped
countries like Pakistan, it is often the only diagnostic test
available.8 WHO recommends this technique as the primary
laboratory diagnostic test for the underdeveloped world, as
it is cheap and simple, and would detect the most infectious
cases of TB, thus breaking the cycle of transmission.13
Advantages of the technique include low cost rapidity and
simplicity, and its high specificity. It detects the most
infectious subsets of patients and is useful in monitoring
response to treatment.8,17 However, the technique is
hampered by several drawbacks: it fails to differentiate
between dead and viable bacteria, speciation is not possible
and most importantly, its sensitivity may vary from 33% to
75%.8,10,11,17,18 The reason for this reduced sensitivity is that
a large number (at least 5 x 103 AFB/ml) of bacilli must be
present in a specimen for the smear to be positive.11,17 This
lack of sensitivity has limited the utility of the technique.
The sensitivity of the test can be increased by examining
multiple specimens10,11,19,20 and by processing the
specimens by centrifugation10,11 and liquefaction techniques
using sodium hypochlorite,21 chitin22 or N-acetyl-Lcysteine in 1% sodium hydroxide solution.11
An adequate volume of sputum must be processed to
get better results; at least 5 ml has been recommended.
Sometimes it is not possible to obtain adequate amount of
sputum, especially in children who cannot expectorate. In
such cases sputum induction can be of use in obtaining the
required amount of sputum.11
Tuberculin Skin Test: It is estimated that two
billion persons around the world have latent tuberculosis
infection and about 10% of these would develop active
disease.23,24 The tuberculin skin test is the only proven
method for identifying latent infection with M.
tuberculosis.4 Although the available tuberculin skin test
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antigens are not very sensitive and specific for detection of
infection with M. tuberculosis, no better diagnostic methods
have yet been devised.25 The tuberculin skin test is one of
the few tests developed in the 19th century that is still in
present use in clinical medicine. Robert Koch prepared the
first tuberculin test material and Von Pirquet first used it to
detect TB in 1907.26 Its design is based on the observation
by Robert Koch that infection with M. tuberculosis caused
cutaneous reactivity to tuberculin, a purified protein
derivative (PPD) of heat-killed M. tuberculosis (delayed
type hypersensitivity reaction). The tuberculin skin test is
not 100 percent sensitive for infection with M. tuberculosis.
Even among patients with proven tuberculosis without
apparent immunosuppression, 10 to 20 percent will have
negative skin reactions. Sensitization to tuberculin can also
be induced by infection with nontuberculous mycobacteria
(NTM) and BCG vaccination. It is not possible to
distinguish between a tuberculin reaction that is caused by
true infection and a reaction that is caused by BCG.27
Problems can arise with use of repeated tuberculin
tests to detect new infection in high-risk populations such as
initially tuberculin-negative contacts of active cases and
workers with occupational exposure. Tuberculin reactions
may decrease in size (reversion phenomenon) or increase in
size because of random variability from differences in
administration, reading or biologic response; immunologic
recall of preexisting delayed type hypersensitivity to
mycobacterial antigens (boosting phenomenon); or new
infection (conversion phenomenon).25-27
Tuberculin skin test results should be evaluated within
the context of each patient's epidemiological and
environmental potential of infection, individual risk factors for
tuberculosis and prevalence of tuberculosis in the facility. The
tuberculin test, like all medical tests, is subject to variability,
but many of the inherent variations in administering and
reading tests can be avoided by careful attention to details. The
preferred skin test for M. tuberculosis infection is the
intradermal, or Mantoux, method. Multiple puncture tests
(Tine and Heaf) and PPD strengths of 1 TU and 250 TU are
not sufficiently accurate and should not be used.25 In high-risk
groups (intravenous drug users, mycobacteriology lab
workers, children less than 4 years of age and populations in
high prevalence settings like Pakistan), an induration of 10
mm or more is considered as positive. However, in
immunocompromised patients including HIV positive
persons, an induration of 5 mm is considered as positive. In
persons with no known risk factors for tuberculosis, an
induration of 15 mm is taken as positive.28

Culture
A definitive diagnosis of tuberculosis is dependant
upon the isolation of Mycobacterium tuberculosis by a
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standard culture technique.4,10,11,17 In general, the sensitivity
of culture is 80-85% with a specificity of about 98%. The
increased sensitivity of the technique is due to its ability to
give a positive culture even when small numbers (10-100
AFB/ml) of bacilli are present in the specimen. Added
advantages of culture are that species identification and
drug susceptibility testing can be carried out.11
The main drawback of the culture technique is the
long time required for mycobacterial growth to occur due to
their slow doubling time of 18-24 hours.1,29 It can take upto
8 weeks for visible growth to occur on solid medium and
another 3 weeks might be required for antimicrobial
susceptibility testing, which is unacceptably a long time in
clinical practice.11 The United States Centers for Disease
Control (CDC) have recommended the identification of M.
tuberculosis cultures and the determination of first line drug
susceptibilities to be performed within 30 days.30

Haematology
Haematologic disturbances are frequently
encountered in cases of tuberculosis. However, these are
quite variable and non-specific. Although mild anaemia is
invariably present, both leucocytosis as well as leucopenia
may be encountered.1,11 Lymphocytic leukemoid reaction
has been described in miliary tuberculosis. Raised
Erythrocyte Sedimentation Rate (ESR), a non-specific
marker of chronic disorders has traditionally been used to
monitor response to treatment. Granulomas in bone marrow
are present in upto 50% of culture positive cases. Gelatinous
transformation of bone marrow has been observed in
tuberculosis. This transformation, however, is also seen in
anorexia nervosa, and chronic debilitating illnesses such as
carcinomas.31,32

Histopathology
Histological hallmark of tuberculosis is the
epithelioid granuloma in which Langhan's giant cells and
caseation necrosis may occur. AFB may be demonstrable in
tissue sections on acid-fast staining.1 However, AFB are
frequently missed or underestimated with acid-fast
microscopy on formalin-fixed, paraffin-embedded tissue.33
Furthermore, the AFB seen in biopsy material may be nontuberculous.1
Ridley and Ridley have divided patients with
tuberculosis into three histological groups. Most patients in
group 1 have chronic skin tuberculosis, the lesions have
minimal necrosis and bacilli are rarely seen. Patients in
group 2 have pulmonary disease and in the lesions show
typical caseation necrosis but AFB are usually scanty. In
group 3, patients have disseminated tuberculosis and in the
lesions exhibit neither granuloma formation nor caseation
necrosis. Instead there is extensive basophilic or
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eosinophilic necrosis with scanty nuclear debris and
numerous AFB are present in the lesions.34
Although biopsies of tuberculous tissues like the
lymph nodes can be histologically suggestive of
tuberculosis,35 a definitive diagnosis of tuberculosis cannot
be made on histopathology.1,36

Serology
Since the introduction of enzyme-linked
immunosorbent assay (ELISA) in 1972 and the availability
of monoclonal antibodies as well as purified antigens, the
serological diagnosis of tuberculosis has become more
promising. Numerous serological tests based upon various
modifications of ELISA or immunochromatographic
methods have been developed for the detection of both
antigens and antibodies.37,38
The serodiagnosis of tuberculosis has been the
subject of investigation for a long time, but we still lack a
test with widespread clinical utility. The available tests have
both a sensitivity and specificity of around 80%.8,39,40 While
evaluating an enzyme immunoassay, utilizing the genusspecific lipopolysaccharide and the species-specific 38 kDa
antigen, we found the sensitivity and specificity of the assay
to be 70% and 98% respectively.38 In HIV seropositive
patients co-infected with tuberculosis, the sensitivity of
antibody tests is much lower, between 10 and 40%.8,40 One
of the main problems encountered in serology, using ELISA
is antigenic cross-reaction, which results from epitopes that
M. tuberculosis shares with other closely related
mycobacteria in the environment. This presents major
difficulties in evaluating the antibody response in
tuberculosis, as well as complicating any attempts to
develop a specific and reactive serodiagnostic test for
tuberculosis. Other reasons for false results could be
background titres due to the presence of anti-M.
tuberculosis antibodies in persons with latent tuberculosis,
prior active TB disease, BCG vaccination, infection with
NTM, persistent bacterial products following resolution of
infection40,41 and heterotypic humoral response to TB.8,41
Incorporation of multiple antigens in a diagnostic test may
increase the sensitivity of an antibodybased test.8,38,40
Serologic tests could be useful for those patients
from whom specimens for culture are hard to obtain such as
those with extrapulmonary tuberculosis, children and
smear-negative cases.37

Miscellaneous Tests
Several different tests have been available for the
diagnosis of tuberculosis but have not found wider use
due to non-specificity and cumbersome procedures. These
include serum protein electrophoresis, which measures
the fall in serum albumin/globulin ratio that occurs in
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many acute and chronic diseases including tuberculosis42
and the adenosine deaminase (ADA) test. The enzyme
adenosine deaminase (ADA) is found in high
concentrations in cerebrospinal fluid (CSF) of patients of
tuberculous meningitis and pleural fluid of patients with
tuberculous pleural effusion. This enzyme plays a role in
the differentiation of T lymphocytes. In tuberculous
pleural fluid, the levels of ADA and CD4 cells are raised,
showing a positive correlation. ADA is considered a
marker of cell-mediated immunity in pleural fluid and
CSF. The test is not very sensitive or specific43,44 and is
no longer used.
The bromide partition test can be done for the
diagnosis of tuberculous meningitis when AFB are not
demonstrable in the CSF. Normal serum to CSF bromide
ratio is 1.6:1. Reduction in this ratio due to shifting of
bromide from serum to CSF indicates probable infection
with M. tuberculosis. Although a sensitive marker of
meningeal inflammation,43 the test is not diagnostic as such
of tuberculosis44 and is mostly obsolete. Other non-specific
markers of tuberculosis are the cytokines interleukin 1 (IL1), interleukin 2 (IL-2) and interferon gamma (IFNgamma),
which are important mediators of host response to
infections, inflammation and immunologic changes.45,46 An
in vitro assay of whole blood for cell-mediated immunity,
based on the release of IFN-gamma from T lymphocytes in
response to stimulation with M. tuberculosis PPD, has
shown excellent agreement between the tuberculin skin test
and the assay, for the identification of latent tuberculosis
infection. The test overcomes some of the shortcomings of
the Mantoux test like the need for return visits and reader
variability.47
Animal pathogenicity tests were extensively used in
the past for diagnosis of tuberculosis. These tests can be
dangerous to the laboratory staff as there is an increased risk
of infection and have been, superseded by the more
sensitive modern techniques and are rarely performed
nowadays.29

Advances in Laboratory Diagnosis of
Tuberculosis
The last two decades have been characterized by a
revolution in biotechnology especially molecular biology.
The technical advances have led to introduction of several
new diagnostic tools for tuberculosis as well as
improvement of the existing techniques.

BacT/ALERT MB Susceptibility Kit,48,49 Mycobacterial
Growth Indicator Tube (MGIT) systems with an oxygen
quenching-based fluorescent sensor50,51 and the ESP (Extra
Sensing Power) Myco-ESP Culture System II based on the
continuous monitoring of pressure changes due to the
consumption or production of gas resulting from metabolic
activity of microorganisms growing in a liquid medium.52
These are all liquid systems that allow for rapid growth
(detection of mycobacterial growth within 1-3 weeks) and
antimicrobial susceptibility testing.11 The high cost and
technical sophistication of these systems, however,
precludes their use outside reference laboratories.

Detection of Lipids
Mycobacteria contain large amounts of lipids. Each
mycobacterium species synthesizes a unique set of mycolic
acids that are components of the cell wall. Mycolic acids are
present in very specific configurations and the type of
mycolic acid can be used to distinguish different
mycobacteria.11 Various techniques can be used to identify
these mycolic acids such as gas chromatography, thin layer
chromatography (TLC) and high performance liquid
chromatography (HPLC).17 HPLC can produce a pattern
that reliably identifies and distinguishes more then 50
mycobacterial species. It can be performed in a few hours
but requires organisms from pure cultures. The initial
equipment cost for HPLC limits its availability.11,17

Molecular Techniques
One of the dramatic achievements in science during
the last decade has been the advancement in molecular
biology. The ability to detect small amounts of DNA or
RNA by amplification techniques has led to the
development and introduction of rapid and accurate
diagnostic techniques in microbiology. Nucleic acid
techniques for detection and identification of bacteria fall
into three basic groups: (1) target amplification by
polymerase chain reaction (PCR), transcription mediated
amplification, nucleic acid sequence based amplification
(NASBA), etc. (2) probe amplification using ligase chain
reaction or Q-beta replicase; and (3) signal amplification, as
in branched DNA assay.53,54

Automated Culture Techniques

Several molecular methods have been developed for
detection of mycobacteria direct from the specimens (the
direct amplification tests or DATs), species identification of
the mycobacterial isolates from culture, and drug
susceptibility testing. These methods can potentially reduce
the diagnostic time from weeks to days.54

Several new automated culture systems have been
commercially introduced in the last few years, which have
reduced the detection time significantly. These include the
radiometric BACTEC 460 TB system, the colorimetric

Several assays for detection of mycobacterial
nucleic acids by the polymerase chain reaction are now
commercially available. Polymerase chain reaction assays
have made diagnosis and specific identification of
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Mycobacterium tuberculosis possible within a day. The test
is rapid, sensitive and specific and can detect fewer than 10
organisms in clinical specimens, compared to 105 bacilli/ml
necessary for AFB smear positivity.1 Although the
specificity of a well-developed PCR can be high, the
sensitivity is significantly less than that of
culture.10,11,17,40,54 In clinical respiratory specimens that are
AFB smear positive, the sensitivity of the amplification
methods is approximately 95%, with a specificity of
98%.11,39,54 However, sensitivity for smear negative cases
has varied from 40% to 77%1 although the specificity has
remained approximately 95%. The American Thoracic
Society recommends that DATs should always be performed
in conjunction with microscopy and culture and that the
result should be interpreted alongside the clinical data.11
Another problem with the DATs is that they cannot
differentiate between dead and viable organisms.1,53 Thus,
the response to chemotherapy cannot be assessed by PCR
assays. Molecular amplification tests are also quite
expensive and technically sophisticated.10
Mycobacterial isolates have traditionally been
identified to the species level based on their reactions in a
series of phenotypic and biochemical tests. However, the
biochemical reactions of isolates of the same species may
vary from each other and from time to time. In many cases
no definitive identification is obtained. Because
biochemical testing is slow, cumbersome and may yield
ambiguous results, laboratories are increasingly using
molecular methods for species identification.55 Molecular
methods are rapid, reliable and reproducible, and even
mixed or contaminated cultures can be analyzed. Advances
in molecular biology have also made it possible to
investigate the genetic mechanisms of drug resistance in M.
tuberculosis and to develop methods for rapid detection of
mutations associated with resistance like the rpoB gene
associated with resistance to rifampicin.54
The technique of DNA fingerprinting also referred to
as Restriction Fragment Length Polymorphism (RFLP) is
being extensively used for epidemiological surveys in the
investigation of TB outbreaks, in other epidemiologic
studies to distinguish between exogenous re-infection and
reactivation, and in investigations of laboratory crosscontamination.1,10

Mycobacteriophage Assays
Bacteriophages are viruses that infect bacteria. The
first mycobacteriophage was isolated from a strain of
Mycobacterium smegmatis in 1947. Since then more than
250 mycobacteriophages have been described. Initial
interest had centred on their potential use in speciation of
mycobacteria by phage typing.56 In the last decade,
mycobacteriophages have been extensively investigated for
Vol. 59, No. 4 (Suppl. 1), April 2009

their use in diagnostic microbiology.8,13,56-58
Two new techniques have been developed for the
diagnosis of tuberculosis that utilize bacteriophage to
specifically target Mycobacterium tuberculosis complex
cells. In the Luciferase Reporter Phage technique, the fire
fly luciferase gene (FFlux) is inserted into the phage
genome, which is expressed when the phage infects the
target cells to produce a detectable photon signal.57,59 The
other much simpler technique utilizes the principle of phage
amplification and does not rely on recombinant phage or
require light detection.57,60 Recently, a bacteriophage assay,
utilizing the principle of phage amplification for detection
of viable Mycobacterium tuberculosis complex in sputum
specimens, has been introduced. The phage is used as a
reporter of cell presence and viability. The test is simple,
does not require sophisticated equipment and is relatively
inexpensive. The results are available in 48 hours. Early
evaluation studies have shown encouraging results.13,57,58,61
Another utility of the phage techniques is in
antimycobacterial drug susceptibility testing where the
same principles have been applied to detect resistance
against rifampicin62 and other anti-tuberculosis drugs.63 Our
own experience with the phage techniques has been quite
encouraging with the overall sensitivity of 81% and
specificity of 95%.61 We have also utilized the phage
technique for rapid detection of rifampicin resistance in
Mycobacterium tuberculosis direct from sputum specimens
with encouraging results (sensitivity of 87.5% and
specificity of 80%).64 The phage assays can be utilized as
potential alternatives to culture in resource-poor countries
like Pakistan which lack proper facilities for the more
definitive diagnostic tests.

Implications of Modern TB Diagnostics
An early diagnosis is the cornerstone of tuberculosis
control. However, regions with high prevalence of
tuberculosis also lack the resources to institute effective
control measures.3,10 It is estimated that three quarters of all
TB cases in Pakistan are never diagnosed.1 The diagnosis is
mostly based upon clinical suspicion or on therapeutic
response to anti-tuberculosis drugs, rather than on the basis
of culture isolation. This results in inappropriate use of antituberculosis drugs. Furthermore, compliance with treatment
remains poor. All these factors are responsible for the
development of drug-resistant tuberculosis and spread of
infection. Despite TB having been declared a national
emergency in 2001, implementation of the national TB
control programme in Pakistan has been hampered by the
underdeveloped health facilities, lack of resources and poor
management.5
Although advances in diagnostic mycobacteriology
have been, at times, spectacular, we still have not come up
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with the ideal diagnostic test for TB; one which is simple,
rapid, inexpensive and accurate. The automated culture and
molecular techniques are sensitive and have reduced the
detection time, but they are too expensive and sophisticated
for wider use in the resource-poor third world countries with
the highest burden of tuberculosis.8,17 The newly introduced
phage assays have the potential of wider utility in
underdeveloped countries like Pakistan as they are
sufficiently sensitive and specific, rapid, simple and
relatively cost-effective. Used in conjunction with smear
microscopy, they have shown excellent results.13,57,58, 61
However, they need to be further evaluated and improved
before their validity can be firmly established.
At present no single test is adequate for the diagnosis
of tuberculosis. While the advancements in TB diagnostics
are encouraging, they are unlikely to have a major impact
on the vast majority of TB patients for whom an early and
inexpensive diagnosis remains elusive. There is a dire need
for development of newer diagnostic techniques and
refinement of existing ones to cater for the particular needs
of the resource-poor third world. If the general trend in
scientific advancement is any indicator, the future looks
promising. In the meantime, we have to make the best use
of what we already have, relying on a judicious combination
of the existing laboratory tests in conjunction with x-rays
and clinical presentation for the diagnosis of TB. The
medical community must combine the best possible use of
the tools already in hand with increased awareness of the
magnitude of the problem, a high index of suspicion, early
case identification and prompt and optimum treatment.
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Abstract
Background: This study was undertaken to see whether
providing free sputum microscopy services to private
practitioners helps in case notification to the national
tuberculosis control program. The knowledge, attitudes and
practices of these practitioners regarding tuberculosis were
also evaluated.
Methods: A questionnaire was administered to all the
private practitioners practicing in a densely populated area
of Karachi. They were asked to fill tuberculosis notification
cards for the first three months and then for another three
months when an incentive in the form of free sputum
microscopy was provided to the practitioners.
Results: Although the majority of the practitioners knew
that cough, fever and weight loss are the main symptoms of
tuberculosis, less than half knew that blood in sputum, poor
appetite and chest pain could also be associated with
tuberculosis. Only 66% of the practitioners indicated
sputum microscopy as the preferred diagnostic method for
tuberculosis. Only 50% of the practitioners self treated the
patients, while the remaining half referred their patients to
specialists. Around 80% of the practitioners were aware of
the four first-line anti-tuberculosis drugs. Less than half of
the practitioners considered sputum microscopy as the most
useful follow-up investigation in a patient with pulmonary
tuberculosis. Generally, there was a poor response in case
notification by private practitioners on provision of free
sputum microscopy.
Conclusion: An overwhelming majority of the practitioners
had poor knowledge concerning the correct treatment
practices in Tuberculosis. Providing sputum free
microscopy does not significantly help in improving
tuberculosis case notification. Strategies for public-private
collaboration in tuberculosis control are needed.
Keywords: tuberculosis, private practice, sputum,
microscopy, knowledge, attitude, behaviour, Pakistan.

Introduction
Tuberculosis (TB) constitutes a major public health
problem in most developing countries of the world. The
emergence of HIV/AIDS, increased migration and the
deterioration of the health services in many countries, has
compounded the problem and caused the incidence of TB to
rise so rapidly over a few years' time that the World Health
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Organization (WHO) was compelled to declare it a global
emergency in 1993,1 the first declaration of this sort ever.
Globally Pakistan has been ranked 8th in terms of
estimated number of cases by WHO, with an incidence of
175/100,000 persons.2 Pakistan alone accounts for 44% of
total TB burden in the Eastern Mediterranean Region of the
WHO comprising 23 countries. In a country of 144 million,
approximately 1.5 million people suffer from TB indicating
a prevalence exceeding 1% of the total population while
210,000 new cases occur each year. Paradoxically, only one
in four cases of TB are ever diagnosed in the country. The
WHO Global Tuberculosis Report of 2002 mentions the
case notification rate for Pakistan was 23/100,000 in the
year 2001.2 From 2000 to 2001, both the Directly Observed
Treatment Strategy (DOTS) coverage and DOTS detection
rate for Pakistan approximately doubled. At 5.6%, however,
the DOTS detection rate is still well below the population
coverage of 24% suggesting that many patients do not have
access to DOTS even within the designated DOTS areas.2
Pakistan has a very strong private health sector
particularly in the major cities, and it is estimated that from
amongst the TB patients seeking treatment approximately
80% initially report to private practitioners (PPs) for their
diagnosis and treatment.3 Resultantly, PPs are currently
diagnosing and treating a significant proportion of TB
patients in the Karachi metropolis, which houses nearly a
third of the population of Pakistan's southern province of
Sindh. Furthermore, as yet, linkages of PPs have yet to
develop with the Provincial TB Control Program along
organized lines. The National tuberculosis control
programme (NTP) of Pakistan aims at achieving 100%
DOTS coverage by 2005, while Sindh is expected to do the
same by August 2003. It is accordingly imperative to make
DOTS more comprehensive by involving the private sector
in our efforts for Tuberculosis control.
This study was therefore undertaken to assess the
impact of free sputum microscopy services to PPs on case
notification to the National TB program and also to evaluate
their knowledge concerning the diagnostic modalities used
and the treatment regimens commonly prescribed in TB.

Material and Methods
The study was performed between May 2002 and
September 2002, in Karachi, Pakistan. The study comprised
of two stages. Prior to the start of the study, a brief analysis
J Pak Med Assoc (Suppl. 1)

of the current situation of referrals from the PPs to the
DOTS sites in Karachi was carried out to provide some
baseline data.
In stage one of the study, all the PPs practicing in a
radius of around two kilometers of a private sector hospital
providing sputum microscopy facilities and located in a
densely populated area of Karachi were identified. An
attempt was made to develop linkages with the nearest
government diagnostic and treatment center.
All private practitioners in this catchment area were
invited to attend an awareness workshop regarding TB and
its control. This program was facilitated by investigators of
the TB program which included a provincial level TB
control coordinator. At that time, all the PPs were requested
to complete a previously prepared self-administered
questionnaire related to knowledge, attitude and practices
regarding TB. All the doctors present at the workshop
completed and returned the questionnaire at that time while
those who were unable to attend the workshop were
contacted personally at their clinics and requested to fill the
questionnaires. A total of 120 PPs completed the
questionnaire. All the PPs were allopathic qualified doctors
examining TB patients in their clinics. Anonymity was
optional and confidentiality guaranteed. The questionnaire
was designed to collect information on number of suspected
TB patients seen on an average every month, the common
presenting symptoms and the diagnostic, treatment and
referral practices employed by the PPs. The workshop
impressed upon the participants the need to follow the
National Guidelines for the Treatment and Control of
Tuberculosis commonly known as 'NTP Guidelines' and the
WHO recommendations for TB control. TB notification
cards were subsequently given to PP. They were asked to fill
patient information on all suspected TB patients over a three
month period. These were collected every fortnight by a
field assistant specially hired for this purpose.
In stage two, at the end of first three months, PPs
were invited to a seminar which again emphasized the
importance of TB control and case notification. All the PPs
including those who did not participate were delivered
letters by hand informing them of free sputum microscopy
facility at the local hospital in that area. They were
requested to fill referral forms for sputum AFB. Again, these
were collected over a three month period every fortnight by
the field officer.
At the end of the study, all the PPs were sent a
questionnaire. Those who were unable to fill any referral
card were asked reasons for not doing so. All PPs were
asked to make recommendations for TB control in Pakistan.
This question was kept open-ended.
Responses to structured questions were entered and
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analyzed using Statistical Package for Social Sciences
(SPSS) (Version 10.0.1, copyright SPSS; 1989-99). All
information was coded before computer entry to retain the
confidentiality of the respondents.
Productive cough for more than three weeks with or
without symptoms of: fever, night sweats, weight loss,
hemoptysis, pleuritic chest pain and dyspnea.
On the spot specimen was taken when the patient
was identified as a pulmonary TB suspect. Subsequently, an
early morning specimen was obtained by giving the patient
a container with the requisite instructions. The third sample
was collected when the patient reported at the laboratory.

Results
On an average each of the general practitioners saw
4-5 TB patients in a month. In response to the question
about the main symptoms of TB, 94% of PPs mentioned
cough, 86% fever and 74% weight loss. 41% thought blood
in sputum was the cardinal symptom in TB, while 30% and
17% considered poor appetite and chest pain, respectively
as the same.
PPs were inquired about the duration that the main
symptoms should last before TB was suspected in a
particular patient. 76% percent felt that the duration should
be at least 2-4 weeks, whereas 30% considered it to be more
than 4 weeks while 4% felt that it should be less than 2
weeks.
Nearly 70% of the PPs were confident of diagnosing
patients themselves, whereas 23% referred their patients to
a government TB center, and 7.4% referred their cases to
specialist clinics. Regarding the possible diagnostic
modalities that they would employ prior to making a
diagnosis of pulmonary TB, 96% marked chest X-Ray, 48%
sputum microscopy, 63% tuberculin test, while 25%
thought that clinical examination itself would suffice for the
purpose. Furthermore, when asked to name the single most
important test to confirm the diagnosis of pulmonary TB,
66% opted for sputum microscopy, 22% favored chest XRay, and 4.8% mentioned tuberculin test while 5.7%
preferred PCR.
About 50% of the PPs preferred to treat patients
themselves, 23% sought the help of a government TB
center, 22% referred the patients to a private consultant,
while 6% considered it appropriate to let the patients decide
for themselves.
When asked to write the prescription for a 60kg man
recently diagnosed as smear positive TB, 83% gave the 4drug regimen of isoniazid, rifampicin, pyrazinamide and
ethambutol for the initial phase. Of these, 80% used
individual drugs while 20% gave all 4 drugs in a fixed dose
combination (FDC) regimen. Seventeen percent of
S-96

physicians gave incorrect regimens, including 2, 3 & 5-drug
regimens. The correct daily dosage for the initial phase (2
months) was 300mg isoniazid, 600 mg rifampicin, 900 to
1500 mg ethambutol and 1500 to 2000 mg pyrazinamide.
The anti-tuberculous therapy prescribed for the initial phase
(Tables 1 and 2) indicate gross errors in dosages (only over
Table 1: Distribution of the private practitioners in terms of their
dosing practices of TB medications for the initial phase.
Drug

Under
dose (%)

Correct
dose (%)

Over
dose (%)

20
6
15
10
0

76
83
52
51
60

4
11
33
39
40

Rifampicin
Isoniazid
Pyrazinamide
Ethambutol
Streptomycin

Table 2: Distribution of the private practitioners in terms of the
duration for which TB medications are given for the initial phase.
Drug

Rifampicin
Isoniazid
Pyrazinamide
Ethambutol
Streptomycin
Myrin P

Under
duration (%)

Correct
duration (%)

Over
duration (%)

1
0
0
0
20
41

50
52
61
53
80
48

49
48
39
47
0
11

50% prescribed the correct dosage of pyrazinamide and
ethambutol) and duration (only half prescribed the correct
duration of rifampicin, isoniazid and ethambutol.
For the maintenance phase, the correct regimen was
either isoniazid/thiacetazone or isoniazid/ethambutol and
isoniazid/rifampicin according to the National TB and
WHO guidelines respectively. None prescribed
thiacetazone. Only 58% prescribed the correct dosage of
ethambutol while less than 50% prescribed the correct
dosages of rifampicin, isoniazid, ethambutol and
thiacetazone. There were 11 different regimens prescribed
for the continuation phase. Only 20 (21%) prescribed the
correct regimens (Table 3).
42% of the PPs considered sputum microscopy as
the most useful follow-up test for pulmonary TB. 33%
opted for chest X-Ray, 19% preferred ESR, 5% chose liver
function tests, while 1% recommended tuberculin test.
Only 22.5% of the PPs kept a record of their TB
patients. All diagnosed cases of tuberculosis detected
through sputum microscopy or otherwise were provided
effective case management and follow-up using the DOTS
strategy.
51 out of 103 PPs filled notification cards before the
S-97

Table 3: Frequency of the different Anti tuberculous medications
prescribed during the continuation phase.
Drug name
H+I
H+I+P
H+I+P+E
H+I+E
H+I+E+Myrin-P
H+P+E
H+E
Myrin
Myrin-P
I+P+E
I+E

Number (%)
19 (20.4%)
8 (8.6%)
7 (7.5%)
20 (21.5%)
1 (1.1%)
1 (1.1%)
1 (1.1%)
2 (2.2%)
21(22.6%)
1 (1.1%)
12 (12.9%)

H= Rifampicin I=Isoniazid E=Ethambutol
P=Pyrazinamide Myrin=Isoniazid, Ethambutol, Rifampicin
Myrin -P= Isoniazid, Ethambutol, Pyrazinamide, Rifampicin

incentive of free sputum microscopy was provided while
only 35 filled referral cards for sputum AFB after the
provision of incentive. Of the 68 who did not fill the referral
card, 32 said that they were too busy. 5 were of the view that
filling of the referral card was not a good idea. 31 said that
they did not see any patient during the three month period.
At the conclusion of study, PPs were asked about
their views on how to control TB in Pakistan, 52 of 103
mentioned that sputum microscopy facility alone is not
enough for the PPs and that there should be availability of
free chest X ray as well as free blood tests for their patients.
A few demanded for monetary incentive. Eighteen
suggested conducting of frequent health education and
awareness programs for the PPs.
All diagnosed cases of tuberculosis detected through
sputum microscopy or otherwise were planned for being
provided effective case management and follow-up using
the DOTS strategy through government diagnostic and
treatment center. However, during the period of our study,
no paramedics or other government outreach workers were
available to provide DOTS at the nearby facility.

Discussion
Private sector is the first source of help for a large
number of TB patients in this part of the world. Patients go
to private health care facility because of resource shortages
in the public sector, and its inability to meet population
expectations thus far.5 Most patients go to private
practitioners because of their more convenient hours and
personalized services.6 However, the knowledge and
practices amongst these practitioners have not been found to
be satisfactory.7,8,9 Many PP in Pakistan practice after
completing 5 years of graduate training. This is different
from PPs in the west who obtain atleast three years of
postgraduate training before practicing independently. The
J Pak Med Assoc (Suppl. 1)

poor performance of private doctors, in our part, clearly
shows the inadequacy of their undergraduate as well as inpractice training.
Majority of the PPs in the study were aware that
cough, fever and weight loss were the main presenting
symptoms of TB, but less than 50% knew that blood in a
sputum, poor appetite and chest pain could also be
associated with TB.
While 70% of PPs were aware that TB needs to be
suspected if the clinical symptoms last 2-4 weeks, 30%
incorrectly thought the symptoms need to last for more than
4 weeks before the diagnosis of TB could be considered.
Such delay in diagnosis would not only result in increased
morbidity and mortality for the patients, but would also
facilitate the spread of the disease amongst the contacts.
Over dependence of PPs on chest X ray10 as the
diagnostic tool as well as for follow-up of a case with
pulmonary TB was noteworthy. Use of sputum microscopy
with or without other investigations for diagnosis for TB by
48% and as a follow-up test by only 42% highlights the
indifference of PP to public health implication of the sputum
status of TB patients. It was surprising to note that 66%
identified sputum microscopy to be the single most
important test for diagnosis of pulmonary TB when actually
only 48% recommended it. This shows that PP often do not
practice what they know is medically correct. A probable
reason for this could be that X-rays are financially more
viable to the referring doctor than the cheaper sputum
examination especially in cases where there is some
financial arrangement between the doctor and the diagnostic
center.10
In our study, 30% of the PPs were not confident
enough to diagnose TB on their own and hence preferred to
refer their patients either to government TB centers or to
private clinics. This figure indicates lack of awareness
amongst PPs who are the source of medical help for the
majority of patients.11 This high referral rate could be one of
the possible reasons for the poor control of the disease, as it
can lead to patients being lost to follow-up.
23% of the patients were being referred to a
government TB facility. The figure of 38% was reported by
a study done in Delhi, India.12 This reflects the lack of faith
PPs have in a government facility. Other reason is probably
the loss of financial benefits PPs would incur on referring
the patients to government run clinics.
In terms of treatment practices, a significant number
were either giving inappropriate dosage or lower than
WHO-NTP recommended duration of anti-tuberculosis
therapy. This is consistent with the Nepal study which
showed that about half the PPs were giving correct dosages,
whereas 69% were treating for inappropriate duration.6
Vol. 59, No. 4 (Suppl. 1), April 2009

Improper case management not only compromises patient
outcome but also exposes family members to unnecessary
risk.6 These inappropriate regimens in terms of dosage and
duration are probably the most important factor leading to a
rise in multi-drug resistant (MDR) TB in Pakistan.13 In
Karachi alone, the resistance rates for the 4 first line drugs
are 27%, 15%, 11% and 13% for isoniazid, ethambutol,
rifampicin and streptomycin respectively.13
Only 25 % PPs kept a record of their patients which
means that tracing treatment defaulters is close to
impossible. It is universally accepted that a partially treated
TB patient is worse than an untreated one as the chronic
cases are the ones who excrete MDR organisms and
increase the community burden of TB.14 It cannot be over
emphasized that essential record keeping and treatment of
defaulters are of utmost importance for the control of TB.
It has been suggested by many experts that providing
free sputum microscopy services to PPs can help increase
the TB detection and notification leading to a better TB
management.10 Based on these recommendations, free
sputum microscopy services were provided. It was
disappointing to note that only 37 out of 103 PPs returned
notification and referral cards for sputum AFB. The decline
in the number could be because doctors were expecting
monetary incentive for their participation in the study. Many
PPs remarked that incentive for free sputum microscopy
was for the patients and there was no incentive for them in
the study. Another probable reason could be the lack of faith
PPs have in the laboratory facilities.
Another very disturbing aspect was the fact that
more than 50% PPs suggested of free chest x ray facility and
other blood tests to control TB in Pakistan. This
recommendation came despite the seminar on National
guidelines for TB management at the start of the study
which had emphasized on sputum microscopy as the best
diagnostic modality for TB.
This study was one of the few ever projects carried
out in Pakistan in the context of private/public collaboration
in TB control. As the Provincial TB control Program is
engaged in currently expanding the DOTS coverage in
Sindh, a tremendous need exists for involving the huge
private sector in the major cities in TB Control efforts. It
was our hypothesis that better case notification could ensue
through provision of certain incentives to PPs leading us to
reach these patients and bring them under Provincial TB
Control Program. However, the study revealed a very
disappointing state of affairs. With the current situation, a
multifaceted approach has to be adopted to improve TB
management. The gaps in the knowledge and practices of
PPs ought to be addressed first. As national resources of
expertise, NTPs should be strengthened to advise,
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contribute and monitor undergraduate, post-graduate and
continuing medical education in TB treatment.4 A simple
booklet should be devised and distributed to PPs to provide
clear information on TB treatment and prevention.
Moreover, NTPs should help educate the public about TB,
its treatment and where to receive it. The situation warrants
better collaborative efforts between PPs and public health
services.15 These include inviting representatives of private
doctors to participate in the planning process of TB control
activities, involving them in case-finding activities within
their areas of practice, providing them with free or
subsidized but reliable laboratory services, making drugs
available for the patient referred by the private doctor to the
TB centre or supplying drugs to individual doctors on
submission of reports and records. Linkages need to be
established between DOTS and PPs. DOTS program need
to expand rapidly. Currently, only 4-5 such centers exist in
Karachi. The physicians have to be ensured that patients
will not be snatched away from them despite their
registration at the government diagnostic and treatment
centre and that the patient will continue to retain his rapport
with their PPs. It is important to provide recognition to PPs
for their services. Private clinics working on the
recommendations of National TB Guidelines could be made
satellite DOT centers. This would allow more enthusiastic
participation of the PPs. Last, the problems encountered by
the PPs should be considered at each stage.
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Performance of ICT-TB test in the detection of pulmonary and
extra-pulmonary tuberculosis
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Abstract
Background: Tuberculosis is a major public health problem of
the developing nations including Pakistan. We need a simple,
economical and non invasive test to make an early diagnosis of
T.B. in order to avoid the complications.
Methods: A study was conducted at the Dept. of Pulmonology,
PGMI LRH Peshawar & Ayub Teaching Hospital Abbottabad
with the collaboration of Deptt of Pathology KMC Peshawar
from Jan 1998 to Dec 2002. A total of 129 patients were included
in the study. Out of these 129 patients 52 were pulmonary TB
(PTB) smear positive, 30 were PTB smear negative, 30 pleural
effusion & 17 were TB lymphadenitis. The control group
consisted of 25 non TB patients and healthy subjects.
Results: Antibody was detected in 23 of 52 (44%) sputum
positive patients, 11 of 30 (36%) sputum negative PTB patients,
10 of 30 (20%) patients of TB pleural effusion and 6 of 17
(35%) patients of TB lymphadenitis. Antibody was detected in
none of the control subjects. The overall sensitivity for Pul-T.B.
Sputum positive patients was 44%, 36% for sputum Negative
Pulmonary TB, 20% for TB pleural effusion and 35% for TB
lymphadenitis. The specificity was 100%. Conclusion: ICT-TB
is a highly specific, but less sensitive aid in the diagnosis of
Pulmonology and extra Pulmonolgy TB.

Introduction

Ayub Teaching Hospital Abbottabad and LRH Peshawar with
the collaboration of Department of Pathology, Khyber Medical
College Peshawar.
A total of 129 patients were selected from the patients
who had been hospitalized in the Pulmonology unit of Lady
Reading Hospital Peshawar and Ayub Teaching Hospital
Abbottabad.
The control group consisted of 25 non TB patients or
healthy subjects who showed no evidence of TB on Chest XRay and AFB Stains.
The sera were separated and ICT was performed
according to the manufacturer's manual. Briefly 30 ml of serum
and three drops of reagent consisting of antihuman IgG coated
particles were applied to each side of the membrane, enabling
reactions to takes place between the membrance fixed antigens
and antibodies in the serum followed by antibody-antihuman
IgG complex formation produc-ing one or more pink lines with
in 15 minutes. The test was positive if the control band was
observed and one or more positive bands were seen. The
specificity and sensitivity were calculated.

Results
The percentage of patients and control subjects who
showed positive antibody response are given in Figure.

Tuberculosis (TB) still ranks as one of the major
diseases and is a leading killer of mankind.1 Currently a large
number of our population is infected with Mycobacterium
Tuberculosis and is at the risk of developing the disease.2 It is a
major public health problem in Pakistan.
The diagnosis of tuberculosis depends upon a number of
tests such as Chest X-ray, acid fast bacilli (AFB) stain and
culture of sputum. These conventional methods are not
satisfactory because sputum AFB stain is less sensitive and AFB
culture takes more than 3 weeks to produce results.3 More
sensitive and specific tests such as Polymerase Chain reaction
(PCR) are too expensive for routine laboratory diagnosis of TB.
The recently introduced serological test ICT-TB rapidly
detects antibodies in the serum of
pulmonary & extra
pulmonary TB patients. It is said to be a reliable test to make an
early diagnosis of TB.

Material and Methods
The study was conducted during the period from
January 1998 to Dec 2002 at the Department of Pulmonology,
Vol. 59, No. 4 (Suppl. 1), April 2009

Figure: Percentage of Pul & Extra Pul T.B. patients with positive antibody response
along with non T.B. patients.
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The assay detected 44% (23 of 52) of sputum
positive cases, 36% (11 of 30) of smear negative pulmonary
TB, 20% (10 of 30 patients) of TB Pleural effusion and 35%
(6 of 17) of TB Lympadenitis patients. None of the control
subjects had positive ICT-T.B. The sensitivity for smear
positive pulmonary TB was 44%. It was 36% for TB smear
negative Pulmonary TB, 20% for TB Pleural effusion &
36% for TB Lymphadenitis. Specificity was 100% as all the
control subjects showed Negative ICT. TB.

Discussion
Tuberculosis is the major public health problem in
Pakistan. An early and accurate diagnosis is necessary to
reduce the morbidity and mortality of this disease. No single
test can detect all cases of Tuberculosis. ICT-TB test is a
valuable tool to diagnose TB in addition to chest X-Ray,
sputum exam for AFB Culture & PCR.
Chang et al found the diagnostic sensitivity of ICTTB as 73% and specificity in the range of 88-4%.3 Other
studies found that tests using the 38 KDA antigen had a
sensitivity of 92% for sputum positive. 70% for sputum
negative patient and 76% for extra-pulmonary tuberculosis
while the overall specificity was 92%.4
Our study gave a specificity of 100% almost similar
to the studies conducted so far, while the sensitivity in our
study was 44% for smear positive patients, 36% for smear
negative Pulmonary T.B, 20% for TB Pleural effusion &
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35% for Tuberculous lymphadenitis. The sensitivity is low
as compared to other studies due to the reason that some
people show poor antibody production due to genetic
variations & differences in study populations.5-7

Conclusion
We conclude that ICT test is highly specific but less
sensitive test for diagnosis of tuberculosis, however in
conjunction with other diagnostic techniques, it may serve
as a valuable aid in clinical diagnosis for both Pulmonary
and extra pulmonary TB. Further larger trials are needed for
its evaluation.
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Abstract
Background: Despite the fact that Directly Observed
Treatment Strategy (DOTS) short course is cost effective
and universally recommended by WHO for effective TB
control, it is beyond the financial reach of several highly
endemic countries. This article aims at identifying barriers
in DOTS's implementation and progress in 22 high burden
countries (HBCs) from TB.
Methods: Medline abstracts, published papers and WHO
reports were retrieved, critically examined and compared
keeping standard parameters of TB control in view.
Results & Conclusion: The increasing caseload, morbidity
and mortality due to TB in high burden countries have
become a major health challenge and threat to the health
systems. The escalated burden of disease and deaths due to
TB has posed a great threat to the international security. In
the last decade little progress has been witnessed in the
implementation of WHO's recommended strategy called
DOTS in the 22 high burden countries. Afghanistan,
Pakistan, India, Brazil, Zimbabwe, S. Africa and Uganda
are some of the countries still facing challenges in the
effective introduction, implementation and expansion of
DOTS. Financial inabilities contribute greatly to the failure
of respective national TB control programs. High burden
countries are usually in the economic recession or passing
through severe socio-political turmoil that has further
reduced spending on TB control. Majority depends on the
international assistance and put little domestic efforts.
Coupled with the lack of political commitment to the issue
of TB control, authors urge high TB control Program
managers in HBCs to increase spending and pay a great deal
of commitment to the universal implementation of DOTS,
increase case detection and case management to attain their
global targets.

Introduction
Since WHO declared Tuberculosis (TB) as a global
emergency in 1993, TB eradication has become a matter of
greater concern among the national, international and local
health authorities. Contributing 85% to the total global
burden, 22 countries have been identified and labelled as
highly endemic countries by WHO.1 In this battle, WHO is
mutually struggling with the high burden countries and
giving financial and technical assistance. Countries have
launched TB control program so far but progress in achieving
Vol. 59, No. 4 (Suppl. 1), April 2009

the desired global targets of detection (70%) and cure rates
(85%) of the detected TB cases under WHO's standard
therapy is still quiescent.2 As a matter of fact only 23% of
infectious cases were detected and treated under the DOTS
strategy in 1999.3 On the contrary reports show that the
burden of new TB cases is not only linearly increased in these
countries but also the number of advance TB states, multiple
drug resistance due to poor control measures is on the speedy
march. Alone from the South-East Asian countries, the
situation is alarming in India, Indonesia, Bangladesh,
Thailand, Myanmar, Pakistan and Afghanistan where 50% of
global bulk of TB cases occur.2 In order to fortify TB control
WHO urges on countries to adopt Directly Observed
Treatment Short-course (DOTS) strategy which is highly cost
effective, ensures effective diagnosis and is considered a
corner stone for treating infectious cases in any setting.1
However many developing countries have been unable to
expand coverage as rapidly as needed. One year after the
Amsterdam Ministerial conference (2000) the recent effort of
WHO in assessing progress in TB control among the high
burden countries have revealed some valuable facts about the
major obstacles in expanding TB control care under DOTS.
According to the report DOTS coverage is profoundly slow
and further expansion is overshadowed by lack of political
back up, inadequate financial and technical resources and
managerial inefficiencies.3,4 Unless immediate action is
taken, TB will continue to elude the brightest minds and
challenge the human and economic resources of nations
around the globe. More than 15 million people will die from
tuberculosis in the next decade if countries do not fine tune
their TB control programs and pledge to implement DOTS
universally.1

Material and Methods
Using Medline search published research data
(abstracts supplemented by full articles) and WHO reports on
TB control mostly in high burden countries were retrieved
and examined independently country by country. A
significant amount of locally available data was also collected
and critically appraised. With respect to financial contribution
and DOTS implementation, each country was individually
assessed, progress measured, incapacities and shortcomings
in the TB control activities traced. Countries were compared
in terms of political commitment, domestic contribution, and
also in making efforts for an effective partnership with
national and international agencies for the sustainability of
S-102

TB interventions. Information collected was presented in
tables and graphics.

Results
Assessing Progress in Tuberculosis Control
With the exception of the Philippines, South Africa,
Thailand, and to some extent India, recent data reveal that
case detection and management under DOTS in the 22 high
burden countries has increased very little from 21% in 1998
to 23% in 1999.3 Among the same list of countries only Peru
and Vietnam have achieved WHO targets of case detection
and treatment. It is anticipated that countries including
Cambodia, Kenya, South Africa, and the United Republic of
Tanzania will reach their global targets in near future if
enough efforts are put in.5-7 Examining the data from 1999
(Table 1), one gets a clear impression that only a small
Table 1: TB Control in 22 HBCs (WHO, 1999).
Country

Zimbabwe
Cambodia
S.Africa
Kenya
Ethopia
Uganda
UR Tanzania
Afghanistan
Philippine
Nigeria
DR Congo
Indonesia
Bangladesh
Peru
Viet Nam
India
Pakistan
Myanmar
Thailand
Russian F
China
Brazil

Incidence per
100,000

% New Smear +
Cases under DOTS

562
560
495
417
373
343
340
325
314
301
301
282
241
228
189
185
177
169
141
123
103
70

55
57
68
53
22
59
51
5
20
12
53
19
28
95
80
6
2
33
40
2
32
7

HBCs= High Burden Countries from TB

fraction of new sputum smear positive cases are managed
under directly supervised therapy. Countries like Pakistan,
Afghanistan and Brazil are far away from covering even half
the number of detected cases under DOTS. In addition to the
common problem of financial insufficiency, countries in
different regions are confronted with diversifying challenges.
Low-income countries like Zimbabwe, S. Africa, and Uganda
are fighting the dual war of HIV/AIDS and TB.8 War in
Afghanistan, Vietnam, Angola and Guinea-Bissau has added
heavily to the increasing sufferings, arresting progress and
lessening the opportunities for establishing an effective
S-103

tuberculosis control.9-11,16
However the examples of Peru, UR Tanzania, Kenya,
Viet Nam, Cambodia, Uganda and China are worth
mentioning here. They attained 100% DOTS coverage (See
Table 2). This success is associated mainly to the domestic
Table 2: Population under DOTS (WHO, 1999).
Country
Russian F
Brazil
Pakistan
Zimbabwe
Afghanistan
India
Philippine
Nigeria
Thailand
DR Congo
Ethopia
Myanmar
China
S. Africa
Indonesia
Bangladesh
Viet Nam
Peru
UR Tanzania
Cambodia
Uganda
Kenya

DOTS Population Coverage
5
7
8
12
14
14
43
45
59
62
63
64
64
66
90
90
99
100
100
100
100
100

contributions by allocating reasonable amount of resources
and effective partnerships and political motivation. For
country wide DOTS expansion the contribution of private
sector is considered a crucial element.1,3,5,6,16 With the
exception of Kenya, Philippines, and Viet Nam other
countries have focused little on integrating the private sector
and NGO's in the TB control. Government collaboration
with other sectors is still a new concept, which greatly
undermines their capacities and potential to expand the
network of TB care.3-7
Kenya and China have established a well-organized
public health system with respect to other countries where TB
services are considered an integral part of the social services.
The hallmark of their success is attributed not only to the
dedicated leadership but also to adequate resource allocation,
efficient information system and decentralized TB control
system. In China TB units have been established in
approximately 80 % of the country with the treatment success
rate of about 96%.3,5 China uses three modes of TB services
with modified form of DOTS (free of cost), flexible
subsidized payments depending on the socio-economic
condition or insurance scheme of the patient and special case
management approaches in the hospitals and other
institutions. Peru has achieved 100% population coverage of
J Pak Med Assoc (Suppl. 1)

DOTS. Peru's effective governmental leadership and policy
declared TB control as a public good. Mobilizing domestic
resources and adopting a sector wide approach improved TB
control. DOTS was additionally simplified and modified to
the community needs and made accessible to majority of the
population.3,5,12-19
Affective partnership and assuring sound funding
resources have served a corner stone for the success in UR
Tanzania, India and China etc. Pakistan and Afghanistan are
among the slow progressing countries in terms of DOTS
expansion. Lack of political motivation, war induced
disruptions and apparent anomalies of the health systems in
the region have curtailed the possibility of improving TB
control activities.1,3,14 Similarly DOTS progress has been
severely bedevilled in Pakistan as well as in Afghanistan
since the economic sanctions were imposed. With respect to
the country's burden of TB cases, Table 2 illustrates DOTS
coverage explicitly low in Russian Federation, Brazil,
Pakistan, Afghanistan and Zimbabwe.3,5-7

Financial Contributions to the TB Control
Due to low spending and poor political attention TB
control programs have been widely suffered particularly in 22
highly endemic countries.3,5,6,15,17 The performance has been
very well wherever TB was the focus of attention of the
governments and private agencies.5,14 The financial estimates
of TB control for the 22 high-burden countries largely differ.
Based on WHO data, Table 3 shows the level of domestic
contribution with regard to the WHO estimated annual cost of
TB control programs.
Furthermore the report on DOTS Expansion Plan
2001 says that realistic estimates for all high burden countries
could not be made due to paucity of the credible data. More
fair cost estimations need to be done by associating the
number of patients who will get treated under DOTS if global
targets have to be met. Of particular attention are the costs of
drugs and the diagnostic supplies for the increasing number
of diagnosed and treated TB cases. In addition, budgets also
need to include spending to raise case detection and cure rates
where targets have not yet been reached.
Report indicated that US$ 674.5 million per year is
required, with existing funding totalling US$ 509 million
from governments and US$ 26.5 million from grant funds.
Still gap remains of US$ 64.5 million per year and an
additional amount of US$ 74.5 million for which the
distribution among regular budgets, loans, grants and gap is
unknown. Report expressed uncertainty on the cost estimates
for Indonesia, India, Nigeria, Bangladesh and Pakistan.
For cost estimation in these five countries it is
important to have more accurate data due to their large
contribution to the total number of tuberculosis cases in the
Vol. 59, No. 4 (Suppl. 1), April 2009

22 high-burden countries, and also due to their need to make
substantial improvements in case detection rates if targets are
to be reached. In Ethiopia, Kenya, S. Africa, Uganda and
Thailand additional funds will be required to deal with the
emerging HIV/AIDS and TB synergism and for multiple drug
resistance in China, India and Russian Federation.
Meticulous and country based estimations are required to
raise case detection and cure rates and their associated costs.3
With the exception of S. Africa, Peru, China where
governments have been putting generous regular funds,
spending in other countries was overtly low and potential
sources to fill the increasing gap of resources were lacking.
(Table 3).
Table 3: Estimated Costs Vs Governmental Contributions to TB
Control (based on WHO 1998 Case Detection Rate).
Country

Est. Annual Cost
Governmental Contribution
(Regular Budgets only)
TB Control Program in US$

S. Africa
Russian F
India
China
Peru
Viet Nam
Kenya
Brazil
UR Tanzania
Thialand
Myanmar
Uganda
Afghanistan
Zimbabwe
Cambodia
DR Congo
Indonesia
Nigeria
Bangladesh
Pakistan
Philippine
Ethopia

170
150
100
88
20
12
16
15
10
10
2
5
2
11
4
10
9
8
6
7
13
8

170
120
50
43
20
8
12
15
5
10
1
3
0
1
0
8
3
3
5
9
1

Out of 22, Peru and Thailand have no resource gap.
South Africa and Brazil are assumed to have no, or only a
small, resource gap. The cost estimates of countries like
Afghanistan, China, Ethiopia, Kenya, Myanmar, Nigeria,
Philippines, Uganda, United Republic of Tanzania and
Vietnam) depict significant deficiencies in the funds allocated
by governments.3,5,6 An interesting and important finding has
been discovered that an overwhelming amount of debt has
triggered reduction in the financial assets allocated to TB
control in all high burden countries. Countries are left with no
other choice rather than cutting their budgets on the health
development and disease prevention (Figure 1).20-22
Countries apparently are unable to fund and launch a
competent TB control efforts. External debt, in most of highly
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Figure 1: The B urden of Debt and G N P per
C apita in high burden C ountries (WH O ,1999)
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Figure: The burden of debt and GNP per capita in high
burden countries (WHO, 1999).

TB endemic poor countries exceeds their gross national
product. Similarly performance in TB control is worsened as
the level of debts increased in the past.23 Not only in these
countries a negligible proportion of the financial resources
are allocated but also TB control has suffered due to lack of
motivation and poor political impetus. National health
development in high burden countries has attained little
attention due to such fiscal inequalities.
Knowing the fact that high burden countries have
either less resources or are less willing to spend, the
international community has shown significant motivation
and interest in joining the battle against TB. Since the
Amsterdam conference leaders of G8 nations and the
European Community have increased their support in taking
drastic steps against the diseases of poverty, with prioritized
action for HIV/AIDS, malaria, and tuberculosis. In majority
of these countries, international organizations such as WHO,
World Bank and western Governments and charity
organizations are assisting in one or the other way.4,6,15

Discussion and Recommendations
The article outlined the fact that success in TB control
has been achieved wherever enough financial resources are
allocate to the DOTS and made it an essential component of
TB control program. Peru, Cambodia, Uganda, UR Tanzania,
Kenya, Vietnam, Bangladesh and China have attained the
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highest cure rates under DOTS. Governmental spending on
TB control is extremely insufficient in other high burden
countries and does not comply with the increasing demands.
With respect to the overwhelming TB cases in these countries
a minute proportion is detected and treated under DOTS.
DOTS implementation is static and prospects to achieve
targets set by WHO are poor unless adequate resources
combined with potent leadership are available. WHO report
on DOTS progress is an important milestone in categorizing
countries and identifying current challenges like TB and
HIV/AIDS synergism, drug resistance and cost estimations
for low-income countries. Gaps and barriers ahead are
enormous and demand a great deal of political motivation and
governmental support in eradicating TB. In the light of recent
report by WHO, countries need to identify their
(governmental) contribution, donor contribution, and
understand resource gaps. To meet the global TB control
targets countries like S. Africa, Zimbabwe, Indonesia,
Pakistan, Afghanistan, India and the Russian Federation need
to work aggressively to update their respective National TB
control programs and adopt country specific approach in
DOTS. Effective partnership and close incorporation of
private sector are highly crucial for sustaining and expanding
TB control activities. Countries need to build sound links of
collaboration among countries, agencies, foundations, and
nongovernmental organizations (NGOs) and prioritising
health issues of their people. To accelerate the expansion of
control measures under DOTS and to reach the targets for
global TB control by 2005 more emphasis ought to be laid on
the strict adherence of the high burden countries to the
Amsterdam Declaration (March 2000 to Stop TB).
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Abstract

high incidence of disease in this region.

The estimated incidence of tuberculosis in
Pakistan is 181 per 100,000; however, there is limited
information on Mycobacterium tuberculosis genotypes
circulating in the country. We studied 314 M.
tuberculosis clinical isolates; of these, 197 (63%) isolates
grouped into 22 different clusters, while 119 (37%) had
unique spoligotypes. Eighty-nine percent of the isolates
were pulmonary (Pul), and 11% were extrapulmonary
(E-Pul). We identified Central Asian Strain (CAS),
Beijing, T1, Latin American-Mediterranean, and East
African-Indian genogroups. Beijing strains, reportedly
the most prevalent spoligotype worldwide, constituted
6% of our strain population. The CAS1 strain
comprised 121 (39%) of the study isolates. No difference
was observed between clustered isolates from cases of
Pul and E-Pul tuberculosis. However, E-Pul isolates
included a greater number of unique spoligotypes than
Pul isolates (P _ 0.005). The overall percentage of drug
resistance was 54%, and that of MDR strains was 40%.
While CAS1 strains were not associated with drug
resistance, the relative risk of MDR was significant in
Beijing strains compared to the non-Beijing groups
(95% confidence interval, 1.2 to 8.9). The fact that the
predominant strain, CAS1, is not associated with drug
resistance is encouraging and suggests that an effective
tuberculosis control program should be able to limit the
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Globally, Pakistan ranks sixth in terms of
tuberculosis (TB) burden, with a World Health
Organization-estimated incidence rate of 181 cases per
100,000 persons or 272,000 new cases annually.32 Pakistan
shares geographical borders with four countries where TB is
endemic, i.e., Afghanistan, Iran, China, and India. In
addition, it is closely associated with other South Asian
countries where TB is highly endemic, i.e., Bangladesh, Sri
Lanka, and Nepal. Despite the high TB burden in the South
Asian region, there are currently very limited data available
pertaining to strains circulating in the country. Both
treatment and detection of TB are significant problems; it is
estimated that 4/5 TB cases in Pakistan remain untreated.7
The situation is further confounded by a lack of availability
of genotypic epidemiological tools that would allow contact
tracing and identification of transmission patterns within the
country.
The most commonly used methods of genotyping
employ the IS6110 element to fingerprint strains.24 In
addition, spacer oligotyping (spoligotyping) based on the
variation of spacers (36 to 41 bp) in the direct-repeat region
of the Mycobacterium tuberculosis chromosome has been
used with great efficiency to define predominant clades
worldwide.18 Although less discriminatory than IS6110
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typing, spoligotyping is a rapid, quick, and robust method of
genotyping M. tuberculosis and is particularly useful in the
study of South Asian M. tuberculosis strains, which
commonly have few copies of IS6110 elements.8,14
Recently, data from international spoligotyping studies have
identified a growing number of important clades or
genogroups.11,28
Beijing strains are an aggressively expanding clone
that has been identified in a number of populations across
the world.13 This family is characterized by a highly similar
multibanded IS6110 pattern and a common spoligotype
pattern with the absence of spacers 1 to 34 and the presence
of only the last nine spacers.30 It includes the M.
tuberculosis W strain associated with multidrug resistance
(MDR) in New York.1,5,15 The Beijing family is reportedly
the most prevalent spoligotype worldwide and constitutes
90 to 92% of the M. tuberculosis strains in China.25,30 High
rates of infection with Beijing strains in the countries
neighboring China suggest that this particular strain may
have radiated from Beijing to other regions. The prevalence
of Beijing strains in Southeast Asia has been reported to be
30 to 100% in different studies. A lower prevalence is
reported in South Asia and the Middle East, 8% in Delhi,27
10% from one region of Iran,10 and 31% in a study in
Dhaka.3
A second predominant cluster in the South Asian
region is the Central Asian strain 1 type (CAS1) or Delhi
type genogroup, which is characterized by the absence of
spacers 4 to 7 and 23 to 34.4 The presence of CAS1 strains
in his region is supported by recent studies of M.
tuberculosis isolates from India27 and Bangladesh.3
To date, there is very limited genotypic information
on M. tuberculosis strains circulating in Pakistan. The
World Spoligotyping Database SpolDB3.0 describes an
update on the global distribution of M. tuberculosis
complex spoligotypes but shows little information about
Pakistan.11 In this study, we have typed M. tuberculosis
isolates from specimens received at the clinical laboratory
of The Aga Khan University Hospital, Karachi, Pakistan, in
2003 and 2004 in order to detect the presence of Beijing
strains within the country. We have also investigated the
association between predominant spoligotypes and drug
resistance among our isolates.

Materials and Methods
This study was conducted with M. tuberculosis
strains isolated at the clinical laboratory of The Aga Khan
University Hospital between January 2003 and June 2004.
During this period, 2,890 samples from suspected TB cases
were cultured and 666 M. tuberculosis strains were isolated.
Only one isolate was included per patient. Samples included
in this study were from patients presenting to our laboratory
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units across the country; therefore, treatment history was
not available. Representative samples from different
geographical locations across the country were selected by
using the stratified random sampling method. Fifty percent
of the strains from each location were selected for inclusion
in the study; a total of 314 strains (only one isolate per
patient) were included. Of these, the largest proportion (135
strains [43%]) was from 14 different locations across
Karachi. A further 179 strains were from the four different
provinces of the country, i.e., 89 from the Punjab Province,
58 from the Sindh Province (excluding Karachi), 30 from
Northwest Frontier Province, and 3 from the Balouchistan
Province.
Two hundred eighty-four isolates were from
pulmonary sites, i.e., sputum (n = 269), pleural exudate
(n = 6), and bronchoalveolar lavage fluid (n = 9), while
30 isolates were from extrapulmonary sites.
Mycobacterial culture and antibiotic susceptibility.
Mycobacterial cultures were performed with both liquid and
solid media. Respiratory samples were decontaminated by
using N-acetyl-L-cysteine sodium hydroxide prior to
culture. Samples from sterile sites were processed without
decontamination.23 All specimens were concentrated by
centrifugation (3,000 g) for 30 min, and sediments were
cultured at 37°C with BACTEC 460 (Becton Dickinson
Diagnostic Instruments Systems) and Lowenstein-Jensen
medium. The growth index of inoculated BACTEC vials
was checked for 4 weeks; Lowenstein-Jensen slants were
incubated for up to 8 weeks. M. tuberculosis was identified
by the BACTEC NAP TB differentiation test (Becton
Dickinson).
Susceptibility testing was performed by the standard
agar proportion method with enriched Middlebrook 7H10
medium (BBL) at the following final drug concentrations:
rifampin, 1 µg/ml and 5 µg/ml; isoniazid, 0.2 µg/ml and 1
µg/ml; streptomycin, 2 µg/ml and 10 µg/ml; ethambutol, 5
µg/ml and 10 µg/ml.17,22,31 Pyrazinamide sensitivity was
tested with BACTEC 7H12 medium, pH 6.0, at 100 µg/ml
(BACTEC PZA test medium; Becton Dickinson) in
accordance with the manufacturer's instructions. To ensure
the selection of strains with high-level resistance for this
study, however, only resistance to the higher concentrations
was used for analysis. MDR was defined in accordance with
standard criteria of resistance to at least isoniazid and
rifampin.
DNA methods: Mycobacteria were cultured on
Middlebrook 7H10 agar. DNA extraction from
mycobacterial colonies was carried out by the
cetyltrimethylammonium bromide method.16 Spoligotyping
was carried out with a commercially available kit from
Isogen Bioscience BV, Maarssen, The Netherlands,
J Pak Med Assoc (Suppl. 1)

according to the manufacturer's instructions. Spoligotyping
based on the 43 spacers of the direct-repeat region of the M.
tuberculosis complex was carried out with primers DRa
(5’GGTTTTGGGTCTGACGAC 3’) and DRb (5’CCGAG
AGGGGACGGAAAC 3’) as originally described by
Kamerbeek et al.18
Data analysis: Spoligotyping results were analyzed
with the Bionumerics software program (BioSystematica).
Dendrograms were generated by the unweighted- pair group
method using average linkages. A cluster was defined as
two or more isolates from different patients with identical
spoligotype patterns. We defined unique spoligotypes as
those which did not cluster with any other sample in our
study. The spoligotypes were compared with the 36 most
prevalent M. tuberculosis subfamilies as identified by the
World Spoligotyping Database SpolDB3.0 of the Pasteur
Institute of Guadeloupe (www.cdc.gov/ncidod/EID
/vol8no11/02-0125-Table.htm).12 In addition, all clusters
obtained were compared with the shared types (STs) present
in
SpolDB3.0
(http://www.pasteur
guadeloupe.fr/tb/spoldb3).11 This database contains
information on the prevalence of spoligotypes in different
countries and their relative occurrence.
Pearson's chi-square test was used to determine
statistical associations between strain types and specific
parameters with SPSS software. Odds ratios were calculated
with 95% confidence intervals. A P value of < 0.05 was
considered evidence of a significant difference.

Results
Study population: The demographic information
for patients whose M. tuberculosis isolates were studied
showed that the majority of 314 M. tuberculosis isolates
were from patients in the 15- to 30-year age group, with
73.4% in the 15- to 45-year age group, compared with 24%
in the > 45-year age group. There were no differences in
terms of gender distribution. The majority (n = 284) of
isolates were from patients with pulmonary disease, of
which 92% were smear positive. The 30 remaining isolates
were from patients with extrapulmonary TB, of which
66.6% were smear positive.
Spoligotyping: All 314 isolates were spoligotyped
and analyzed (Fig. 1). A total of 197 (63%) isolates were
grouped into 22 different clusters, while 119 (37%) isolates
had unique spoligotypes. Previously, 18 different STs had
been identified as having geographic specificity to Pakistan
as listed in SpolDB3.0 (11). We compared our 22 clusters
with this list and found them to include six of the
spoligotypes attributed to Pakistan in SpolDB3.0. These six
spoligotypes included ST1 (Beijing strain), ST26 (CAS1),
ST53 (T1), ST11 (East African Indian strain 3), ST25, and
ST486 (11). Our isolates did not include ST27, ST37, ST48,
Vol. 59, No. 4 (Suppl. 1), April 2009

Figure 1: Dendrogram of Pakistani isolates (Pearson correlation). All isolates were
spoligotyped, and data were analyzed with the Bionumerics software program. A
dendrogram was calculated on the basis of the Jacquard index for pairwise analysis
of strains by the unweighted-pair group method using average linkages. The
clustering pattern of 314 isolates is illustrated. The five most predominant shared
spoligotypes, CAS1 (n _ 121), Beijing (n _ 18), T1 (n _ 7), ST357 (n _ 7), and East
African-Indian strain 3 (EAI3; n _ 5), are indicated.

ST50, ST52, ST172, ST236, ST281, ST381, ST428, ST520,
and ST794, which have previous been identified by
SpolDB3.0 as being present in Pakistan.
Six further clusters were also identified with
homology to ST357, ST288 (CAS2), ST142, ST203,
ST289, and ST127 (Table 1). Of these, only ST127 was
identified as ubiquitous while the others had all previously
been reported as rare or localized to regions of North
America, Europe, and Australia, with the exception of
ST288 (also in India and Iran) and ST357 (identified in
Iran). Clusters Pak1 to -10 were unique and not homologous
to STs within SpolDB3.0. We also compared our strains
with the 36 most common STs in SpolDB3.012 and found
one isolate homologous with ST64 or Latin AmericanMediterranean strain 6. Overall, 18 Beijing strains (ST1)
were identified, making up 6% of the isolates studied. These
strains were from different locations in Pakistan; 9 were
from the city of Karachi, 6 were from the Punjab Province,
and 3 were from the Northwest Frontier Province.
The most prevalent shared spoligotype in our
population, however, was ST26 or CAS1, also known as the
Delhi strain (27); 39% (n = 121) of the strains analyzed
belonged to this spoligotype. In addition, differing levels of
homology with CAS1 was also shown by other strains in the
study population; 13 strains showed 96% homology, 24
S-108

Table 1: Spoligotypes shared by M. tuberculosis isolates evaluated in this study.

a ST as identified in SpolDB3.0.
b Rules as defined by absence of spacers (10).
c Filled boxes represent positive hybridization while empty boxes represent absence of spacers.
d Number of isolates.

strains showed 92% ho mology, and 31 strains showed 80%
homology. The related CAS2 strain was also present. The
Table 2: Cluster distribution among pulmonary and
extrapulmonary M. tuberculosis isolates.
Spoligotype
group

No. of isolates (% of total)
Pulmonary
Extrapulmonary
111 (40)
17 (6)
56 (20)
95 (34)
279

CAS1
Beijing
Other clusters
Unique
Total

10 (28.6)
1 (2.86)
3 (8.57)
21 (60)
35

P value

0.276
0.697
0.167
0.005a

a Statistically significant difference between pulmonary and extrapulmonary M.
tuberculosis isolates (95% CI, 8.794 to 43.106).

CAS clade included a total of 174 isolates.
Analysis of agewise clustering of M. tuberculosis
spoligotypes indicated that of the 228 isolates, 145 (64.4%)
were clustered in the 15- to 45-year age group, compared
with 45 (59%) out of a total of 76 isolates that clustered in
the > 45-year age group. The difference was not significant
(odds ratio, 1.6; 95% confidence interval [95% CI], 0.953 to
2.716). Similarly, there was no association between patient
age groups and the occurrence of the CAS1 or Beijing
strain.
Pulmonary versus extrapulmonary isolates: We
analyzed the association between clustered and
nonclustered (unique) spoligotypes and the source

Table 3: Association of antimicrobial resistance with spoligotypes.
No. (%) of strains

Characteristic
Clustered spoligotypes

Sensitivity to first-line drugsb
MDR
Isoniazid resistancec

Unique

All

Beijing

CAS1

Othersa

spoligotypes

spoligotypes

6 (33)
12 (67)

57 (47)
49 (40.5)

22 (40)
19 (34.5)

60 (50)
45 (37.5)

144 (45.9)
125 (39.8)

0

10 (8.3)

12 (21.8)

8 (6.7)

30 (9.6)

Rifampin resistanceb

0

1 (0.8)

1 (1.8)

3 (2.5)

6 (1.9)

Resistance to other drugsd
Total

0
18

4 (3.3)
121

1 (1.8)
55

4 (3.3)
120

9 (2.9)
314

a Includes a total of 22 clusters.
b Rifampin, isoniazid, streptomycin, ethambutol, and pyrazinamide.
c Other than MDR.
d Resistance to one or more first-line agents other than isoniazid and/or rifampin.
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(pulmonary or extrapulmonary) of the M. tuberculosis
isolates (Table 2). There was no statistically significant
difference in the distribution of clustered spoligotypes
(CAS1, Beijing, or others) between the pulmonary and
extrapulmonary groups. However, 60% of the isolates from
extrapulmonary sources were unique, compared with 43%
of the pulmonary isolates. This difference was statistically
significant (P = 0.005; 95% CI, 8.8 to 43.1).
Drug resistance patterns: Of the 314 strains
included in this study, 45.9% were sensitive to all five of the
first-line agents tested. Among the 170 drug-resistant
isolates, 74% were MDR (Table 3). Analysis of the
association of MDR with cluster type showed that the
Beijing strains in this population were highly associated
with MDR (P = 0.017 [Pearson's chi-square test]). The
relative risk of MDR in the Beijing strains at 3.024 is
significantly higher than in the non-Beijing groups (95% CI,
1.182 to 8.872). In addition, ST Pak6 (Table 1) was also
classified as MDR.
The MDR rate in the predominant CAS1 cluster, on
the other hand, was not significantly different from that in
other circulating clustered and unique spoligotypes (P =
0.844 [Pearson's chi-square test]).

Discussion
This report presents the largest amount of
epidemiological data on M. tuberculosis isolates from
Pakistan to date. Previously, the limited data available from
this area were those based on the IS6110 restriction
fragment length polymorphism genotyping method21,26 or
were from studies of immigrant Pakistanis carried out in
Europe.19 In this region where TB is endemic, it is critical
to identify predominant strain types in order to study
transmission patterns within the country and to understand
the epidemiology of the disease in Pakistan. This is all the
more important as Pakistan is host to a very large number of
immigrant populations and migrant workers from
neighboring countries where TB is endemic (Afghanistan
and Bangladesh), and the movement of these populations
would influence strain distribution in the entire region.
We found the CAS1 or type 26 strain14 to be
predominant (39%) among the 314 isolates tested, followed
by Beijing isolates (6%). CAS1 has been also identified as
a predominant strain in Delhi27 and Mumbai, India.2
Furthermore, our results also compare well to data from
Delhi, India, where 22% of 105 isolates were of the CAS1
strain and 8% were Beijing isolates.27 Another Delhi-based
study showed that 75% of the strains belonged to the Delhi
genogroup,4 while a study carried out in Dhaka,
Bangladesh, identified Beijing strains as the most common
type in that population.3 Geographically speaking, India
provides us with the closest comparison. Additional
Vol. 59, No. 4 (Suppl. 1), April 2009

clustered spoligotypes identified in Indian studies were
ST18, ST23, ST31, ST21, ST13,4 ST26, ST54, and ST1
(27). Of these, we identified ST26 (n = 121), ST1 (n = 18),
and ST21 (n = 1) among our Pakistani isolates. The
identification of a dominant spoligotype common to India
and Bangladesh illustrates an important trend in the M.
tuberculosis infection pattern in the South Asian region.
Recent transmission of TB is indicated by the
increased incidence observed in the younger age group (15
to 45 years). However, we did not find any significant
clustering between age groups and spoligotypes in our
study. This is in contrast to other studies, which have
indicated significant clustering in younger and also in older
age groups.27 Our data further confirm that the predominant
genogroups CAS and Beijing are well established in the
region and are not a result of recent introduction.
We found CAS1 to be equally associated with drug
sensitivity or drug resistance and did not find it to be
associated with MDR TB (P = 0.844). This correlates with
a report by Singh et al.27 but does not correlate with a study
of 65 isolates from Bombay, India, reporting an association
of CAS1 with MDR.20 The difference may be attributed to
the smaller sample size in the earlier study20 and also to the
fact the study in Bombay had only included strains from one
hospital in an urban setting and was therefore likely to
include a larger proportion of resistant strains.
As our study was based on referred patients
presenting at a clinical laboratory, we were unable to
determine any epidemiological associations between
patients and strains. However, it was clear that the
predominant clusters-CAS1 and Beijing - were present in
locations dispersed throughout the country and were
therefore not associated with a recent or epidemic strain.
We found that the extrapulmonary isolates were
significantly associated with unique spoligotypes. There is
little information as to the pathogen dynamics that result in
dissemination to extrapulmonary sites in the host. A recent
study by de Viedma et al.9 suggests increased infectivity of
strains which are found at extrapulmonary locations. Given
that the predominant TB site is pulmonary and that
extrapulmonary disease may be associated with morevirulent isolates, it is not surprising to observe less genetic
variation in pulmonary compared to extrapulmonary
isolates.
In our study population, we noted a higher relative
risk of MDR among Beijing strains. Association between
Beijing strains and MDR varies worldwide; whereas such
an association is reported in studies in the United States,
Estonia, and Vietnam,6 it has not been noted in countries
such as China and Indonesia, where the representation of
the Beijing strains in the population is greater.29 However, a
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recent study in Mumbai, India, also showed a high
frequency of Beijing strains (35%) among the MDR
isolates.2
The diversity of global TB clinical isolates has been
illustrated by the major spoligotype families and patterns
identified by the World Spoligotyping Database at the
Pasteur Institute, Guadeloupe. SpolDB3.0 shows that the 24
most prevalent isolates represent 53% of the strains present
worldwide.11 We did not compare all of our strains against
SpolDB3.0. However, we ran comparisons of all of the
clusters identified in our study (Table 1) with SpolDB3.0
and also of the 36 most common spoligotypes identified by
the database. By using this methodology, in addition to the
CAS and Beijing strains, we identified the East AfricanIndian family, the T group, and the Latin AmericanMediterranean family of M. tuberculosis in our population.
In addition to the predominant groups identified, we
also were able to identify the occurrence of clusters of rare
or localized STs listed in SpolDB3.0 that have previously
been found in North America, Australia, and Europe in
addition to those found in neighboring Iran and India. While
more community-based data are required in order to
understand transmission patterns and to monitor strain
resistance, our study provides essential information about
M. tuberculosis strains circulating in Pakistan. Strain
analysis, together with virulence studies, will also help in
pinpointing isolates associated with higher morbidity and
mortality, with the aim of directing efforts to limit the
spread of those strains within the region. In addition,
knowledge of prevalent strains will help evaluate the
efficacy of commonly used TB vaccines in the region.
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Abstract

Introduction

Objective: The objective was to bring evidence about the
contribution of seasonal migration to defaulting and low
treatment success rate (TSR) in Balochistan province of
Pakistan.

Tuberculoses is endemic in Pakistan. With the
population of 152 million about 1.5 million people are
infected and Pakistan ranks sixth among the 22 high-burden
tuberculosis countries worldwide (177 per 100,000) and
death toll due to TB mounts to round 50,000 annually.1
About 75% patients fall in the earning age group 14-49
years.1 According to the World Health Organization
(WHO), Pakistan accounts for 43 percent of TB disease in
the WHO Eastern Mediterranean Region.

Methods: Directly Observed Therapy (DOTS) has been
implemented in 22 districts of Balochistan province. A
cohort study was conducted in five randomly selected
districts between October 2005 and March 2006. A total of
291 new PTB patients during the two quarters were
interviewed before summer migration by using a structured
and pre-tested interview schedule regarding their health
seeking behavior and other determinants about seasonal
migration to determine default and TSR among migrant and
non-migrant patients.
Results: The overall default rate at surveyed districts was
very low (2.4%) as compared to national level which is
17%, whereas it was 4.4% among migrant patients. It was
evident that TSR was also high which was 96% and 100%
among migrant and non-migrant patients respectively. It
shows that migration has very low impact on default and
low TSR. The main factors of low default and high TSR
were the high commitment of patients for seeking their
medical checkup as well as regularity in medication by both
migrant as well as non-migrant patients.
Conclusion: The high degree of commitment for seeking
medical checkup and regularity in medication were the two
main factors for low default rate and high TSR in the
surveyed districts.
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The Ministry of Health of Government of Pakistan
began implementing the DOTS strategy since 1995, with
Balochistan as a pilot province. Between 2000 and 2002,
DOTS coverage increased in Pakistan from 9 to 45 percent.2
In 2001, the government declared TB a national emergency
that is why DOTS is continuously expanding and overall TB
control system is steadily improving.
From 2000 to 2001, both DOTS coverage and the
DOTS detection rate for Pakistan were approximately
doubled. Comparing 1999 and 2000 cohorts the default rate
(17%) is still the highest among high burden countries
(HBCs) and a major barrier to reaching the global target of
85% cure rate and 70% case detection rate (CDR) by 2005.
In Balochistan more than 40% population always migrate
from south to north and north to south. The relationship
between migration and emergence/re-emergence of
infectious disease has long been reported.3 The National TB
Program (NTP) therefore needs to address problems of case
finding, diagnosis and treatment in migrant patients. The
S-112

present study was therefore undertaken keeping in view the
same scenario for finding out the main reasons of default in
Balochistan specially focusing on seasonal migration.

Migration due to season (Table 2) was the most
commonly reported reason for migration. This was followed
by search for job, heritage and others.

Material

Table 2: Reasons /Period of Migration.

A cohort study was conducted in five randomly
selected districts (Bolan, Khuzdar, Nushki ,Sibi and
Nasirabad) of the twenty two DOTS implemented districts
of the province of Balochistan in (2005-6) using the random
number list of Epi Info. By assuming that the least frequent
predictor of defaulting exists in 2% of non-defaulters and
10% of defaulters, therefore, the least reliable sample size
was 322 patients, at 95% confidence interval and 80% study
power. With 20% drop outs, the total sample size was
approximately 400 PTB patients. But it was only 291
positive cases during the period of two quarters.
A total of 291 new sputum smear positive pulmonary
TB patients registered during the two quarters (1st October,
2005 to 30th March, 2006) were interviewed before summer
migration by using a structured and pre-tested interview
schedule regarding (age, sex, occupation, literacy, income
level, causes and period of migration) to determine default
and TSR among migrant and non-migrant patients. To train
the field staff a training workshop was organized at each
district. The data collected by the field staff and was cross
checked with routine records maintained at center/health
facilities. Statistical analysis was performed by using the
Chi-square test for test of association between time of
migration and main reasons of migration.

Results
There were 142 (49%) males and 149 (51%) females
(Table 1). Out of these the migrant cases were 86 females

Reason of Migration

April

In Search of Job
Due to Season
Heritage
Due to Some other reasons.
Total

Month of Migration
May
June
July

10
40
06
04
60

10
16
02
01
29

07
27
04
02
40

04
32
02
02
40

Total
31
115
14
09
169

The main reasons of migration with the association
of month of migration was checked for the independence of
the two criteria at 5% level of significance, Chi-square test
was applied and it is calculated as 8.65 and compared with
the tabular value as 16.92. It is calculated that the two
criteria are dependent.
The majority of patients migrate during the month of
April and July, while the weather is hot in their basement
areas. It has been also observed during the study that 56%
of the respondents were not satisfied with the existence TB
treatment services.
Karl Pearson's Coefficient of means square
contingency is calculated as 0.2207 and lies in the
range of 0 < c < 0.866. It is evident that almost all TB
carriers migrate during summer season due to hot
weather to the area where weather is pleasant and
some of them in search of job. Most of the patients
migrate at the beginning of the hot season i-e in the
month of April.

Table 1: Comparative Analysis of Migrants & Non Migrant and Default Rate.
Districts

Sibi
Bolan
Nasirabad
Noshki
Khuzdar
Total

Total Number of Cases

Migrant Cases

Default Cases

28
108
51
25
79
291

15
70
26
16
42
169

5
0
0
1
1
07

and 83 males. The default cases among migrant female and
male were 8.45% and 3.38% respectively whereas there
were no default in non-migrant cases.
Majority of cases were from Bolan district 108
(37.1%) and most migrant cases 41.4% were also from the
same district (Table 2). Most default cases were reported
from Sibi district.
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Percentage
Default in Migrant
Default in Total Cases
33.33 %
00.00%
00.00%
6.25 %
2.00 %
4.14 %

18%
0%
0%
4%
1.26%
2.40 %

Discussion
The overall default rate at surveyed districts was
very low (2.4%) as compared to national level, which is
17%, whereas it was 4.4% among migrant patients. TSR
was evidently high, 96% and 100% among migrant and
non-migrant patients respectively. The study shows that
J Pak Med Assoc (Suppl. 1)

migration has very low impact on default and low TSR. The
low default rate is due to DOTS coverage by the NTP during
last five years and awareness, commitment of patients with
their treatment.
A pervious study from Tiruvallur district,
Tamil Nadu (India), had reported irregular and
incomplete treatment on account of migration is
likely to increase the burden of TB in the
community. 4 The main factors of low default and
high TSR in the present study were the high
commitment of patients for seeking their medical
checkup as well as regularity in medication by both
migrant as well as non-migrant patients.
Two most important sources of patients'
information about TB were their physician and hospitals.
The majority of patients (53%) reported fever followed by
coughing were the major symptom motivating the patients
to seek health care.
More than half 56% of the respondents were not
satisfied with available services at the TB service
centre and 87% of the respondent's emphasised that
there is need to improve services of TB centers. The
most important source of patient's information and
awareness were physician and hospitals staff. This
study was limited only up to five districts there similar
such studies are required in other districts of the
province.

Conclusion
It is concluded from the study that to over come the
problems of treatment, the existing services in the TB
centers should be improved. Coverage can be enhanced if
treatment facility is provided through mobile network. For
creating more awareness the electronic media may be used.
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Abstract
Objective: to study the impact of involving religious
leaders in increasing awareness of the community regarding
timely care seeking with the ultimate goal of increasing case
detection rate of tuberculosis in Balochistan.
Methods: An intervention study conducted between April
2005 and March 2006 in which baseline knowledge of
religious leaders about Tuberculosis (TB) was assessed by a
questionnaire interview followed by one day orientation and
training workshop. Trained religious leaders launched TB
Vol. 59, No. 4 (Suppl. 1), April 2009

awareness campaign by delivering speech (Surmon or
Khutbaa) in Friday weekly prayers. The impact of this
campaign was assessed by interviewing the patients
attending the TB clinics of six districts and recording of
Case Detection Rate (CDR) of 2nd, 3rd, 4th quarter of 2005
and 1st quarter 2006 in these districts.
Result: A significant increase in knowledge about TB and
its symptoms (95-100%) and about duration of cough for
TB suspects (90%) was noted among the religious leaders
after training. They conveyed the message to masses in
effective manner. 27.88 % patients attended the TB clinics
S-114

on advice of religious leaders The relation and trust of
religious leaders on TB clinics increased significantly
(100%). The CDR increased in intervention districts from 2
to 40%.
Conclusion: Awareness about TB in these religious leaders
improved and they conveyed the message to the masses.
Involving the religious leaders in raising awareness of the
community proved to have a beneficial impact on the health
seeking behavior of TB suspects, and on increasing CDR in
the community.

Introduction
Pakistan has the seventh highest TB burden globally
and account for 44% of the total TB burden in the Eastern
Mediterranean Region of the WHO (EMRO). In Pakistan
among the total population of 154.794 million., 101,562 TB
cases (all forms) were notified (incidence: 66/100,000
population).1,2
Pakistan is an Islamic state with about 98% Muslims
and 2% religious minorities including Christian, Hindu,
Parsi.8 Religion play a major role in the lives of the masses.
Balochistan is the largest (218,400 sq ms) but the least
populated province of the country with the literacy rate of
26.4%.7 It has 400 tribes, sub-tribes and clans. It has three
main language groups: Baluchi, Pushto and Brahvi, as well
as Persian, sindhi, and saraiki is also spoken in various areas
but Urdu is widely understood in all regions of the province.
Though people speak different languages, there is a
similarity in their literature, beliefs, moral order and
customs. The cementing factor is religion which provides a
base for unity and common social order.7,8
The National targets of DOTS strategy was to reach
70% Case Detection Rate (CDR) and 85% Treatment
Success Rate (TSR) by 2005.3-5
Previously Balochistan reported 28% CDR, 80%
TSR and 12% default rate. (PTP Balochistan 2005).6 In
order to raise the CDR to 70% and reduce the default rate
less than 5%, there was a need to develop innovative
interventions so that important targets set by WHO are
achieved.
Muslims are directed to offer prayers (Nama'az) five
times every day and Friday afternoon prayers (Jumma) hold
special place when in addition to the Nama'az, leader
(Ima'am) also deliver a speech (sermon or Khutba) before
the Namaaz listening which attentively is mandatory..
Accordingly, it is importnat to assess the knowledge
of their leaders, raise their awareness about the disease and
involve them in motivating the community.
In other Muslim countries like Iraq,9 Iran,10-13
Syria,14 Sudan,15 Somalia16 and Tanzania17 other social
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groups like family physicians,18 Health Care Workers and
role of Laboratory 12 were studied for their role in
awareness of TB and measure to make early diagnosis
possible to facilitate the control of TB, but no such study has
been done on the knowledge of Religious Leaders (R.L) and
their role in awareness of TB.
In view of the above, an intervention study was
designed to involve religious leaders, in raising awareness
of the community about the adequate health seeking
behavior with the ultimate goal of increasing the CDR.
Three districts of Balochistan province were selected
randomly to assess the knowledge of religious leaders about
TB. Workshops were then held to educate RL about the
importance of early case detection, proper health seeking
behavior and other aspects of TB control. This was followed
by a campaign, launched with the help of religious leaders,
to raise awareness about TB among the local population.
The impact of the intervention was evaluated by
interviewing the patients who were attending TB clinics and
CDR was compared between the intervention and control
districts.

Material and Methods
An interventional study conducted in three
randomly selected districts out of 29 districts of Balochistan
province of Pakistan, from April 2005 to March 2006.
The qualified RLs regularly who had religious
education and who were offering leading Friday weekly
prayers in three interventional districts were offered to
participate in this programme on voluntary basis. Those
consented to participate were included in this study. Three
more districts which were socially, geographically and
ethnically identical with interventional districts were
included as controls.
After base line interview by trained staff in all
intervention and control districts, the R.Ls in interventional
districts were provided one day orientation/ training
workshop about knowledge of symptoms, duration and
treatment of TB and facilities available regarding TB in
their area. The training material about TB was developed in
Urdu, the spoken language of all participants, which
included topics like history, symptoms, duration of
treatment of TB and the importance of completion of
treatment. The role of religion to help patients of TB was
described by one senior religious leader. Posters and other
relevant literature about TB published by National and
Provincial Tuberculosis control Programme was also
distributed among the participants of workshops. After
workshops a campaign was started in intervention district
by religious leaders about awareness of tuberculosis, in
which they delivered speech about TB during Friday
afternoon sermon (Khutbaa-e-Jumma).
J Pak Med Assoc (Suppl. 1)

The response of this campaign was assessed by
interviewing consented patients at seven TB clinics of six
districts. Patients were asked that who has prompted them to
come to TB clinic for treatment. The CDR was noted in all
six districts from 2nd quarter to 4th quarter of 2005 and 1st
quarter of 2006.

Results
Eighty seven religious leaders were included in this
study. Out of which, 76 (87.35%) were Muslim, 7 (8.04%)
Table 1: Response of Religious Leaders to advised
people about Tuberculosis.
Response

Before
Intervention
n=42

Yes
No
Don't Know/ No Answer

#
17
10
15

After
Intervention
n=39
#
39
0
0

%
40.48
23.81
35.71

Control
District
n=45

%
100

#
32
13
0

%
71.11
28.89
0.00

Table 2: Patients response at TB clinics, in intervention
and control districts.
Intervention District
.n=226
Response
Religious Leader
Doctor
NGOs
Others ( Relatives and friends)

#
63
76
1
86

%
27.88
33.63
0.44
38.05

%
17.82
21.78
5.45
54.95

Table 3: Number of Religious Leaders(RL) and the
rise in Case Detection Rate (CDR).
District

No of RL

Ratio in Population

Rise in CDR

8
15
16

1:29316
1:13333
1:6250

2%
20%
40%

K. Saifullah
Mastung
Nushki

Forty two R.Ls consented to participate in the
program in 3 intervention districts, only one religious leader
in Nushki district refused to participate. Total forty two RLs
in three districts and forty five RLs in three control districts
contacted and interviewed..
After the intervention, in intervention districts, these
Religious Leaders were interviewed again to assess the
knowledge and practice about awareness of TB. Three
religious leaders were excluded from the study who were
not available, as two were relieved from their duties and one
was not available who went on "Tableegh" (the religious
duty) for 4 months.

Discussion

Cont District
.n= 202
#
36
44
11
111

Hindu and 4 (4.59%) were Christian. Ethnically 47
(54.04%) were Baloch, (including Balochi and Brahvi
speaking) 27 (31.03%) Pashtoons and 13 (14.94%) other
tribes. The majority of people in Killa Saifullah
(intervention district) and Pishin (control district) speaks
Pashto, in Nushki (intervention district) and Kharan (control
district) speak Balochi and in Mastung (intervention
district) and Kalat (control district) speak Brahvi.

The religious leaders basic knowledge about TB was
based on wrong sources of information, mostly on "Unani"
non medical books, and they were also consulting non
medical ways of treatment. This situation exist in Asian
countries, in India even family physicians had many
misunderstanding about the diagnosis and treatment of TB.
After training workshops and distribution of literature about
TB, the knowledge and attitude of religious leaders
significantly changed and 92.3% religious leaders became
in contact with TB patients. In Iran such programme was
launched for the training of private sector Physicians and
emphasizing for continuation of such programmes for
control of tuberculosis.12 In Iraq, Hashem Dhafer found that
the optimal knowledge of patients about TB is 64.4%.9 In
other countries also people has false concepts about TB and

Table 4: Impact of awareness of religious leaders on case detection rate. Case notification and detection
rates in the intervention and control districts.

2nd Quarter 2005
3rd Quarter 2005
4th Quarter 2005
1st Quarter 2006

Smear +ve
Case Notification rate
Smear +ve
Case Notification rate
Smear +ve
Case Notification rate
Smear +ve
Case Notification rate

total notified ss+ve
Case notification rate*
estimated no ss +ve
CDR**

Killa Saifullah (I.D)†

Pishin (C.D)‡

Nushki (I.D)

Kharan (C.D)

Mastung (I.D)

Kalat( C.D)

75
32
17
32.8
46
19.6
39
16.6
237
101.05
211.1
112.3

61
19.5
47
15.05
28
8.97
43
13.77
179
57.33
281.0
63.7

60
60
20
20
60
60
64
64
204
204.00
90.00
226.7

23
11.6
60
32.27
47
23.71
28
14.13
158
79.72.
178.4
88.6

10
5
8
4
3
1.5
23
11.5
44
22.00
180.0
24.4

13
4.1
7
2.21
4
1.26
19
6
43
13.57
285.1
15.1

*Case Detection Rate, †Intervention District, ‡Control District, **Significant rise in CDR in intervention districts, p< 0.05.
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cultural beliefs about TB may become risk factor in spread
of disease.18 In United states Jane E. Poss found that
etiology of tuberculosis varies by cultures.19
In our study religious leaders visited and trusted
more after intervention campaign as compare to control
districts, indicates that TB awareness programme is
acceptable for religious leaders, which resulted in increase
of CDR from 2-40%. In other countries, specially in big
cities people become influenced by electronic media, in
Colombia health education campaign in media resulted in
52% rise in smear positive cases.20 In Iran and Iraq private
physicians were involved in diagnostic and preventive
programmes to control the TB.9
The role of religious leaders is becoming eminent in
Pakistan. Many social and medical programmes are
including religious leaders, like Polio eradication
programme, AIDS control programme and Population
planning because Political support, the support of health
professionals and the community are vital for success of
these programes.21

Provincial TB Control Programme Balochistan also
supported this project.
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As a result of intervention, the knowledge of
religious leaders about TB increased significantly and they
successfully conveyed the massage to their audience which
resulted in visit of 27.88% more patients to TB clinics. The
intervention resulted in increase in case detection rate from
2 to 40 % in intervention districts.
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Abstract
Objective: To determine the prevalence of HIV among
registered TB patients including Multi Drug Resistant TB
cases and also to evaluate acceptability of HIV testing
among TB patients.
Methods: A cross sectional study was conducted at five
different sites between 7th April & 7th June, 2008. The sites
included three satellite clinics of Dow University of Health
Sciences, Karachi which were Dr. Iqbal Yad Chest Clinic,
MDR Clinic and Malir Chest Clinics. DOTS Centre of
Liaquat University of Medical & Health Sciences Hospital,
Hyderabad (LUMHS) and Civil Hospital Sukkur. Informed
consent was obtained prior to collecting information. All
diagnosed TB patients registered with designated study sites
for anti TB treatment, including sputum smear +ve, sputum
smear -ve, MDR TB and extra pulmonary TB were
explained the objectives of the study and invited to
participate and those who consented were enrolled using a
take all approach. A total of 729 persons participated in the
study. All confirmed HIV positive study participants were
transported and referred to the ARV Center of Sindh AIDS
Control Programme by one of the team members for further
assessment and anti-retroviral treatment.
Results: There were 729 study participants. Four hundred
and three (55.3%) were males and 326 (44.7%) were
females. More than half (57.8%) of the subjects were
married. Mean age of the study participants was 31 years.
Average age of males was 32 and females 29 years. Five
hundred and seven (69.5%) were sputum smear + ve and
138 (18.9%) were sputum-ve while 77 (10.6%) had extra
pulmonary and seven (1%) had MDR TB. Four (<1%) study
subjects were confirmed HIV positive. Significant
association was found in confirmed HIV +ve study subjects
and risk factors for HIV transmission. Only two persons
declined to participate in the study.
Conclusion: The prevalence of HIV among TB patients in
Pakistan is still low but with evolving HIV epidemic in the
country, the HIV prevalence among TB patients is likely to
increase. Therefore screening of TB patients for HIV and
coordinated collaborative efforts of TB and AIDS control
program at national, provincial and district level are
Vol. 59, No. 4 (Suppl. 1), April 2009

desirable for proper management and control of both
diseases.

Introduction
Pakistan is currently experiencing a concentrated
HIV epidemic in the country with HIV prevalence of more
than 5% among some high risk populations.1 Recently
conducted studies by the National AIDS Control Program
under HIV/ AIDS Surveillance Project (HASP) have
documented HIV prevalence among IDUs from 5% to 31%
in different cities of Pakistan. Similarly 2% & 7% HIV
prevalence among Hijras in Larkana and MSM in Karachi
respectively has been documented.2,3
Disease burden of Tuberculosis in Pakistan is the
eighth highest in the world4 and contributes 44% of total TB
cases in the EMRO region of the WHO while estimated
incidence and prevalence of TB in Pakistan is 181/100,000
and 329/100,000 respectively.5
Data from all over the world suggests that both HIV
and TB facilitate (complement) each other.6-8 HIV infection
accelerates the progression of TB infection to active disease
and TB infection accelerates the progression of HIV to
AIDS possibly by activating dormant lymphocytes, viral
replication and increasing rate of decline of CD 4 cell
count.9,10 People with both HIV and TB infection are 30-50
times more likely to get active TB.6-8 Risk of death due to
concurrent HIV/ TB is twice that of HIV or TB alone.6-8
Patients with both TB and HIV infection are five times more
likely to die during anti TB treatment than patients who are
not HIV infected.9,10
With the growing HIV epidemic and high TB
prevalence in Pakistan there is a serious threat of TB/ HIV
co-infection with attendant high morbidity and mortality in
the country. Currently there are no data available on the
magnitude of TB/ HIV co-infection in Pakistan particularly
the prevalence of HIV in TB patients. Determining the HIV
status of TB patients is essential for optimal patient
management.11
A multi centre study was conducted in Sindh
province from April-June, 2008 to determine the prevalence
of HIV among registered patients of TB including Multi
S-118

Drug Resistant TB cases and to assess acceptability of HIV
testing among TB patients.

Methods
Study Design
This was a cross sectional study conducted at five
different sites. A total of 729 study subjects participated in
the study. The study was approved by ethical review board
of BRIDGE. Informed consent was obtained prior to
collecting information. All confirmed HIV positive study
participants were transported and referred to the ARV (Anti
Retro Viral) Center of Sindh AIDS Control Programme by
one of the team members for further assessment and antiretroviral treatment.

Study Sites

confidentiality.
Pre test HIV counseling was provided with the help
of flip charts. Those that consented for HIV testing,
provided blood samples. The blood samples were collected
by finger prick under aseptic condition and were tested on
rapid HIV testing kit Bioline SD HIV-1/2 3.0, manufactured
by Standard Diagnostics, Inc. Korea.
Those cases which were non reactive on rapid
testing were provided results with post-test counseling.
While for reactive cases on rapid test, another specimen
(5cc) of blood (venous blood) was drawn and sent to
Referral Laboratory of Sindh AIDS Control Program for
confirmation on ELISA and/or other tests according to
WHO/Government of Pakistan diagnostic criteria. The
guidelines require using three tests principle or three
different antigens. Reactive samples were further tested on
Abbott Determined ICP method, DAD Behring and
Varonistika kits.

The study was conducted at three satellite clinics of
Dow University of Health Sciences, Karachi which were
Dr. Iqbal Yad Chest Clinic, MDR Clinic and Malir Chest
Clinics. DOTS Centre of Liaquat University of Medical &
Health Sciences Hospital, Hyderabad (LUMHS) and Civil
Hospital Sukkur. Hyderabad and Sukkur are the two biggest
cities of Sindh province followed by Karachi.

All confirmed HIV cases were provided post test
counseling and were referred to ARV treatment Centre of
Sindh AIDS Control Program for treatment assessment,
while those cases which were not confirmed were provided
results with post test counseling.

Sample size calculation

Data Management & Statistical analysis

The sample size was calculated at 709. This takes
into account a presumed proportion of 0.21 % HIV among
TB subjects from a pilot study that could be detected with a
precision of ± 0.03% and 95% confidence level (two-tailed)
tests. To reduce the affect of drop outs and refusals 729
subjects were enrolled.

All questionnaires were checked for completeness,
and data was double entered using Epi data version 3.1.
Once the data were cleaned, analysis was performed using
SPSS version 13.0 qualitative variables like gender,
occupation, household income, educational status, TB
diagnosis, history of travel, blood transfusion, history of
genital ulcer, history of drug, use, history of injecting drugs
used sharing of needles/ syringes, injecting drug used of
spouse, sharing of needles/ syringes, and history of
imprisonment.

Sampling Method
All diagnosed TB patients registered with designated
study sites for anti TB treatment, including sputum smear
+ve, sputum smear -ve, MDR TB and extra pulmonary TB
were explained the objectives of the study and invited to
participate and those who consented were enrolled using a
take all approach. Case definitions developed by WHO and
National guidelines were followed to identify study
participants.

HIV screening test and HIV confirmatory tests were
reported as percentages or proportions while the significant
association between the risk factor and HIV confirmatory
tests were assessed by using Chi-square independent test or
Fisher exact where required. P-value <0.05 was considered
as significant.

Exclusion Criteria
TB patients under 16 year and those who did not
give their consent were not included in the study.

Data Collection
Structured questionnaire developed in English &
translated into Urdu (national language) was administered
after getting informed consent. The questionnaire was
administered by trained interviewers ensuring privacy and
S-119

Ethical Considerations
The study proposal was approved by Ethical Review
Committee of Bridge Consultants Foundation which is
registered with the Office of Human Research Protection,
National Institutes of Health, USA. Informed consent was
obtained from the study participants before enrolment in the
study and HIV testing confidentiality and privacy of the
study participants was maintained.
J Pak Med Assoc (Suppl. 1)

Table 2: TB Diagnosis.

Results
A total 729 study participants diagnosed with TB and
registered with TB DOTS treatment centers at five
designated study sites were included in the study. The
demographic characteristics are described in Table 1. 55.3%
Table 1: Demographic characteristics of the patients.
Characteristics

n= 729 (%)

Variables
T.B Diagnosis
Sputum Smear +ve
Sputum Smear -ve
Extra Pulmonary
MDR T.B

507 (69.5)
138 (18.9)
77 (10.6)
7 (1.0)

n= 729 (%)
Table 3: HIV Risk Factors & History of Drug Use.

Gender
Male
Female
Marital Status
Married
Unmarried
Mean Age
Average Age
Males
Females
Present Occupation
Unemployed
Overseas worker
Air crow/Sea man
Driver
Police/Military
Showbiz
Health care providers
Industrial worker
Office worker
Others
House hold monthly income
Mean income
Educational status
No formal education
Upto five years schooling (Primary)
Upto ten years schooling (Secondary)
Upto 12 years schooling (Higher Secondary)
Graduate

403 (55.3)
326 (44.7)
421 (57.8)
300 (41.2)
31
32
29
245 (33.3)
11 (1.5)
1 (0.1)
27 (3.7)
10 (1.4)
3 (0.4)
8 (1.1)
72 (9.9)
28 (3.8)
324 (44.4)
4369
381 (52.3)
175 (24.0)
124 (17.0)
30 (4.1)
19 (2.6)

(403/729) were males and 44.7% (326/729) were females.
57.8% (421/729) subjects were married. Mean age of
participants was 31 years. Average age of males was 32 and
females 29 years. 44% (324) study subjects were employed
while 33.3% (245) were unemployed. 52.3% (381) subjects
were not literate while 24.0% (175) had received education
up to five years of schooling. Average monthly income was
Rs. 4369 (US$ 58).
69.5% (507) were sputum smear + ve, 18.9% (138)
were sputum-ve, 10.6% (77) had extra pulmonary and 1%
(7) had MDR TB (table 2). 27 (4%) study subjects had
history of travel abroad including 20 (3%) who traveled
abroad with their spouse. 105 (14%) had a history of blood
transfusion or dialysis. 132 (18.1%) had history of genital
ulcer, urethral or vaginal discharge. 78 (10.7%) had a history
of sexual contact with other than wife/husband including
rape (Table 2). 56 (8%) had history of drug (narcotic) use
and 33 (5%) reported history of imprisonment (Table 3).
Vol. 59, No. 4 (Suppl. 1), April 2009

History of Travel Abroad

n= 728 (%)

Yes
27 (3.7)
708 (96.3)
No
History of Travel Abroad of Spouse
Yes
20 (2.7)
No
708 (97.3)
History of Receiving Blood Transfusion/ Dialysis
105 (14.4)
Yes
No
623 (85.6)
History of Genital Ulcer/Urethral/Vaginal Discharge
Yes
132 (18.1)
589 (80.9)
No
7 (1.0)
Don't know / No reply
History of Sex with other than wife / husband, including Rape
Yes
78 (10.7)
No
648 (89.0)
2 (0.3)
Don't know / No reply
History of Drug use (Narcotic)
56 (7.7)
Yes
No
672 (92.3)
History of Injecting Drug Use (Sharing of Needles / Syringes)
Yes
5 (0.7)
719 (98.8)
No
4 (0.5)
Don't know / No reply
History of Injecting Drug Use of Spouse (Sharing of Needles / Syringes)
Yes
10 (1.4)
No
699 (96.0)
19 (2.6)
Don't know / No reply
History of Imprisonment
33 (4.5)
Yes
695 (95.5)
No
Table 4: HIV Voluntary offer, Screening and Confirmatory tests.
Variables
Voluntary HIV Testing Offer
Accepted the offer
Declined the offer
Result of HIV Screening test
Reactive
Non - Reactive
Indeterminate
Result of HIV Confirmatory tests
HIV + ve
HIV -VE

n= 728 (%)

726 (99.7)
2 (0.3)
5 (0.7)
719 (98.8)
4 (0.5)
4 (0.5)
724 (99.5)

Seven hundred and twenty seven (99.7%) patients
accepted the voluntary HIV testing offer. Out of 729
study subjects 0.7% (5) were reactive on initial HIV
S-120

screening while 4 study subjects were confirmed HIV
positive (Table 4).

be due to proper pre test counseling of the study participants
by a trained counselor.

Significant association was found in confirmed HIV
+ve study subjects and history of blood transfusion, history
of genital ulcer, urethral/ vaginal discharge, sexual contact
with other than wife/husband and history of injecting drugs,
sharing of needles/syringes and history of imprisonment as
given in (Table 5,6).

Tuberculosis is endemic in Pakistan since its
inception and presently it is responsible for 5.1% of total
national disease burden. The total number of persons living
with tuberculosis is estimated at 1.5 million in Pakistan, a
country with a population of 161.37 million. There are 1108
TB diagnostic centers actively involved in sputum smear

Table 5: Risk factor associated with HIV and Confirmatory results.
TB Diagnosis

HIV Confirmatory Test +ve

HIV Confirmatory Test - ve

P-value

Sputum Smear + ve
Sputum Smear -ve
Extra pulmonary
MDR TB
History of Travel Abroad
Yes
No
History of Receiving Blood transfusion / Dialysis
Yes
No
History of Genital ulcer/ Urethral/Vaginal Discharge
Yes
No
Don't Know

4 (0.8)
0
0
0
HIV Confirmatory Test +ve
1 (3.7)
3 (0.4)
HIV Confirmatory Test +ve
3 (2.9)
1 (0.2)
HIV Confirmatory Test +ve
3 (2.3)
1 (0.2)
0

502 (99.2)
138 (100)
77 (100)
7 (100)
HIV Confirmatory Test - ve
26 (96.3)
698 (99.6)
HIV Confirmatory Test - ve
102 (97.1)
622 (99.8)
HIV Confirmatory Test - ve
129 (97.7)
588 (99.8)
7 9100)

0.623

0.141

0.010

0.012

Table 6: Risk factor associated with HIV, Screening and Confirmatory results
History of Sex with other than wife/husband

HIV Confirmatory Test +ve

HIV Confirmatory Test - ve

P-value

Yes
No
Don't Know
History of drug (Narcotic)
Yes
No
History of injecting drug use (sharing of needles/ syringes)
Yes
No
Don't Know
History of injecting drug use of Spouse (sharing of needles/ syringes
Yes
No
Don't Know
History of Imprisonment
Yes
No

2 (2.6)
2 (0.3)
0
HIV Confirmatory Test +ve
3 (5.4)
1 (0.1)
HIV Confirmatory Test +ve
2 (40)
2 (0.3)
0
HIV Confirmatory Test +ve
1 (10)
3 (0.4)
0
HIV Confirmatory Test +ve
3 (9.1)
1 (0.1)

76 (97.4)
646(99.7)
2 (100)
HIV Confirmatory Test - ve
53 (94.6)
671 (99.9)
HIV Confirmatory Test - ve
3 (60)
717 (99.7)
4 9100)
HIV Confirmatory Test - ve
9 (90)
696 (99.6)
19 (100)
HIV Confirmatory Test - ve
30 (90.9)
694 (99.9)

0.04

0.0001

0.0001

0.0001

0.0001

P value <0.05 is considered significant.

Discussion
The prevalence of HIV among TB patients was less
than one percent (0.5%). Although the present study has
documented a low prevalence of HIV in high risk
population of TB patients but estimated prevalence of HIV
among general population is 0.1%, which is much less than
0.5%. The TB patients who were found to be positive for
HIV had known risk factors for HIV. Only two patients
declined to be tested for HIV. This high acceptability could
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examination for Acid Fast Bacilli (AFB) and reporting to
the National Tuberculosis Program (NTP). During the first
three quarters of 2008 these centers examined 454,854
sputum samples and detected 54,704 AFB positive cases.12
Tuberculosis is quite common in HIV infected persons and
several HIV infected persons seek medical advice for
symptoms of tuberculosis. HIV infected individuals are
screened for tuberculosis in endemic countries but TB
patients are generally not offered HIV test and the infection
J Pak Med Assoc (Suppl. 1)

may go unrecognized resulting in treatment failure,
prolonged morbidity and prolonged propagation of
infection in the community.13 The studies conducted in
India, a neighboring country with similar cultural and socioeconomic characteristics has documented 0.4 to 27% of
HIV prevalence among TB patients.14 While recently, HIV
infection is evolving as a concentrated epidemic among
IDUs, MSM & HSWs.1-3 This low prevalence of HIV
among TB patients is probably because the epidemic has not
matured to the level it is in India and is still restricted among
certain high risk groups. However, in many HIV affected
countries the epidemic starts from vulnerable groups and
spreads to the general population through bridging
populations.
Treating two diseases instead of one i.e. TB and HIV
together will be very challenging in a country where the
healthcare system is fragile and several front line general
practitioners or family physicians are not trained to deal
with co-infection. To prevent such a situation it is
imperative that HIV screening be included in DOTS
program. HIV screening also requires pre and post test
counseling, provision of HIV and STI testing facility and
referral to ARV treatment centers. This study clearly calls
for inclusion of HIV/STI prevention to be included in
counseling of tuberculosis patients as an integral component
of DOTS program.
Although HIV prevalence among TB patients is low
(0.5%) but considering an evolving epidemic in the country
it is highly likely that the prevalence of HIV in TB patients
will increase with the maturation of HIV epidemic in
Pakistan. Therefore it is necessary to include risk
assessment for HIV in the DOTS protocol.
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